rfhg_70322.1

Basic information about the TSS

---

TSS ID: rfhg_70322.1 Species: human Chr: chr5		Start: 96752039 End: 96752048 Strand: +
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	dELS,CTCF-bound (EH38D3734365,EH38E2393351)
Category:	dELS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000675734.1:4 GeneID: 831 HGNC/MGI_ID: HGNC:1515 UniProt_ID: Nearer transcript ids and distances:

Gene_name: calpastatin Gene_symbol: CAST Gene_synonyms: Gene_source: HGNC:1515

TATA-Box annotation

---

Distance to TSS:	8441
Nearest PromoterID:	NR_104285
Entrez ID:	831
Nearest Unigene:	Hs.436186
Nearest Refseq:	NM_001750
Nearest Ensembl:	ENSG00000153113
Gene Name:	calpastatin
Gene Alias:	BS-17|PLACK
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	0.600000
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@CAST p2@CAST p3@CAST p4@CAST p5@CAST p6@CAST p7@CAST p8@CAST p9@CAST p10@CAST
Sample		p1@CAST	p2@CAST	p3@CAST	p4@CAST	p5@CAST	p6@CAST	p7@CAST	p8@CAST	p9@CAST	p10@CAST
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	22.99	3.12	1.17	0.39	1.17	3.51	1.56	0.78	1.75	0.39
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	23.27	3.84	1.21	0.20	1.42	5.87	0.20	1.42	1.42	0.40
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	22.18	3.28	0.96	0.39	2.12	6.17	1.35	0.58	2.51	0.77
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	20.38	2.08	1.04	1.25	1.66	4.99	1.87	0.42	1.04	0.21
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	21.60	2.02	0.90	0.22	2.02	4.50	0.45	1.12	1.80	0.22
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	20.93	2.52	0.97	0.00	2.13	3.68	1.36	1.16	1.94	1.36
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	35.51	5.01	1.31	0.87	3.70	9.59	0.44	1.09	1.74	1.09
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	41.18	3.39	2.91	0.73	1.21	8.96	0.24	1.45	1.70	1.94
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	33.13	2.99	2.35	0.64	1.28	5.77	0.00	1.07	1.07	1.07
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	26.66	3.48	3.48	0.58	4.06	8.11	1.74	1.74	1.16	0.58
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	31.13	4.04	4.45	0.00	3.23	7.68	0.40	2.02	0.81	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	25.21	4.47	4.07	1.22	4.88	4.88	0.81	0.41	3.25	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	18.21	15.47	6.13	4.84	3.06	3.22	4.35	4.03	0.81	3.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	15.04	13.38	4.81	5.56	3.16	3.31	3.31	2.41	0.75	1.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	20.64	12.51	5.93	4.39	2.85	3.51	3.73	3.07	0.00	3.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	18.86	7.80	4.53	4.28	3.02	1.01	2.77	2.77	0.50	2.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	16.60	9.61	4.59	4.80	1.53	2.84	4.37	1.75	0.22	1.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	15.19	9.70	4.22	5.06	1.27	4.22	2.11	1.27	0.42	1.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	14.40	6.40	5.33	4.80	1.60	0.00	2.67	2.13	0.00	1.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	15.35	13.39	6.02	4.96	2.11	3.16	3.91	2.11	0.75	1.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	17.11	11.76	4.95	5.75	1.47	2.67	2.81	2.54	0.53	1.74
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	15.88	11.74	5.70	3.63	1.90	2.93	2.59	2.76	1.04	1.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	15.38	13.31	5.95	4.27	1.42	2.46	3.49	1.94	0.26	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	15.05	10.19	3.64	4.85	1.70	3.40	3.40	2.18	0.73	2.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	17.03	11.09	4.90	5.16	1.55	4.13	5.93	3.61	0.26	2.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	15.83	7.60	8.55	2.85	2.22	3.80	4.43	1.58	0.32	1.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	19.23	10.99	4.40	4.40	1.10	2.20	1.65	1.65	0.00	2.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	16.03	15.32	6.60	5.19	3.77	2.83	4.48	3.30	0.71	2.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	14.21	12.92	5.33	3.23	0.97	2.42	2.58	1.78	0.97	1.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	15.56	14.66	6.51	5.61	1.27	3.08	2.71	2.35	0.54	1.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	18.00	8.58	4.61	4.19	1.05	3.14	1.47	1.05	0.63	2.51
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	17.39	9.96	6.25	4.49	1.17	1.56	3.13	1.76	0.20	1.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	17.30	9.92	4.64	5.28	1.27	0.63	3.38	2.53	0.42	2.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	20.29	11.55	7.09	6.76	1.65	2.64	4.12	2.97	0.49	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	19.45	9.16	7.29	4.11	1.68	1.68	1.87	2.99	0.19	2.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	17.05	9.58	7.47	4.98	1.53	2.11	1.34	2.49	0.57	1.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	13.49	14.92	6.34	4.70	1.43	2.25	2.86	1.43	0.20	2.04
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	11.69	10.48	5.64	4.03	1.41	2.62	3.43	2.42	0.60	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	16.21	12.42	7.83	5.13	1.89	2.70	3.24	1.35	0.27	2.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	16.08	12.96	5.28	4.80	2.16	3.60	4.08	1.68	0.96	3.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	14.35	11.06	4.23	6.59	1.88	1.88	2.82	2.12	0.71	2.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	13.76	12.00	5.86	3.95	1.46	2.64	3.51	2.34	1.02	2.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	14.55	13.50	5.69	6.54	0.84	2.11	3.37	2.11	0.84	2.74
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	16.78	15.21	6.47	4.37	2.45	2.62	2.10	2.10	0.35	1.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	20.08	16.06	8.23	5.42	2.61	3.21	3.01	2.21	0.60	2.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	20.24	17.45	5.58	7.68	1.63	2.33	1.86	3.26	0.47	2.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	15.59	14.15	7.68	5.52	0.72	1.68	2.16	2.40	0.72	2.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	14.60	12.52	8.64	6.56	0.89	2.68	2.38	2.38	0.60	2.09
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	13.40	17.00	10.05	7.66	0.24	3.11	1.91	2.15	0.72	1.91
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	14.56	16.78	10.92	4.85	1.82	3.44	2.63	2.63	0.81	2.43
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	18.86	13.12	9.84	6.15	1.84	2.46	3.07	1.64	1.23	1.43
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	15.34	14.90	8.23	6.45	1.33	1.33	2.89	2.00	0.67	2.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	97.95	125.93	41.98	41.98	13.99	0.00	0.00	13.99	27.98	13.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	17.39	10.65	8.52	2.84	1.06	2.84	2.48	3.19	1.06	1.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	11.60	12.59	7.62	4.97	1.33	1.99	0.66	1.33	0.66	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	15.10	34.40	21.81	15.10	6.71	2.52	4.19	0.84	2.52	3.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	16.99	6.89	11.48	5.51	1.38	3.21	2.30	2.76	0.46	0.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	10.70	17.50	8.10	5.19	0.97	2.27	1.30	3.57	0.65	1.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	6.74	13.81	5.46	5.46	0.00	0.96	1.61	1.61	0.64	1.28
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	13.52	15.72	6.92	7.23	1.26	2.20	1.26	1.57	0.63	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	4.23	11.28	8.46	2.82	0.71	0.00	0.71	0.00	0.00	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	5.61	10.09	9.53	3.36	0.00	0.00	1.68	1.12	1.12	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	15.13	35.83	27.86	19.90	0.80	1.59	3.98	3.18	1.59	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	7.14	12.91	12.23	5.78	0.68	0.34	2.38	0.68	1.36	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	5.20	16.90	8.45	10.40	0.00	1.95	1.62	1.30	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	5.32	12.78	6.03	7.81	0.00	0.71	1.42	0.35	0.00	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	32.33	161.64	80.82	64.66	0.00	0.00	0.00	16.16	16.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	39.49	142.15	94.77	94.77	7.90	15.79	15.79	0.00	7.90	15.79
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	11.21	16.09	11.70	9.26	0.49	0.49	1.95	0.49	0.49	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	9.92	10.41	14.88	9.92	0.50	1.98	2.98	0.00	0.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	8.44	13.14	18.76	5.63	2.35	1.41	0.47	0.94	0.00	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	9.94	12.92	18.88	14.90	0.99	1.99	0.33	0.66	0.99	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	11.75	10.52	22.27	15.47	0.31	0.93	1.55	0.93	0.00	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	12.23	14.37	21.40	13.76	0.61	1.83	1.53	0.61	0.61	0.61
Adipocyte - breast, donor1	11376-118A8	17.58	11.56	12.83	4.28	6.97	6.65	2.85	9.19	4.91	3.17
Adipocyte - breast, donor2	11327-117E4	25.19	16.84	25.19	8.50	4.65	3.37	2.09	3.85	2.09	3.53
Adipocyte - omental, donor1	11473-119C6	27.35	7.25	31.93	6.62	9.29	6.62	2.42	7.89	6.87	2.16
Adipocyte - omental, donor2	11474-119C7	16.44	15.70	9.72	2.99	21.68	7.47	2.99	5.98	2.24	3.74
Adipocyte - omental, donor3	11475-119C8	23.78	6.03	10.05	2.34	7.37	5.02	4.02	7.70	4.02	3.01
Adipocyte - perirenal, donor1	11476-119C9	15.95	3.83	14.04	3.19	13.40	3.83	5.10	8.29	6.38	1.91
Adipocyte - subcutaneous, donor1	11259-116F8	8.80	4.40	2.20	1.10	0.00	1.10	0.00	0.00	0.00	1.10
Adipocyte - subcutaneous, donor2	11336-117F4	17.61	16.26	7.68	5.87	3.61	3.16	1.81	2.71	0.90	3.61
Adipocyte - subcutaneous, donor3	11408-118E4	12.69	19.46	4.87	2.43	8.86	0.87	2.09	3.48	0.00	3.48
Adipocyte differentiation, day04, donor1	13019-139D4	30.31	35.01	8.41	8.02	6.26	9.78	2.15	5.08	0.98	7.24
Adipocyte differentiation, day04, donor2	13022-139D7	26.25	15.44	4.12	4.12	1.54	6.43	2.57	2.57	1.54	2.32
Adipocyte differentiation, day04, donor3	13025-139E1	23.14	36.52	11.43	6.41	4.74	5.85	2.23	5.02	1.95	7.81
Adipocyte differentiation, day04, donor4	13028-139E4	37.03	32.92	45.26	16.46	6.47	3.53	1.18	2.94	0.59	4.70
Adipocyte differentiation, day08, donor1	13020-139D5	58.96	40.94	11.58	5.55	8.77	13.83	0.88	5.47	1.13	8.04
Adipocyte differentiation, day08, donor2	13023-139D8	29.69	27.43	9.04	3.23	2.58	7.10	0.65	2.90	1.94	3.87
Adipocyte differentiation, day08, donor3	13026-139E2	39.99	23.99	7.46	8.00	3.73	6.40	1.07	5.33	2.13	5.87
Adipocyte differentiation, day08, donor4	13029-139E5	30.05	19.48	34.50	11.69	5.56	5.01	0.00	2.23	0.00	2.78
Adipocyte differentiation, day12, donor1	13021-139D6	47.00	11.64	8.73	3.33	3.74	6.24	1.25	1.66	0.83	2.50
Adipocyte differentiation, day12, donor2	13024-139D9	27.63	19.84	6.53	3.27	2.51	6.53	1.00	3.77	0.75	5.27
Adipocyte differentiation, day12, donor3	13027-139E3	35.34	23.89	5.56	2.29	2.95	6.22	2.95	1.64	0.98	3.60
Adipocyte differentiation, day12, donor4	13030-139E6	45.67	21.92	31.97	7.92	7.61	5.48	0.91	1.83	1.22	2.74
Alveolar Epithelial Cells, donor1	11510-119G7	8.62	9.28	1.55	1.77	1.99	2.87	1.33	0.88	0.66	0.44
Alveolar Epithelial Cells, donor2	11590-120G6	3.94	3.23	0.72	0.72	0.36	2.51	0.36	0.00	0.36	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	1.20	4.79	0.00	1.20	0.00	1.20	1.20	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	16.01	10.61	5.40	5.04	11.51	4.32	7.74	2.88	4.14	1.44
Amniotic Epithelial Cells, donor2	11613-122A2	10.04	1.67	1.67	6.69	8.37	1.67	1.67	8.37	1.67	1.67
Amniotic Epithelial Cells, donor3	11694-123A2	8.83	6.37	3.29	3.49	6.57	0.62	8.63	2.05	2.47	1.03
Anulus Pulposus Cell, donor1	11248-116E6	19.57	33.76	17.51	14.65	5.61	2.98	2.86	3.20	1.03	3.09
Anulus Pulposus Cell, donor2	11463-119B5	14.94	20.33	16.90	11.02	4.90	2.20	1.96	1.96	0.73	1.96
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	12.58	13.48	3.15	3.59	8.99	1.80	4.49	4.04	0.45	2.70
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	11.29	17.80	10.42	5.64	9.55	3.04	6.95	9.55	5.21	1.74
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	8.56	10.70	6.42	4.28	12.84	2.14	4.28	6.42	6.42	6.42
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	9.57	18.53	8.97	6.88	7.17	4.48	8.67	2.99	1.79	2.69
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	8.85	15.18	7.59	11.38	12.65	2.53	3.79	3.79	8.85	2.53
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	8.58	6.60	1.98	5.28	7.92	0.66	3.30	5.28	2.64	1.98
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	11.37	11.37	8.12	4.87	8.77	2.27	3.90	3.25	1.62	1.30
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	7.28	13.11	8.25	8.74	7.28	4.37	6.31	7.77	3.88	1.94
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	8.91	7.72	5.94	6.53	2.97	1.78	4.16	4.75	1.19	2.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	11.30	14.31	9.79	6.40	7.53	1.13	4.90	7.91	3.01	1.13
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	6.53	13.06	7.26	4.35	7.26	5.81	11.61	7.26	5.81	2.90
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	2.51	6.27	2.51	1.25	6.27	3.76	5.02	1.25	0.00	1.25
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	11.86	12.68	5.93	7.74	8.24	3.29	5.44	5.60	2.64	1.15
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	12.28	13.65	4.09	1.36	10.92	1.36	8.19	4.09	2.73	2.73
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	12.21	8.90	3.92	4.98	5.43	3.17	3.77	4.37	1.51	1.21
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	8.57	10.18	11.79	7.50	9.11	1.07	8.04	4.82	1.07	1.07
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	9.82	15.30	6.61	5.67	7.94	2.83	5.29	5.48	2.46	1.89
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	11.23	8.02	5.08	7.48	5.08	3.21	5.08	4.01	4.54	1.60
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	5.85	18.53	7.80	2.93	7.80	1.95	3.90	3.90	2.93	1.95
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	7.96	14.10	6.97	5.47	9.79	4.31	6.97	5.64	2.16	1.99
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	10.81	4.80	6.00	0.00	8.41	1.20	7.20	1.20	3.60	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	0.00	7.08	3.54	7.08	21.24	3.54	3.54	3.54	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	11.66	16.64	10.46	7.55	11.49	1.54	6.35	4.12	2.92	1.89
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	4.19	4.19	8.39	4.19	4.19	0.00	4.19	0.00	0.00	4.19
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	9.71	16.02	6.80	7.77	8.74	4.37	8.74	7.28	3.40	1.46
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	6.83	15.94	9.11	7.21	7.59	3.42	4.55	7.59	3.04	2.28
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	7.27	10.90	4.85	3.63	6.06	1.21	2.42	3.63	1.21	2.42
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	5.13	9.69	7.98	3.99	11.97	3.42	5.13	3.42	4.56	1.14
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	9.19	14.32	6.63	5.77	9.19	1.50	6.20	3.42	4.49	1.71
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	10.84	8.52	5.16	5.94	7.74	2.84	4.90	2.32	2.06	1.03
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	8.91	15.01	10.32	5.16	8.45	1.88	5.63	4.22	6.57	3.75
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	5.79	12.86	7.07	8.04	5.14	2.57	4.18	5.47	3.86	1.29
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	11.42	7.13	6.42	3.57	7.13	2.14	4.28	1.43	3.57	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	10.53	14.62	6.43	5.26	4.09	1.17	5.85	7.02	2.34	1.17
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	10.24	9.03	5.72	6.62	7.23	2.11	6.02	3.01	4.52	1.51
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	8.32	7.13	1.19	7.13	5.94	4.75	5.94	2.38	3.56	1.19
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	8.14	20.34	4.07	6.61	11.70	2.54	7.12	8.14	3.56	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	9.68	13.24	4.58	7.64	12.99	2.29	6.11	4.08	4.84	1.27
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	5.72	3.81	1.91	3.18	3.81	0.64	5.08	5.08	1.27	1.91
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	7.34	15.54	8.20	4.75	10.36	1.73	6.47	8.63	5.18	1.73
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	9.10	10.80	8.04	3.18	11.43	2.33	5.72	5.08	2.12	1.06
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	9.28	6.67	4.35	4.35	4.64	1.45	4.35	2.90	2.32	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	7.56	18.89	11.34	10.39	16.06	1.89	8.50	1.89	2.83	2.83
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	8.65	12.21	6.27	5.42	8.31	3.73	4.07	5.59	4.24	2.71
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	16.21	13.90	2.32	4.63	9.27	9.27	9.27	0.00	0.00	2.32
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	14.79	14.79	6.34	8.45	2.11	2.11	12.68	4.23	2.11	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	10.72	13.72	4.72	5.79	4.93	4.29	7.93	4.72	1.72	2.14
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	12.63	6.02	6.62	4.21	6.62	1.20	7.22	2.41	1.20	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	4.37	19.68	5.10	2.92	3.64	3.64	5.10	5.83	2.19	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	7.36	13.79	6.90	6.21	8.74	2.53	6.90	4.14	3.22	2.07
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	7.65	5.10	7.65	12.75	10.20	0.00	10.20	2.55	5.10	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	11.69	5.08	5.59	4.83	3.56	3.05	4.83	4.58	1.02	1.53
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	10.12	13.01	7.23	5.78	7.23	2.27	5.37	3.92	3.10	3.10
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	9.18	7.96	3.67	4.90	6.43	2.45	3.98	2.14	2.45	1.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	6.69	11.95	7.65	6.69	6.69	2.87	1.91	7.65	3.82	2.39
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	11.53	17.74	6.43	5.10	5.32	2.66	5.10	5.10	3.55	1.11
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	9.15	9.15	3.05	1.53	1.53	0.00	4.58	0.00	1.53	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	4.43	12.74	8.86	3.88	7.20	2.77	3.88	3.32	2.77	0.55
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	9.00	14.03	8.47	6.09	7.15	2.12	5.03	3.18	3.71	1.06
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	5.82	8.00	4.00	3.27	8.00	0.36	3.27	2.91	1.45	3.63
Astrocyte - cerebellum, donor1	11500-119F6	3.68	11.91	10.69	5.40	7.98	1.11	1.11	2.82	4.79	0.86
Astrocyte - cerebellum, donor2	11580-120F5	3.42	13.18	12.49	7.70	6.16	1.03	3.08	1.71	2.91	1.20
Astrocyte - cerebellum, donor3	11661-122F5	0.42	8.60	9.86	5.66	4.19	0.21	0.84	1.47	2.73	1.26
Astrocyte - cerebral cortex, donor1	11235-116D2	20.22	14.29	9.06	3.83	8.02	1.74	2.79	3.49	4.53	2.09
Astrocyte - cerebral cortex, donor2	11316-117D2	16.82	38.66	10.35	9.06	13.27	4.37	2.75	2.43	5.82	4.04
Astrocyte - cerebral cortex, donor3	11392-118C6	11.49	20.14	7.91	4.47	3.28	2.98	2.83	1.94	4.77	3.88
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	36.70	48.74	0.57	6.08	0.69	2.29	2.98	0.69	1.03	1.03
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	36.58	45.10	1.13	3.88	0.63	3.01	2.88	0.63	1.13	0.75
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	47.00	42.33	1.14	4.32	1.02	3.53	3.87	0.68	0.91	1.14
Basophils, donor1	12241-129G9	3.40	36.35	21.45	42.11	2.62	1.57	0.78	2.62	1.83	3.14
Basophils, donor2	12242-129H1	12.99	65.66	51.59	89.84	3.97	3.25	5.05	4.33	12.27	1.80
Basophils, donor3	12243-129H2	8.23	63.94	25.72	66.74	3.53	1.32	1.76	6.32	1.32	3.82
Bronchial Epithelial Cell, donor1	11511-119G8	4.10	6.25	5.17	4.31	16.60	1.08	6.47	4.10	7.11	0.86
Bronchial Epithelial Cell, donor2	11591-120G7	5.94	1.83	0.46	1.83	3.66	1.83	1.83	0.00	0.91	0.46
Bronchial Epithelial Cell, donor3	11672-122G7	7.17	7.17	0.00	14.35	7.17	7.17	7.17	0.00	35.87	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	18.20	6.90	0.63	3.14	14.44	4.39	10.67	0.00	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	9.36	7.07	6.24	5.20	16.22	2.29	7.69	0.42	1.25	0.83
Bronchial Epithelial Cell, donor6	11461-119B3	20.04	7.37	2.30	4.61	8.75	7.60	7.37	3.22	2.07	1.15
Bronchial Epithelial Cell, donor7	11769-123I5	19.25	9.36	7.20	3.78	22.67	5.94	14.04	3.06	7.38	1.80
Burkitt's lymphoma cell line:DAUDI	10422-106C8	0.00	9.17	0.62	1.96	4.53	0.00	9.69	2.06	0.72	0.31
Burkitt's lymphoma cell line:RAJI	10476-106I8	0.00	31.21	1.40	4.19	0.00	0.00	1.63	0.70	2.10	1.40
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	7.35	7.35	1.28	3.52	0.96	0.32	2.24	0.32	1.28	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	0.00	20.68	0.00	10.34	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	8.45	45.65	49.59	87.91	2.25	3.94	0.56	6.76	1.69	5.07
CD14+ Monocytes, donor2	11305-117B9	8.17	64.03	100.41	140.13	0.93	1.48	1.67	6.68	2.97	2.78
CD14+ Monocytes, donor3	11381-118B4	8.78	49.83	30.74	72.01	0.88	0.66	0.66	5.71	1.32	3.73
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	18.40	44.15	3.68	15.00	0.28	1.13	0.57	5.94	2.83	3.68
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	23.88	62.55	4.93	17.44	0.38	4.17	2.27	4.17	5.31	4.17
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	14.46	71.99	42.41	49.97	0.33	3.29	0.33	5.26	1.64	7.23
CD14+ monocytes - mock treated, donor1	11863-125A9	4.19	64.32	42.35	104.94	5.20	0.87	1.01	15.47	1.88	5.49
CD14+ monocytes - mock treated, donor2	11873-125C1	3.32	31.68	43.75	90.82	2.72	2.41	2.41	9.66	1.51	3.92
CD14+ monocytes - mock treated, donor3	11883-125D2	3.55	59.70	50.70	91.91	2.84	2.13	1.18	10.90	2.84	6.16
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	5.69	37.33	36.33	97.43	1.51	2.51	1.17	10.21	1.67	3.35
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	15.18	24.84	38.64	75.63	1.10	6.90	0.28	5.52	0.83	2.48
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	18.10	31.98	44.88	65.45	1.98	9.67	0.99	7.44	0.99	2.48
CD14+ monocytes - treated with BCG, donor1	11860-125A6	4.11	26.63	24.28	71.86	0.39	1.57	0.20	9.99	2.15	3.33
CD14+ monocytes - treated with BCG, donor2	11870-125B7	4.27	30.27	32.40	88.67	0.71	0.89	0.53	10.33	1.60	3.38
CD14+ monocytes - treated with BCG, donor3	11880-125C8	7.40	31.56	39.61	66.81	1.31	2.61	1.09	10.23	1.31	3.92
CD14+ monocytes - treated with Candida, donor1	11868-125B5	20.60	35.35	37.93	90.37	1.40	10.77	0.47	9.37	0.94	3.28
CD14+ monocytes - treated with Candida, donor2	11878-125C6	25.35	38.02	47.52	136.76	2.64	11.09	0.53	14.26	2.11	1.58
CD14+ monocytes - treated with Candida, donor3	11888-125D7	22.19	19.97	37.72	77.66	3.33	5.55	0.00	9.98	2.22	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	5.95	38.23	30.94	97.28	1.78	2.23	1.78	13.09	1.34	4.02
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	8.78	27.74	28.93	69.04	1.60	5.19	0.80	7.38	2.20	3.59
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	8.12	28.52	34.77	55.59	2.91	2.50	1.46	4.58	2.08	1.87
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	13.04	44.38	41.41	95.40	2.52	3.89	0.69	11.21	2.06	4.35
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	12.22	30.09	32.12	77.81	2.26	9.73	1.13	8.37	0.90	2.49
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	12.22	30.55	39.72	58.49	1.75	5.24	0.87	5.67	2.18	3.93
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	3.77	36.58	22.33	86.61	1.88	1.08	0.81	11.03	2.15	4.84
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	5.41	44.49	32.28	110.96	2.79	1.57	1.40	10.12	2.62	5.23
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	6.31	49.24	33.24	81.64	0.42	2.10	1.26	10.52	4.63	3.37
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	5.88	36.56	31.78	80.47	4.41	2.57	0.55	7.72	1.65	2.20
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	10.22	27.48	34.17	72.21	1.06	2.11	0.35	8.10	1.76	1.76
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	3.07	37.73	29.83	59.23	0.88	3.07	0.44	4.39	1.32	1.75
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	8.89	38.01	23.71	79.17	1.05	2.79	0.52	9.07	1.39	4.01
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	13.01	34.94	35.31	89.57	0.74	3.35	0.74	9.66	0.37	3.72
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	17.46	40.09	38.58	72.21	1.72	5.39	1.08	7.76	1.51	3.02
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	19.66	34.40	27.44	74.94	2.46	2.46	1.23	10.24	3.28	4.09
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	8.34	25.03	30.83	77.19	2.32	4.17	0.46	8.58	0.70	2.32
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	7.89	28.77	29.93	47.79	3.48	2.32	0.93	5.10	2.09	3.02
CD14+CD16+ Monocytes, donor1	11789-124B7	0.87	28.55	18.96	34.22	1.96	0.00	2.83	7.19	2.40	5.01
CD14+CD16+ Monocytes, donor2	11801-124D1	0.92	19.63	31.18	51.28	0.92	0.46	3.00	11.55	2.08	4.85
CD14+CD16+ Monocytes, donor3	11912-125G4	0.65	29.24	28.38	35.52	1.30	0.22	1.52	4.98	1.08	3.68
CD14+CD16- Monocytes, donor1	11788-124B6	0.78	50.61	52.79	130.03	1.87	0.16	1.09	11.99	2.65	4.20
CD14+CD16- Monocytes, donor2	11799-124C8	0.70	36.85	53.62	115.44	1.22	0.00	0.70	11.00	1.92	2.79
CD14+CD16- Monocytes, donor3	11910-125G2	0.89	83.61	92.76	193.31	2.01	0.22	1.34	15.83	3.57	6.24
CD14-CD16+ Monocytes, donor1	11790-124B8	1.02	26.03	13.27	21.95	2.55	0.26	4.08	10.72	2.55	6.89
CD14-CD16+ Monocytes, donor2	11800-124C9	0.44	19.54	19.76	26.57	1.98	0.22	4.17	13.17	3.51	7.90
CD14-CD16+ Monocytes, donor3	11911-125G3	0.00	27.37	20.84	32.63	3.79	0.00	4.84	8.42	2.95	6.11
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	2.03	67.07	0.00	10.16	0.00	2.03	2.03	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	6.78	99.66	0.68	21.02	0.68	0.00	0.00	0.00	2.71	1.36
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	3.11	73.53	1.04	15.53	0.00	0.00	1.04	0.00	2.07	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	4.80	68.23	2.13	18.66	1.60	0.53	1.07	0.00	3.73	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	2.68	103.46	1.07	18.23	0.00	0.00	2.14	0.54	1.07	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	4.91	89.15	2.11	14.04	0.00	0.70	0.00	0.00	5.62	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	5.49	87.06	3.92	17.26	0.00	1.57	0.78	0.78	4.71	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	7.91	84.37	0.00	22.41	0.00	0.00	0.00	2.64	2.64	1.32
CD19+ B Cells, donor1	11544-120B5	23.84	92.87	3.29	20.55	1.64	1.64	1.64	0.00	4.11	0.00
CD19+ B Cells, donor2	11624-122B4	18.86	92.13	3.63	18.14	0.00	2.90	0.00	0.00	3.63	0.00
CD19+ B Cells, donor3	11705-123B4	22.21	81.78	6.06	23.22	1.01	2.52	1.01	0.00	4.04	0.50
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	97.38	0.00	0.00	0.00	0.40	8.08	0.00	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	69.91	0.40	0.00	0.00	0.00	5.19	0.40	0.00	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	6.02	13.05	2.01	7.03	0.00	0.00	1.00	0.00	2.01	0.00
CD34+ Progenitors, donor2	11625-122B5	14.61	22.47	8.43	26.40	1.12	4.49	3.37	0.56	1.12	0.56
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	12.02	5.64	0.75	2.63	0.75	1.50	0.75	0.00	0.75	0.38
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	14.88	6.09	0.90	2.71	0.23	1.13	1.35	0.90	1.35	0.68
CD4+ T Cells, donor1	11225-116C1	65.34	67.84	11.43	30.71	2.14	10.35	2.50	0.71	5.00	0.00
CD4+ T Cells, donor2	11306-117C1	61.85	80.83	8.57	45.31	2.45	6.12	4.29	0.00	11.02	0.00
CD4+ T Cells, donor3	11382-118B5	55.51	68.62	12.50	39.04	5.49	8.23	3.96	0.30	10.98	0.30
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	24.50	45.18	1.02	12.51	4.85	2.55	12.76	0.77	11.23	1.02
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	24.26	31.22	0.67	13.93	2.70	2.25	11.90	0.90	9.66	0.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	21.27	35.93	2.30	15.81	4.89	1.15	13.80	0.57	10.06	0.57
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	172.10	52.15	7.11	14.70	11.85	45.04	6.64	0.95	9.48	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	104.65	37.93	1.40	8.43	9.13	20.37	4.92	1.40	10.53	0.70
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	125.26	26.37	0.00	0.00	13.18	19.78	3.30	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	4.34	36.85	2.89	20.67	2.89	0.58	9.83	1.88	9.25	1.16
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	7.12	30.16	1.69	14.74	4.07	1.53	11.86	0.51	7.46	0.17
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	4.03	26.44	0.97	11.93	3.22	0.00	11.12	0.81	5.64	0.64
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	78.00	56.93	9.41	23.31	15.69	16.14	6.72	0.90	8.52	0.90
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	28.30	52.06	4.19	29.35	9.08	4.19	5.59	1.75	11.88	1.40
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	52.36	39.60	5.28	28.60	8.80	5.72	8.80	0.44	18.04	0.88
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	8.43	27.83	0.42	12.65	1.69	0.84	9.28	1.26	3.79	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	3.74	20.15	2.29	8.93	2.29	0.42	5.82	0.00	5.61	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	2.00	16.71	0.33	10.36	1.00	0.00	4.34	0.67	4.68	0.67
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	80.49	35.35	1.09	11.69	3.81	12.78	3.26	0.27	7.07	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	52.52	32.16	0.54	15.01	0.54	4.82	1.61	0.54	8.58	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	37.66	21.52	0.00	5.38	1.79	3.59	1.79	0.00	5.38	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	5.93	54.89	3.89	22.07	4.26	0.56	7.60	1.67	8.90	1.30
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	1.95	32.06	4.55	17.55	4.12	0.43	6.50	1.08	7.15	0.43
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	2.10	44.13	3.99	18.28	2.73	0.00	7.36	1.47	12.19	1.47
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	34.38	50.56	2.53	20.22	6.07	6.57	5.06	1.01	8.09	1.01
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	19.06	35.96	2.60	20.80	3.90	2.60	4.33	0.43	9.96	0.43
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	23.10	60.58	6.54	32.25	2.18	3.05	3.92	0.00	14.38	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	14.85	80.17	5.44	26.72	4.95	3.46	4.95	2.47	14.85	0.99
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	13.85	62.78	3.69	16.62	6.46	0.92	10.16	1.85	18.46	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	12.56	48.85	2.79	18.15	2.79	0.00	9.77	1.40	15.35	1.40
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	23.82	79.76	8.58	39.32	7.20	1.38	9.14	3.32	14.95	2.22
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	22.33	94.72	6.38	43.68	7.36	1.47	11.53	3.19	23.56	3.44
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	18.48	77.00	7.70	44.66	7.70	1.54	6.16	3.08	20.02	7.70
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	11.82	97.77	6.80	38.32	7.52	1.07	8.59	4.66	14.32	1.79
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	6.92	87.25	8.31	19.39	6.92	1.38	13.85	2.77	19.39	1.38
CD8+ T Cells, donor1	11226-116C2	58.93	61.88	12.77	34.38	8.84	12.77	4.58	2.29	8.84	2.29
CD8+ T Cells, donor2	11307-117C2	20.27	85.60	13.89	41.30	4.51	1.50	3.38	2.25	15.77	1.13
CD8+ T Cells, donor3	11383-118B6	40.15	64.13	6.82	22.98	5.81	5.30	3.53	1.01	7.57	0.25
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	0.00	15.14	1.38	4.13	0.23	0.00	0.00	0.23	0.46	0.46
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	0.00	15.10	1.92	2.40	0.00	0.00	0.00	0.00	0.00	0.48
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	0.00	13.68	0.82	3.56	0.00	0.00	0.00	0.27	0.82	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	0.00	20.71	1.50	3.60	0.00	0.00	0.00	0.00	0.30	0.60
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	0.00	12.24	1.68	1.92	0.00	0.00	0.24	0.48	0.48	0.48
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	0.00	13.64	1.59	3.41	0.00	0.00	0.23	0.00	0.45	0.45
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	0.00	14.34	0.87	1.74	0.00	0.00	0.00	0.00	0.43	0.43
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	0.00	18.95	0.79	4.21	0.00	0.00	0.00	0.26	0.53	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	0.00	13.84	2.35	3.28	0.00	0.00	0.00	0.70	0.47	0.70
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	0.00	16.30	1.21	2.42	0.00	0.00	0.00	0.00	0.30	0.60
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	0.00	13.94	1.16	3.49	0.00	0.00	0.00	0.58	0.29	0.29
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	0.00	13.85	0.80	2.40	0.00	0.00	0.27	0.27	0.27	0.27
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	0.00	13.13	1.31	3.94	0.00	0.00	0.00	0.00	0.44	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	0.00	13.21	4.10	4.10	0.91	0.00	0.00	0.00	0.00	0.46
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	0.00	23.87	4.48	5.97	0.00	0.00	0.00	0.00	0.00	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	0.00	13.33	2.52	2.16	0.00	0.00	0.36	0.00	0.36	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	0.00	12.95	0.86	4.60	0.00	0.00	0.00	0.29	0.86	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	0.00	15.56	2.12	5.19	0.00	0.00	0.00	0.47	0.00	0.24
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	0.00	20.60	1.90	0.95	0.00	0.00	0.00	0.00	0.63	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	0.00	9.53	1.23	3.08	0.00	0.00	0.00	0.31	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	0.00	17.63	1.28	3.21	0.00	0.00	0.00	0.00	0.64	0.32
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	0.00	14.15	1.15	1.53	0.00	0.00	0.38	0.00	0.76	0.38
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	0.00	11.43	0.39	1.97	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	0.00	12.86	0.00	3.78	0.76	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	0.00	5.62	0.80	1.61	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	0.00	7.69	0.70	2.10	0.70	0.00	0.70	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	0.00	12.02	2.00	2.00	0.00	0.00	0.00	0.00	1.00	0.00
Cardiac Myocyte, donor1	11525-119I4	42.04	5.48	20.11	9.14	9.14	3.66	0.00	3.66	1.83	5.48
Cardiac Myocyte, donor2	11605-120I3	10.38	12.35	1.98	1.98	1.48	2.47	0.49	0.99	0.49	0.00
Cardiac Myocyte, donor3	11686-122I3	12.84	13.89	13.89	4.95	3.37	5.16	3.05	5.05	3.16	2.32
Chondrocyte - de diff, donor1	11261-116G1	20.45	23.23	29.81	15.60	8.67	3.81	4.85	2.77	0.69	3.12
Chondrocyte - de diff, donor2	11338-117F6	12.79	13.15	8.53	7.11	4.26	3.55	1.07	3.55	0.00	2.84
Chondrocyte - de diff, donor3	11410-118E6	12.74	19.34	20.37	11.26	5.23	2.50	0.34	3.98	0.91	3.41
Chondrocyte - re diff, donor2	11339-117F7	35.81	12.53	17.91	9.85	5.37	8.95	5.37	1.79	4.48	0.90
Chondrocyte - re diff, donor3	11411-118E7	15.37	10.51	12.13	8.90	2.02	2.43	1.21	2.43	0.00	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	17.67	17.79	40.97	10.67	27.89	6.08	9.52	5.74	6.89	2.64
Ciliary Epithelial Cells, donor2	11323-117D9	14.32	17.96	10.26	4.28	10.05	3.63	6.84	3.85	2.99	1.50
Ciliary Epithelial Cells, donor3	11399-118D4	13.81	18.50	9.29	4.07	10.97	3.36	7.43	3.72	8.41	3.19
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	31.73	23.11	6.24	5.78	4.49	3.39	2.20	2.20	3.12	3.48
Corneal Epithelial Cells, donor1	11526-119I5	2.85	6.81	0.44	3.07	5.71	0.44	3.29	1.98	3.07	0.00
Corneal Epithelial Cells, donor2	11606-120I4	5.69	3.41	1.14	2.28	10.24	2.28	6.83	3.41	7.96	0.00
Corneal Epithelial Cells, donor3	11687-122I4	9.46	5.88	7.92	6.39	10.99	2.30	5.11	1.53	3.32	1.53
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	62.57	32.19	0.50	2.15	0.33	15.68	1.98	3.47	2.15	3.14
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	56.46	39.74	0.32	1.89	0.32	15.14	3.15	2.21	2.52	2.84
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	31.06	48.31	6.90	3.45	0.00	20.70	3.45	0.00	0.00	6.90
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	52.59	32.83	0.76	2.38	1.08	12.20	1.94	2.38	1.40	3.46
Dendritic Cells - plasmacytoid, donor1	11228-116C4	3.76	22.89	4.44	13.32	0.68	0.34	0.68	1.02	6.49	0.68
Dendritic Cells - plasmacytoid, donor2	11309-117C4	0.65	30.03	9.79	18.28	1.31	0.65	0.00	0.65	4.57	0.65
Dendritic Cells - plasmacytoid, donor3	11385-118B8	1.94	12.10	1.94	8.23	0.00	0.00	0.48	0.97	3.87	1.45
Endothelial Cells - Aortic, donor0	11207-116A1	15.51	15.18	31.69	19.68	3.34	6.84	2.84	1.67	1.83	0.83
Endothelial Cells - Aortic, donor1	11263-116G3	12.32	9.98	15.84	10.56	2.35	5.87	2.93	0.59	1.17	0.59
Endothelial Cells - Aortic, donor2	11340-117F8	14.71	28.56	5.94	11.31	3.11	2.55	1.41	1.70	1.70	1.41
Endothelial Cells - Aortic, donor3	11412-118E8	16.91	14.55	7.47	22.80	5.50	7.47	1.18	3.54	1.97	0.79
Endothelial Cells - Artery, donor1	11264-116G4	6.98	18.91	8.44	10.76	2.91	3.49	0.87	1.45	1.45	1.45
Endothelial Cells - Artery, donor2	11341-117F9	13.41	28.23	8.23	17.41	1.88	5.41	3.76	0.94	1.41	1.18
Endothelial Cells - Artery, donor3	11413-118E9	10.34	24.02	5.79	10.69	2.98	3.33	1.93	1.05	1.23	0.88
Endothelial Cells - Lymphatic, donor1	11236-116D3	24.38	23.50	9.53	15.74	3.55	7.98	3.32	3.10	4.43	2.66
Endothelial Cells - Lymphatic, donor2	11317-117D3	32.25	33.77	9.13	18.26	8.82	12.78	3.65	2.43	5.17	0.91
Endothelial Cells - Lymphatic, donor3	11393-118C7	34.39	34.39	9.87	12.69	2.54	10.15	1.13	3.10	3.38	1.97
Endothelial Cells - Microvascular, donor1	11265-116G5	5.65	13.67	7.73	14.56	1.49	2.08	2.97	0.89	1.49	0.89
Endothelial Cells - Microvascular, donor2	11342-117G1	11.45	6.77	12.50	13.02	0.52	3.12	3.12	0.52	0.00	1.04
Endothelial Cells - Microvascular, donor3	11414-118F1	4.40	14.32	10.35	11.63	0.85	1.70	0.57	0.43	1.42	0.71
Endothelial Cells - Thoracic, donor1	11266-116G6	16.40	26.01	24.01	27.21	11.20	7.60	4.80	3.60	1.60	0.80
Endothelial Cells - Thoracic, donor2	11343-117G2	5.24	15.72	3.67	5.77	3.67	3.67	1.05	2.62	1.57	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	36.90	28.95	19.26	26.96	2.86	14.04	5.59	1.99	3.60	1.86
Endothelial Cells - Umbilical vein, donor2	11324-117E1	45.63	30.42	16.08	25.85	3.48	14.99	5.43	2.82	3.04	1.09
Endothelial Cells - Umbilical vein, donor3	11400-118D5	51.66	43.36	10.26	22.96	2.93	17.10	4.89	2.20	3.18	1.95
Endothelial Cells - Vein, donor1	11267-116G7	12.51	10.24	3.41	6.83	0.00	3.41	0.00	0.00	1.14	0.00
Endothelial Cells - Vein, donor2	11344-117G3	6.29	6.99	3.49	10.48	0.70	0.70	1.40	0.00	1.40	0.00
Endothelial Cells - Vein, donor3	11416-118F3	10.83	18.68	10.68	10.52	1.41	2.83	1.73	1.88	0.94	0.79
Eosinophils, donor1	12244-129H3	15.25	60.99	15.25	45.74	0.00	0.00	15.25	0.00	30.49	0.00
Eosinophils, donor2	12245-129H4	44.56	62.71	24.75	21.45	1.65	4.95	1.65	3.30	1.65	0.00
Eosinophils, donor3	12246-129H5	78.47	28.53	7.13	49.94	7.13	14.27	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	3.66	8.06	2.69	3.91	7.57	0.98	3.91	0.98	2.20	0.73
Esophageal Epithelial Cells, donor2	11587-120G3	10.40	6.24	2.08	4.16	6.24	4.16	2.08	4.16	4.16	4.16
Esophageal Epithelial Cells, donor3	11668-122G3	32.54	16.27	0.00	0.00	16.27	0.00	16.27	0.00	16.27	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	33.66	13.96	12.32	3.28	8.21	7.80	6.98	3.69	3.28	4.52
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	13.25	7.12	4.60	2.63	7.12	2.30	1.86	3.94	1.20	1.75
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	13.00	7.48	37.38	8.88	3.79	2.82	3.03	2.06	0.87	1.73
Fibroblast - Aortic Adventitial, donor1	11245-116E3	21.47	17.71	16.01	8.73	12.73	7.76	5.09	6.55	2.91	2.67
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	34.53	46.54	33.03	15.28	42.72	14.74	9.01	12.56	5.60	5.05
Fibroblast - Aortic Adventitial, donor2	11326-117E3	18.14	21.52	17.61	8.12	7.17	6.12	5.17	6.54	3.27	3.90
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	7.64	5.27	65.87	14.23	7.38	2.37	2.11	2.90	2.11	1.05
Fibroblast - Aortic Adventitial, donor3	11401-118D6	19.27	23.59	75.08	18.94	8.97	5.32	6.64	1.66	2.99	2.66
Fibroblast - Cardiac, donor1	11268-116G8	16.78	8.62	6.35	2.27	9.07	2.27	4.08	3.18	4.08	2.27
Fibroblast - Cardiac, donor2	11345-117G4	3.79	18.95	3.03	4.55	2.27	3.03	1.52	4.55	3.79	1.52
Fibroblast - Cardiac, donor3	11417-118F4	5.36	13.56	6.15	3.15	5.84	1.42	1.73	3.15	1.26	3.15
Fibroblast - Cardiac, donor4	11452-119A3	30.31	34.86	14.85	9.40	6.97	6.37	1.21	3.03	3.64	3.33
Fibroblast - Cardiac, donor5	11456-119A7	15.74	18.27	30.96	18.02	6.98	5.33	3.68	2.79	2.03	3.30
Fibroblast - Cardiac, donor6	11460-119B2	23.50	21.22	10.91	8.94	3.18	5.76	2.88	2.88	2.43	2.88
Fibroblast - Choroid Plexus, donor1	11492-119E7	7.37	17.95	6.03	4.15	6.43	2.41	1.21	4.02	4.02	2.28
Fibroblast - Choroid Plexus, donor2	11572-120E6	15.10	8.20	7.77	4.31	4.31	3.88	3.45	5.61	4.75	1.29
Fibroblast - Choroid Plexus, donor3	11653-122E6	17.58	10.25	8.79	4.39	5.86	8.79	5.86	1.46	4.39	2.93
Fibroblast - Conjunctival, donor1	11531-120A1	5.54	35.98	4.61	13.38	1.15	1.38	1.38	2.54	3.00	4.84
Fibroblast - Conjunctival, donor3	11692-122I9	16.62	23.91	59.36	35.62	2.20	1.70	2.71	7.29	3.39	2.71
Fibroblast - Dermal, donor1	11269-116G9	26.30	25.59	7.51	7.51	4.23	3.99	3.05	2.11	0.94	2.82
Fibroblast - Dermal, donor2	11346-117G5	25.47	17.45	7.55	5.66	2.36	6.13	1.42	3.30	1.42	2.36
Fibroblast - Dermal, donor3	11418-118F5	20.67	21.52	21.88	15.59	3.02	4.11	2.54	1.45	0.48	2.90
Fibroblast - Dermal, donor4	11450-119A1	25.32	34.82	39.00	21.37	6.22	6.33	4.52	2.03	2.49	2.83
Fibroblast - Dermal, donor5	11454-119A5	30.18	34.19	8.20	11.69	4.36	8.37	2.09	2.27	3.14	4.19
Fibroblast - Dermal, donor6	11458-119A9	30.86	34.11	7.96	11.04	3.41	12.34	4.06	3.41	2.27	3.41
Fibroblast - Gingival, donor1	11237-116D4	22.70	37.90	77.04	24.99	11.66	3.33	4.79	2.29	1.25	5.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	33.80	35.63	16.24	15.46	11.79	7.34	7.60	4.98	3.41	11.00
Fibroblast - Gingival, donor2	11318-117D4	18.19	38.88	12.91	14.36	5.01	4.61	3.56	2.37	2.24	3.03
Fibroblast - Gingival, donor3	11394-118C8	24.75	52.40	98.72	41.19	4.25	4.35	3.09	4.25	1.64	7.25
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	14.54	28.05	44.67	15.58	1.04	6.23	2.08	3.12	2.08	6.23
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	15.51	30.84	31.72	12.33	1.76	2.82	1.23	3.17	3.17	6.87
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	27.28	39.13	9.82	10.91	6.55	8.42	3.74	4.37	1.71	6.24
Fibroblast - Gingival, donor6 (control)	11922-125H5	17.58	44.63	18.66	18.26	7.17	5.27	3.92	3.65	2.30	5.81
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	8.12	37.41	20.82	12.35	4.59	2.12	3.53	5.29	5.65	13.41
Fibroblast - Gingival, donor7 (control)	11924-125H7	23.84	25.45	44.02	19.74	5.41	3.66	5.12	3.80	2.49	3.95
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	24.41	21.68	43.36	20.59	6.54	7.09	5.18	3.27	2.32	3.55
Fibroblast - Gingival, donor8 (control)	11926-125H9	24.57	21.06	43.11	20.18	4.28	7.46	4.39	2.30	2.52	6.25
Fibroblast - Gingival, donor9 (control)	11927-125I1	14.38	36.68	49.16	29.20	3.96	2.20	3.23	11.01	13.35	8.07
Fibroblast - Lung, donor1	11270-116H1	8.16	14.95	13.59	9.52	0.00	5.44	0.00	2.72	1.36	1.36
Fibroblast - Lung, donor2	11347-117G6	17.91	58.19	40.29	23.87	14.92	8.95	2.98	2.98	1.49	4.48
Fibroblast - Lung, donor3	11419-118F6	11.82	35.88	23.21	16.88	5.06	1.90	1.90	1.27	0.42	3.17
Fibroblast - Lymphatic, donor1	11506-119G3	5.00	8.33	14.99	29.16	1.67	0.83	2.50	4.17	1.67	1.67
Fibroblast - Lymphatic, donor2	11586-120G2	2.80	12.59	8.39	6.99	4.20	0.00	2.80	0.00	1.40	1.40
Fibroblast - Lymphatic, donor3	11667-122G2	0.56	3.64	5.32	3.92	0.56	0.28	0.56	0.28	0.00	0.28
Fibroblast - Mammary, donor1	11540-120B1	9.34	56.43	6.50	12.99	9.34	2.44	1.62	6.50	2.03	5.68
Fibroblast - Mammary, donor2	11620-122A9	3.99	7.99	0.00	0.00	3.99	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	0.00	5.96	0.00	0.00	5.96	0.00	0.00	0.00	5.96	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	32.20	47.33	12.61	12.41	5.24	9.12	4.07	2.91	1.55	4.66
Fibroblast - Periodontal Ligament, donor2	11319-117D5	37.16	72.05	19.72	21.08	4.55	7.43	4.40	2.43	2.58	5.92
Fibroblast - Periodontal Ligament, donor3	11395-118C9	34.88	79.25	87.82	30.29	19.28	9.18	7.96	5.81	3.67	10.10
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	19.84	39.69	58.77	20.99	4.58	2.67	2.29	4.20	4.96	7.25
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	14.58	27.81	5.40	5.13	2.43	5.13	2.16	2.70	1.62	5.40
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	19.83	29.46	35.95	14.84	3.36	3.48	1.39	4.41	1.51	7.19
Fibroblast - Pulmonary Artery, donor1	11250-116E8	12.38	20.78	6.19	4.75	12.71	5.42	2.87	2.43	2.43	3.54
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	4.27	31.90	3.45	8.33	3.66	1.02	1.83	2.44	2.44	2.64
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	5.35	15.37	12.70	8.69	0.00	0.67	1.34	0.67	1.34	2.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	14.23	11.86	20.56	13.44	0.79	1.98	3.56	1.58	1.58	1.19
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	16.87	36.51	11.31	7.74	9.13	6.15	3.57	4.56	3.97	4.56
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	19.72	27.53	10.12	4.44	7.28	3.55	3.02	7.46	6.04	6.04
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	28.38	21.29	22.86	8.47	2.17	5.12	0.39	5.32	1.58	3.35
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	19.25	21.96	15.04	9.63	9.93	6.92	5.11	3.91	3.31	3.31
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	27.64	36.70	21.37	12.41	7.99	8.85	5.07	11.66	4.43	10.69
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	14.68	32.90	37.46	13.92	20.25	6.58	5.31	4.30	6.07	8.10
Fibroblast - skin normal, donor1	11553-120C5	19.36	24.28	28.88	11.65	11.16	4.76	4.10	7.06	3.45	5.25
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	29.68	36.49	75.19	17.85	49.73	18.85	7.42	3.81	3.81	4.21
Fibroblast - skin normal, donor2	11561-120D4	22.40	28.43	31.24	11.45	15.97	6.63	4.42	7.13	3.62	6.13
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	24.78	40.80	14.81	7.56	13.60	9.37	3.93	7.56	3.93	5.14
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	27.84	26.68	12.59	6.30	2.73	3.81	2.07	8.70	2.57	7.54
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	30.26	35.56	34.87	24.62	6.84	4.79	4.44	9.23	3.76	7.35
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	19.05	29.89	7.55	4.93	11.50	6.24	3.61	5.58	2.63	6.90
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	27.16	28.87	8.20	5.75	10.12	7.67	6.60	5.33	3.20	6.28
Fibroblast - skin walker warburg, donor1	11554-120C6	19.90	27.66	10.12	5.74	10.29	6.92	3.37	2.53	3.20	4.05
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	17.56	17.41	20.70	8.78	10.04	7.06	5.80	3.45	1.57	2.67
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	132.96	132.96	199.44	155.12	132.96	110.80	44.32	0.00	22.16	66.48
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	115.91	30.50	16.56	16.56	79.31	14.82	13.94	5.23	20.92	6.10
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	38.66	10.40	10.23	7.11	29.47	12.66	20.80	2.43	2.25	1.39
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	32.79	28.37	5.99	9.11	41.12	12.49	23.68	3.12	2.34	2.86
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	32.71	42.16	12.26	13.54	75.12	8.18	32.71	4.09	3.83	5.88
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	6.12	6.12	0.77	0.00	0.77	1.53	0.00	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	5.10	0.64	0.64	0.64	0.00	2.55	0.00	0.00	0.00	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	16.26	5.99	1.71	0.29	0.00	5.99	0.00	0.00	0.29	0.86
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	15.72	15.72	3.58	3.03	0.28	2.76	0.55	0.28	0.00	2.76
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	22.60	5.02	1.60	1.60	1.37	1.83	2.51	0.00	0.91	0.91
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	13.08	9.51	1.39	1.19	0.40	2.58	0.99	0.00	0.00	1.19
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	14.01	7.67	2.91	2.38	0.26	2.64	1.59	0.53	0.26	1.32
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	20.87	2.94	2.94	1.63	1.96	3.26	1.96	0.33	0.65	2.61
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	9.73	8.40	1.33	1.33	2.21	1.77	1.77	0.00	0.44	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	7.49	6.08	2.26	0.85	1.27	2.12	0.99	0.14	0.57	0.57
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	10.59	6.40	4.68	2.09	2.34	2.22	1.72	0.37	0.62	0.37
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	6.18	6.72	1.88	0.81	2.69	0.54	2.15	0.00	0.00	0.27
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	12.27	10.16	3.96	3.35	0.74	4.71	1.12	0.12	0.50	1.49
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	12.46	10.38	4.71	2.63	1.80	4.43	1.11	0.28	0.14	1.25
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	11.38	4.27	3.05	3.05	2.24	5.49	0.81	0.20	0.20	0.41
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	13.69	10.04	7.99	6.16	2.05	4.34	4.34	0.23	0.46	0.68
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	14.20	10.21	10.59	6.98	1.62	4.73	3.74	0.25	0.12	1.25
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	16.61	14.43	8.52	8.52	1.53	4.37	2.62	0.44	0.22	0.44
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	16.55	9.75	5.02	2.66	1.77	1.48	3.25	0.89	0.30	1.77
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	12.08	9.54	10.01	3.81	3.97	4.77	2.38	0.48	0.00	1.43
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	12.73	9.61	3.57	2.01	1.56	4.69	1.79	1.12	0.67	0.45
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	10.28	9.07	3.63	3.63	1.01	3.63	1.21	0.00	1.41	1.01
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	12.21	14.42	7.80	4.24	3.05	4.92	2.54	0.34	1.02	1.19
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	21.02	14.01	10.29	5.76	4.88	7.09	5.23	1.06	1.24	1.06
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	21.96	15.19	6.45	7.28	2.19	5.31	2.60	0.94	2.08	3.02
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	16.74	12.30	6.32	4.95	1.54	5.64	1.71	1.20	1.54	1.88
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	12.95	13.50	5.86	4.20	1.88	2.32	1.33	0.33	0.77	2.21
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	18.80	12.31	5.24	4.41	4.99	6.41	3.91	0.92	1.25	2.58
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	20.21	9.19	3.68	3.68	4.08	6.13	4.49	0.41	2.04	1.63
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	12.79	8.46	3.51	2.89	1.44	4.54	2.89	0.41	1.86	1.03
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	12.80	12.45	4.15	2.65	1.50	3.46	1.84	0.46	1.50	1.96
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	15.51	12.51	3.84	3.67	0.67	2.50	1.67	0.67	1.00	1.67
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	15.21	7.94	2.87	3.09	0.44	2.87	0.88	0.44	0.66	1.54
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	13.41	11.44	4.18	2.58	1.35	2.46	1.35	0.61	0.61	2.09
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	16.70	11.18	3.24	2.27	2.43	2.59	1.95	0.49	2.11	0.97
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	20.21	9.30	2.89	3.21	1.60	2.89	0.64	1.28	0.64	0.96
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	13.17	8.53	3.79	3.70	1.33	3.22	1.52	0.95	1.33	2.18
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	15.50	9.65	1.74	3.95	0.47	3.16	1.42	0.47	0.47	0.95
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	13.08	10.34	2.74	2.43	0.91	2.43	1.52	0.91	1.22	0.61
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	11.92	11.08	4.39	2.82	0.94	3.55	1.25	0.42	0.63	1.57
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	18.00	10.98	4.17	4.17	0.88	3.51	3.29	1.10	1.10	1.32
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	14.03	11.50	3.09	4.77	1.68	2.81	2.52	0.28	1.96	1.40
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	10.93	15.00	5.83	4.91	1.11	3.24	1.11	1.48	2.50	2.22
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	12.03	9.89	5.08	3.74	0.80	2.41	1.60	0.53	1.34	1.07
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	13.01	11.32	4.28	3.98	0.31	1.84	1.68	1.07	2.14	1.68
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	10.36	9.46	4.66	3.76	0.39	3.11	1.04	0.39	2.20	1.42
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	20.33	16.54	5.69	5.15	0.81	3.80	1.90	1.63	0.81	1.08
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	17.33	12.72	6.27	4.79	0.74	1.84	2.03	1.11	3.32	2.58
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	12.94	16.01	7.68	3.07	1.32	3.29	1.54	0.88	2.41	1.54
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	52.56	36.69	11.90	3.97	1.98	8.93	4.96	2.98	0.99	6.94
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	13.19	15.17	11.48	5.54	1.19	2.11	2.24	1.32	3.83	2.24
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	10.69	13.11	10.09	7.67	0.81	1.82	2.22	2.02	5.85	2.02
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	54.14	32.28	18.81	10.17	5.34	10.42	5.59	4.83	6.35	4.07
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	4.98	13.74	2.79	2.79	1.39	1.59	1.19	0.60	0.00	1.39
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	4.62	6.01	1.85	0.31	0.62	1.23	1.08	0.15	0.46	0.77
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	5.52	12.68	4.30	2.05	2.05	2.05	2.25	0.41	0.61	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	4.38	3.44	0.94	0.31	0.00	1.56	0.00	0.31	0.00	0.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	1.98	1.13	1.41	0.00	0.57	0.85	0.00	0.28	0.00	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	2.31	5.07	1.84	2.77	0.00	2.31	3.69	0.46	0.00	1.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	9.90	0.00	0.00	2.47	0.00	2.47	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	10.06	2.71	1.16	0.00	0.77	2.32	0.77	0.00	1.16	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	9.63	3.21	1.60	1.60	0.00	1.60	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	13.91	5.22	0.00	0.00	0.00	1.74	1.74	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	13.02	2.93	0.33	0.00	1.30	4.23	0.00	0.00	0.33	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	7.82	4.53	2.06	1.24	0.82	0.41	0.82	0.00	0.41	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	3.33	3.33	0.00	3.33	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	16.78	4.75	1.68	0.84	0.56	3.36	0.00	0.00	0.28	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	17.32	3.60	1.31	0.33	0.33	3.60	0.33	0.00	0.00	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	8.39	4.19	0.84	0.84	0.00	5.87	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	15.27	7.32	1.27	0.32	0.32	4.13	0.95	0.00	0.00	0.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	12.91	5.43	1.70	0.34	0.34	3.74	0.68	0.34	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	14.62	6.26	6.26	0.00	0.00	4.18	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	13.74	8.02	4.01	1.15	0.57	2.29	1.15	0.00	0.00	1.72
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	9.47	6.22	2.37	0.59	0.30	1.78	0.30	0.59	0.00	0.89
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	16.94	6.78	6.78	1.69	1.69	3.39	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	11.60	13.25	5.38	1.66	1.66	5.80	2.07	2.07	0.83	0.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	12.43	5.75	4.37	2.07	0.23	5.98	0.46	0.69	0.69	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	5.27	10.54	5.27	0.00	0.00	0.00	0.00	0.00	0.00	5.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	16.53	8.84	3.46	2.69	1.54	1.92	3.84	0.38	0.38	1.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	14.99	10.76	6.52	3.26	2.61	5.22	2.28	1.63	0.98	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	15.38	9.36	9.36	2.68	2.01	0.67	2.68	0.00	0.67	1.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	17.72	9.25	13.48	5.39	1.54	1.16	2.31	1.16	0.00	1.93
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	18.14	13.35	13.35	4.79	4.45	5.82	2.05	1.03	1.37	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	4.97	12.42	14.91	0.00	4.97	4.97	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	30.20	11.80	7.08	3.30	0.94	3.30	1.42	0.47	0.47	1.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	15.69	13.88	8.45	7.85	1.21	1.81	1.81	2.41	1.81	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	23.91	14.24	7.12	4.58	1.02	2.54	3.05	0.51	1.02	2.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	22.73	11.57	7.18	3.59	2.79	3.59	3.99	0.40	1.20	2.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	21.21	9.87	9.37	5.92	1.97	5.92	3.45	0.49	0.99	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	20.07	12.98	5.90	0.00	2.36	2.36	1.18	0.00	1.18	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	21.59	4.67	4.08	2.92	0.00	3.50	3.50	0.58	1.17	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	22.38	8.78	4.83	3.07	3.07	2.19	0.88	0.44	1.76	0.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	17.80	6.78	4.24	5.93	0.85	1.70	0.00	0.00	1.70	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	22.09	4.78	1.19	1.19	0.60	4.18	0.60	0.00	0.60	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	16.50	6.79	1.94	1.94	0.00	5.82	1.46	0.49	0.97	0.97
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	15.98	12.55	5.71	1.14	1.14	0.00	2.28	1.14	0.00	2.28
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	5.41	24.95	19.96	7.07	4.16	1.66	1.66	2.49	2.08	1.66
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	3.37	19.12	26.99	13.49	4.50	3.37	5.62	3.37	1.12	1.12
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	11.10	21.57	21.57	9.83	6.98	1.59	3.17	5.39	3.17	2.85
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	15.87	19.22	13.79	5.43	6.68	2.51	3.76	3.34	2.09	2.51
Hep-2 cells mock treated, biol_rep1	11898-125E8	29.94	13.93	26.23	8.70	30.98	7.54	6.73	1.62	0.35	2.32
Hep-2 cells mock treated, biol_rep2	11899-125E9	33.59	13.84	24.48	6.75	33.09	6.41	7.93	1.35	0.51	1.69
Hep-2 cells mock treated, biol_rep3	11900-125F1	30.94	12.97	22.30	7.74	30.03	5.92	6.14	1.14	1.37	0.91
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	27.66	15.30	23.83	8.96	27.66	6.67	7.43	1.31	0.66	0.98
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	37.61	16.12	24.71	9.03	26.00	6.45	7.74	0.64	1.07	1.50
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	33.15	13.35	21.74	7.10	22.60	7.32	8.18	0.86	0.65	1.94
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	22.79	16.31	22.42	9.09	25.03	7.60	8.22	1.25	0.75	1.62
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	26.59	11.49	26.93	6.00	27.62	7.72	6.35	1.20	0.86	0.69
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	24.35	13.46	16.34	7.69	26.27	5.77	10.89	1.92	1.60	3.52
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	10.07	18.47	1.68	11.19	1.12	3.92	1.12	2.24	0.56	0.56
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	3.46	5.63	2.16	1.30	0.43	0.43	0.00	0.43	0.43	1.30
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	21.15	5.29	7.93	7.93	0.00	5.29	2.64	0.00	2.64	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	4.23	9.52	8.11	5.64	0.71	0.71	1.06	0.35	1.06	0.35
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	4.36	5.81	0.73	5.09	0.00	2.18	0.73	1.45	1.45	1.45
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	11.71	5.25	12.59	4.55	1.92	5.42	0.52	0.87	0.52	1.05
Hepatocyte, donor1	11523-119I2	116.22	16.95	2.42	2.42	14.53	18.16	2.42	2.42	1.21	1.21
Hepatocyte, donor2	11603-120I1	62.49	15.08	5.39	1.08	2.15	6.46	0.00	2.15	1.08	2.15
Hepatocyte, donor3	11684-122I1	73.62	12.88	3.68	1.84	6.14	9.82	3.68	1.23	1.23	3.07
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	0.65	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.65	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	17.48	33.21	12.23	6.64	70.09	3.67	15.91	13.28	5.59	4.89
Iris Pigment Epithelial Cells, donor1	11530-119I9	17.84	17.01	10.84	4.67	16.19	6.31	8.64	4.53	6.59	1.92
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	12.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	20.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	9.69	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	10.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	35.60	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	25.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	9.14	0.00	0.00	0.00	0.00	4.57	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	12.99	0.00	0.00	0.00	0.00	1.62	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	8.34	0.00	0.00	0.00	0.00	3.33	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	32.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	9.26	0.00	0.00	0.00	0.00	2.65	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	13.30	0.00	0.00	0.00	0.00	3.33	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	10.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	6.93	0.00	0.00	0.00	0.00	2.52	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	12.37	0.00	0.00	0.00	0.00	1.55	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	43.90	0.00	0.00	0.00	0.00	14.63	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	12.92	0.00	0.00	0.00	0.00	1.94	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	12.88	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	35.84	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	10.59	0.00	0.00	0.00	0.00	0.81	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	4.20	0.00	0.00	0.00	0.00	0.42	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	0.00	0.00	0.00	0.00	14.37	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	12.06	0.00	0.80	0.00	0.00	3.21	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	10.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	15.08	0.00	0.00	0.00	0.00	15.08	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	11.33	0.00	0.00	0.00	0.00	3.30	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	13.60	0.00	0.00	0.00	0.00	2.72	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	58.97	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	5.38	0.00	0.00	0.00	0.00	1.08	1.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	3.81	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	10.84	0.00	0.00	0.00	0.00	1.28	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	12.76	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	47.41	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	7.85	0.00	0.71	0.00	0.00	2.14	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	9.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	12.35	0.00	0.00	0.00	0.00	1.54	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	17.56	0.00	0.00	0.00	0.00	3.51	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	12.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	5.56	0.00	0.00	0.00	0.70	0.70	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	6.64	0.00	0.00	0.00	0.00	2.21	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	9.73	0.00	0.00	0.00	0.00	3.24	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	6.10	0.00	0.00	0.00	0.00	1.74	0.00	0.00	0.00	0.87
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	13.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	10.45	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	9.60	0.00	0.00	0.00	3.20	4.27	1.07	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	11.08	0.00	0.00	0.00	0.00	1.39	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	2.85	0.00	0.00	0.00	0.00	2.85	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	9.20	0.92	0.00	0.00	0.92	0.92	0.92	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	15.13	0.00	0.00	0.00	0.00	3.03	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	43.46	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	13.75	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	11.42	28.07	9.14	17.79	98.08	3.10	24.23	4.73	5.88	5.39
Keratinocyte - epidermal, donor2	11349-117G8	13.47	7.61	0.00	4.69	8.78	2.93	4.69	1.17	1.17	1.76
Keratinocyte - epidermal, donor3	11421-118F8	41.27	10.13	8.71	5.77	13.82	12.68	14.39	1.23	3.60	1.14
Keratinocyte - oral, donor1	11251-116E9	48.02	15.32	13.17	12.83	31.67	12.15	39.62	3.86	8.51	2.50
Keratocytes, donor1	11527-119I6	8.60	28.88	4.81	9.63	0.69	2.06	1.03	2.75	4.13	2.41
Keratocytes, donor2	11607-120I5	2.34	30.47	2.34	15.23	0.00	0.00	0.00	0.00	1.17	2.34
Keratocytes, donor3	11688-122I5	14.62	21.93	20.55	11.66	1.19	5.73	1.38	3.95	1.38	1.78
Krukenberg tumor cell line:HSKTC	10687-109F3	37.36	2.20	17.58	2.20	52.75	4.40	24.18	2.20	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	5.39	8.63	26.97	6.47	16.18	7.55	3.24	2.16	5.39	0.00
Lens Epithelial Cells, donor2	11609-120I7	16.03	24.68	41.75	11.65	17.53	2.31	5.42	4.04	4.38	2.65
Lens Epithelial Cells, donor3	11690-122I7	20.48	11.00	8.58	3.94	16.04	6.86	13.62	3.03	6.76	1.31
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	16.25	14.35	5.34	10.79	1.54	5.93	0.59	1.19	1.30	0.95
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	13.40	8.93	3.91	13.67	0.84	4.19	0.28	1.12	0.28	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	19.36	12.75	5.04	14.64	0.94	7.24	0.47	1.26	0.79	0.63
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	11.29	9.68	4.30	6.45	0.00	3.23	0.00	1.08	0.54	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	11.98	9.77	3.47	11.66	0.32	3.47	0.32	1.26	1.26	0.63
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	11.21	7.22	2.70	6.79	0.54	3.45	0.75	0.65	0.86	0.22
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	15.59	11.90	2.05	8.62	1.64	4.10	1.23	0.41	2.05	0.82
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	6.83	7.84	1.77	7.84	0.76	2.02	0.25	0.76	0.76	0.25
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	9.29	9.71	2.39	9.01	0.56	1.97	1.13	0.56	0.56	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	13.05	11.07	7.12	11.07	0.79	3.56	1.19	1.58	1.19	0.79
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	18.81	8.34	2.52	11.05	0.78	3.30	1.94	0.97	0.78	0.78
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	6.67	5.74	1.30	5.55	0.56	1.30	0.19	0.93	0.74	0.19
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	13.94	11.85	3.14	7.32	0.00	2.09	2.09	1.39	1.39	0.35
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	9.06	6.68	5.96	8.35	0.95	3.82	0.48	0.48	0.95	0.48
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	10.71	6.32	3.02	7.55	0.82	2.61	0.96	1.10	1.10	0.27
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	16.94	7.70	5.54	12.32	0.92	3.70	1.85	1.23	3.08	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	8.11	5.30	2.18	9.04	0.94	0.62	0.94	0.00	0.62	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	12.26	9.33	1.83	7.87	0.73	3.66	0.73	1.46	0.55	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	13.82	9.87	3.29	8.89	0.00	1.97	0.66	1.32	0.00	0.33
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	8.20	3.81	4.10	5.56	0.88	2.05	0.59	0.00	0.59	0.29
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	9.46	6.97	1.99	5.97	0.00	1.99	0.50	0.00	0.75	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	13.58	11.64	4.85	10.67	0.97	6.79	2.42	1.94	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	12.39	11.85	5.92	8.89	0.54	2.42	0.54	0.81	0.81	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	12.56	9.39	2.88	8.17	1.06	2.72	1.06	1.36	1.36	0.76
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	17.11	6.22	2.59	6.22	0.00	1.04	0.52	1.56	1.04	0.52
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	14.24	11.10	4.40	10.05	0.63	5.23	0.42	1.05	1.05	0.42
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	10.38	8.12	2.26	8.57	0.30	2.56	0.60	1.50	0.30	0.15
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	11.01	6.88	2.06	6.19	0.69	2.06	0.00	0.69	0.69	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	7.90	8.47	3.39	8.47	0.38	3.95	0.19	1.69	0.75	0.94
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	9.33	7.10	1.91	7.63	0.85	2.54	0.85	1.48	0.64	0.64
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	12.11	9.21	3.88	6.30	0.48	2.42	0.97	0.97	0.97	0.97
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	8.93	5.95	3.64	5.29	0.66	2.32	0.66	0.66	0.66	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	9.42	5.95	3.35	7.31	0.74	3.10	0.37	0.62	0.87	0.12
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	22.95	10.00	7.03	13.33	1.48	6.29	1.85	0.00	2.59	0.74
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	10.62	2.22	2.22	4.94	0.25	5.68	0.49	0.25	1.24	0.49
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	9.90	6.05	2.20	6.60	0.41	3.02	0.55	0.82	0.69	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	20.58	10.29	5.79	11.90	1.29	5.47	0.96	1.61	1.93	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	15.52	8.22	3.35	10.35	0.91	3.35	0.30	1.22	2.13	0.91
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	14.14	7.84	3.36	13.02	0.56	4.48	0.84	1.54	1.40	0.70
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	12.09	13.87	4.98	8.18	1.07	3.91	1.78	1.07	1.07	0.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	12.12	4.36	0.48	4.36	0.97	1.45	0.48	1.45	0.48	0.97
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	7.94	5.60	1.40	4.36	0.16	1.87	0.47	0.78	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	11.82	6.80	2.51	8.24	0.00	1.79	0.36	0.72	0.36	0.72
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	9.47	9.47	1.63	6.53	0.65	4.25	0.33	0.00	0.65	0.65
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	6.12	3.77	1.41	4.24	0.47	1.18	0.47	0.00	0.47	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	16.34	14.48	5.45	11.39	2.35	6.31	1.73	1.86	2.48	0.87
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	8.71	5.12	2.05	3.33	0.77	0.77	0.51	0.51	0.77	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	11.93	9.25	2.39	4.48	0.30	3.88	0.30	0.60	1.49	0.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	2.27	4.53	2.27	0.00	13.60	0.00	6.80	2.27	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	8.44	2.30	3.84	0.77	6.14	0.77	5.37	2.30	3.07	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	2.97	1.48	1.48	0.00	4.45	0.00	2.23	0.74	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	6.77	1.69	0.85	0.85	6.77	0.00	4.65	1.27	0.85	0.85
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	8.44	2.81	2.11	0.00	4.22	0.70	4.22	0.00	0.70	2.11
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	3.74	0.93	0.00	0.00	3.74	0.93	2.80	0.93	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	4.64	2.06	0.52	0.00	4.12	0.52	3.09	1.55	2.06	1.03
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	5.95	2.38	0.00	0.00	7.14	0.00	3.57	1.19	1.19	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	3.39	2.04	2.04	0.00	5.65	0.45	2.71	0.90	1.36	0.68
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	12.80	4.65	1.16	0.58	10.18	1.16	6.69	2.33	2.33	0.29
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	9.90	5.85	2.25	0.90	9.45	1.35	1.80	0.90	0.45	0.90
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	6.64	3.93	1.63	1.35	7.99	0.68	2.57	0.95	0.68	0.27
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	6.68	0.51	1.54	1.54	4.62	1.54	5.14	1.03	1.54	0.51
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	10.59	5.65	2.12	0.35	8.47	1.41	4.23	4.59	1.41	0.71
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	9.33	2.67	0.00	0.67	9.99	0.00	3.33	1.33	0.00	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	6.11	1.53	0.00	1.53	5.60	1.53	6.11	0.51	2.55	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	13.07	5.87	2.13	0.80	10.41	1.60	7.47	1.60	2.40	0.53
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	11.15	4.16	2.83	1.32	10.01	1.51	9.45	2.27	1.13	0.76
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	9.20	1.23	0.61	0.61	6.75	0.00	2.45	0.00	0.61	0.61
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	4.08	4.08	0.82	2.45	7.34	2.45	4.89	0.00	3.26	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	10.62	4.58	3.54	0.42	12.29	1.87	6.04	1.46	0.83	0.83
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	13.45	3.36	3.08	2.24	10.37	2.52	5.32	1.12	1.40	1.12
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	9.27	4.12	1.03	0.00	8.24	1.03	4.12	1.03	1.03	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	11.03	5.23	2.03	0.58	11.90	1.74	5.52	1.16	1.16	0.29
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	15.25	2.39	2.99	0.60	8.67	2.69	4.19	0.60	1.79	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	11.07	5.53	2.21	0.55	7.19	1.66	7.19	1.66	3.32	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	10.60	1.77	1.06	1.06	7.42	2.12	2.83	1.77	0.35	0.35
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	11.80	3.32	2.58	1.48	8.11	2.58	3.69	0.37	1.84	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	8.06	1.15	1.15	0.00	3.45	0.00	8.06	1.15	1.15	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	4.22	2.69	1.54	0.38	10.36	1.92	1.92	0.38	1.54	0.38
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	6.79	1.70	1.13	0.00	8.49	1.13	2.83	0.57	3.40	0.57
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	9.85	2.46	0.82	0.00	9.03	1.64	2.46	0.82	0.82	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	7.23	0.00	1.36	0.00	5.42	0.00	1.36	0.90	0.90	0.45
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	5.03	0.00	2.15	1.44	6.46	1.44	0.72	0.72	2.15	1.44
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	7.47	7.47	1.49	0.75	14.19	2.24	4.48	0.75	0.75	1.49
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	10.03	2.23	1.86	0.74	8.55	1.11	3.72	1.49	1.11	1.11
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	12.06	1.72	2.58	0.43	9.48	2.15	6.46	0.86	3.02	1.29
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	2.57	4.28	0.86	0.86	8.56	1.71	2.57	0.86	0.00	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	10.00	4.33	2.00	1.67	7.33	2.33	6.00	3.00	1.00	1.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	9.65	2.41	1.81	0.60	3.62	0.00	1.81	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	7.11	2.84	1.42	0.00	2.84	0.71	3.55	0.00	0.71	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	11.00	3.78	0.69	1.37	8.59	1.37	5.84	1.72	1.72	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	6.44	1.07	0.54	1.07	9.12	1.07	5.37	1.61	1.61	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	6.06	2.69	2.02	1.35	5.39	1.35	4.71	2.02	1.35	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	10.37	1.85	0.37	0.37	9.63	0.74	4.44	1.85	2.59	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	8.14	5.81	3.49	2.33	5.81	2.33	4.65	1.16	2.33	1.16
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	9.52	0.00	1.06	0.00	7.40	0.00	9.52	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	6.00	3.20	1.20	1.60	10.40	1.20	5.20	0.00	2.40	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	6.54	3.63	0.00	0.00	8.00	0.00	2.91	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	5.37	2.30	2.30	1.53	8.43	0.77	3.83	0.00	2.30	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	4.44	0.99	0.49	0.99	5.43	1.97	2.47	1.48	0.49	0.49
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	7.53	1.88	0.94	0.00	6.59	0.00	0.94	1.88	2.82	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	4.53	0.50	1.01	1.01	7.04	1.51	1.51	0.50	2.01	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	5.41	2.25	1.80	0.00	4.96	0.45	3.15	0.45	0.45	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	5.16	1.72	0.00	1.72	1.72	1.72	8.61	1.72	3.44	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	6.68	3.12	1.34	0.00	5.79	1.34	2.23	1.78	0.45	0.89
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	7.04	2.74	0.78	0.00	6.26	1.17	4.69	0.78	0.78	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	7.92	0.66	1.32	0.00	7.26	0.66	4.62	0.66	0.66	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	5.71	4.15	2.08	0.00	8.30	2.08	5.19	2.08	0.52	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	5.69	2.19	1.31	0.00	7.44	1.75	2.19	1.31	0.88	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	13.98	2.80	0.56	0.00	10.62	1.68	5.03	2.80	1.12	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	13.25	2.65	2.65	1.32	4.86	0.00	0.88	0.88	0.00	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	9.64	1.93	0.77	0.77	9.64	1.54	3.86	1.16	3.09	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	13.17	1.01	1.52	1.01	7.09	0.51	4.05	1.01	1.52	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	11.53	5.29	1.44	1.44	9.61	1.92	4.33	2.88	2.88	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	10.73	6.36	0.40	0.80	7.55	1.19	2.39	0.00	1.19	0.40
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	8.51	4.25	1.22	0.00	7.29	1.82	1.82	2.43	2.43	0.61
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	8.30	1.38	0.69	1.38	8.30	0.69	5.53	0.69	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	15.20	3.42	0.76	0.76	6.84	1.90	6.46	1.14	1.52	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	11.88	2.58	0.52	0.00	7.75	2.07	3.61	1.55	3.61	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	7.26	1.81	1.81	1.81	5.44	0.60	2.42	2.42	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	10.46	3.49	2.22	0.95	6.02	0.95	5.07	1.90	0.95	0.32
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	9.60	1.60	1.60	0.00	9.60	1.60	4.80	0.00	1.07	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	9.19	2.87	1.15	0.00	8.05	0.57	4.02	0.00	1.72	1.15
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	8.74	3.60	0.00	1.03	7.71	1.54	3.60	0.51	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	3.54	3.54	0.71	0.71	7.78	0.00	1.41	1.41	1.41	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	6.24	4.54	1.13	1.13	5.67	0.57	1.70	0.57	1.13	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	7.49	2.08	2.50	0.42	7.49	0.42	2.50	1.25	1.25	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	7.05	1.57	3.13	0.00	5.48	0.78	4.70	0.78	0.78	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	6.26	2.09	2.09	0.84	6.26	1.67	4.59	0.42	2.92	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	3.25	2.32	0.46	0.46	5.58	2.32	3.25	0.46	1.39	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	5.35	0.00	0.67	0.67	7.36	2.01	3.35	0.00	0.67	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	10.16	4.28	2.14	0.53	10.69	0.53	5.88	1.60	3.74	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	4.85	3.64	2.83	1.62	6.06	1.21	4.45	1.21	1.62	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	3.67	0.92	0.00	0.00	3.67	0.92	0.00	0.00	2.75	0.92
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	6.22	3.56	1.78	0.89	6.22	1.78	4.45	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	9.12	2.85	2.28	0.57	5.70	0.57	5.13	0.57	2.28	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	6.14	1.53	0.77	0.00	6.14	1.53	1.53	0.00	0.77	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	14.23	3.28	3.83	1.09	13.68	2.74	3.28	1.09	0.55	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	6.24	3.56	1.34	0.45	5.35	1.34	2.67	1.34	0.00	0.89
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	9.62	4.42	1.30	1.04	7.02	0.78	5.20	1.30	1.30	0.26
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	9.95	1.33	2.65	1.33	7.96	1.99	4.64	1.99	1.99	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	10.39	4.16	0.00	0.00	2.08	2.08	2.08	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	24.84	47.41	3.65	12.54	0.00	3.19	0.68	5.24	1.14	7.98
Macrophage - monocyte derived, donor2	11313-117C8	56.89	30.28	1.65	3.12	0.92	8.26	1.65	4.04	0.92	4.22
Macrophage - monocyte derived, donor3	11389-118C3	40.50	38.54	17.96	14.94	0.79	7.34	1.31	3.41	1.57	5.90
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	12.21	7.97	7.97	5.31	28.14	3.72	13.28	1.06	1.59	1.06
Mallassez-derived cells, donor2	11929-125I3	33.59	12.36	11.25	5.55	47.38	12.99	33.91	1.27	2.06	1.74
Mallassez-derived cells, donor3	11930-125I4	48.92	18.07	14.45	9.73	51.98	17.23	28.35	3.34	3.34	1.39
Mammary Epithelial Cell, donor1	11273-116H4	95.16	22.52	23.32	11.46	45.24	26.70	25.31	2.39	1.79	3.39
Mammary Epithelial Cell, donor2	11350-117G9	72.39	16.50	18.82	11.87	30.69	20.85	20.27	1.16	1.45	0.58
Mammary Epithelial Cell, donor3	11422-118F9	16.46	17.71	3.99	5.74	28.19	3.74	12.97	0.75	1.50	1.00
Mast cell - stimulated, donor1	11487-119E2	137.62	64.40	43.39	86.10	15.59	40.68	30.51	6.78	4.07	8.14
Mast cell, donor1	11563-120D6	56.02	56.13	2.49	9.41	10.06	10.71	13.84	2.27	3.03	4.00
Mast cell, donor2	11565-120D8	104.61	199.40	35.36	75.19	46.66	34.47	19.91	15.45	20.80	17.53
Mast cell, donor3	11566-120D9	77.22	225.80	36.25	77.44	46.83	15.08	18.46	18.91	21.39	13.96
Mast cell, donor4	11567-120E1	84.04	195.55	33.33	62.94	40.07	22.34	18.97	13.83	25.35	17.02
Mast cell, expanded and stimulated, donor5	11940-126A5	36.82	31.27	32.27	41.14	14.31	4.55	16.30	4.10	4.55	4.55
Mast cell, expanded and stimulated, donor8	11942-126A7	16.93	11.09	8.76	51.95	2.92	0.58	8.76	1.75	1.75	2.33
Mast cell, expanded, donor5	11939-126A4	34.99	32.01	14.68	17.21	13.88	3.10	12.73	2.75	7.57	2.98
Mast cell, expanded, donor8	11941-126A6	28.29	40.50	2.34	10.71	13.39	2.18	15.06	4.35	4.69	5.02
Melanocyte - dark, donor1	11502-119F8	23.98	21.39	10.15	18.01	15.02	12.14	4.58	2.89	2.89	1.19
Melanocyte - dark, donor2	11582-120F7	9.69	10.38	1.04	2.77	0.35	2.77	2.42	0.00	0.69	2.08
Melanocyte - dark, donor3	11663-122F7	23.76	30.86	2.10	2.25	1.52	7.39	2.75	2.61	1.81	6.23
Melanocyte - light, donor1	11274-116H5	9.87	15.28	0.71	1.41	0.47	1.88	1.18	1.41	0.47	2.82
Melanocyte - light, donor2	11351-117H1	4.09	10.24	0.68	0.68	0.68	0.00	0.68	0.68	0.68	1.36
Melanocyte - light, donor3	11423-118G1	4.34	6.94	1.73	2.60	0.00	0.00	0.87	1.73	0.00	3.47
Melanocyte, donor1 (MC+1)	12641-134G4	13.54	15.51	11.56	3.96	1.25	5.31	1.87	2.08	1.04	4.37
Melanocyte, donor2 (MC+2)	12739-135I3	19.36	18.02	1.34	4.57	2.15	5.65	3.23	0.27	1.34	2.42
Melanocyte, donor3 (MC+3)	12837-137B2	24.11	19.02	7.23	4.29	0.54	5.89	2.14	1.87	1.61	2.41
Meningeal Cells, donor1	11493-119E8	5.83	21.71	22.83	12.78	3.47	4.09	4.59	3.35	4.71	2.11
Meningeal Cells, donor2	11573-120E7	8.80	14.52	15.85	6.16	2.20	3.52	5.28	3.52	1.76	1.32
Meningeal Cells, donor3	11654-122E7	21.68	15.08	31.87	10.60	8.64	13.20	7.01	5.79	8.15	2.53
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	21.96	27.66	8.27	7.41	6.27	5.42	3.71	2.00	3.42	3.14
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	21.54	8.65	15.60	6.64	4.83	6.14	4.03	2.42	1.01	1.31
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	2.63	10.51	0.00	5.26	0.00	0.00	1.31	0.00	1.31	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	3.92	1.31	15.70	6.54	2.62	0.00	0.00	0.00	0.00	1.31
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	10.76	13.63	7.89	5.74	0.72	2.87	2.15	0.72	1.44	1.44
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	26.47	7.20	13.13	2.96	3.60	5.29	3.18	2.75	5.72	1.48
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	23.12	6.03	13.57	4.02	6.03	10.05	2.51	3.02	2.01	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	5.93	7.25	8.57	9.45	1.54	0.44	1.54	0.66	1.10	1.10
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	5.84	15.34	2.19	5.11	0.00	2.19	2.92	0.00	0.00	1.46
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	4.30	5.93	9.62	9.00	2.66	0.82	0.82	0.61	0.61	1.02
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	17.31	11.63	43.91	20.78	7.89	3.05	5.12	7.48	2.49	2.22
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	1.49	3.72	4.46	1.49	0.37	1.12	0.00	0.37	1.12	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	18.95	15.53	16.58	6.45	0.13	5.53	0.66	3.29	3.16	1.97
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	2.67	6.23	2.67	2.67	3.26	1.19	0.30	2.08	1.19	1.19
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	7.01	9.34	0.00	2.34	0.00	0.00	0.00	2.34	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	6.40	12.17	1.92	3.84	1.28	0.64	0.00	0.64	0.64	2.56
Mesenchymal stem cells - adipose, donor0	11217-116B2	17.37	23.39	6.03	8.15	1.42	4.61	2.84	2.84	0.71	1.42
Mesenchymal stem cells - hepatic, donor0	11218-116B3	15.01	15.95	13.45	6.57	0.31	3.75	0.31	4.69	1.88	1.56
Mesenchymal stem cells - umbilical, donor0	11214-116A8	6.53	16.69	6.53	2.18	2.18	1.45	1.45	1.45	1.45	2.90
Mesothelial Cells, donor1	11247-116E5	33.94	11.67	5.57	3.18	11.14	6.63	6.36	2.65	1.33	2.92
Mesothelial Cells, donor2	12156-128G5	19.52	11.01	21.52	2.00	22.02	2.50	4.00	0.50	0.50	2.50
Mesothelial Cells, donor3	11402-118D7	20.31	13.44	20.23	6.87	8.74	5.85	5.56	2.60	1.88	1.73
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	232.26	112.08	4.05	14.85	0.00	32.41	6.75	13.50	2.70	17.55
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	83.98	50.24	2.96	9.60	1.23	14.04	1.97	4.68	1.72	7.14
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	75.68	32.98	2.36	5.01	1.47	12.07	4.12	5.30	0.88	5.30
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	86.43	69.14	0.00	0.00	3.46	3.46	3.46	3.46	3.46	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	63.85	32.54	0.93	7.44	0.62	9.61	1.86	2.17	1.55	3.10
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	57.25	23.85	1.45	3.94	1.66	11.82	1.87	2.07	1.04	4.56
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	106.54	50.95	4.63	13.90	0.00	6.95	0.00	6.95	0.00	6.95
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	57.06	37.54	2.25	7.26	1.75	7.26	1.25	3.00	1.50	4.50
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	108.46	29.33	2.79	9.31	2.79	9.78	2.79	4.65	1.86	4.65
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	38.93	38.93	19.47	19.47	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	56.90	36.99	2.03	5.49	0.20	9.75	1.22	3.25	2.64	4.27
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	59.39	21.38	1.98	7.92	1.98	8.32	2.38	3.17	2.38	4.36
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	111.17	59.86	0.00	8.55	8.55	42.76	0.00	0.00	0.00	8.55
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	28.32	22.12	1.77	8.85	0.00	8.85	0.88	1.77	0.00	7.08
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	61.17	17.86	1.14	3.80	1.52	11.78	0.76	4.56	1.52	4.94
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	103.96	69.74	5.26	21.05	1.32	9.21	3.95	0.00	2.63	3.95
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	41.81	25.68	1.91	8.70	0.64	12.95	0.85	1.70	1.06	2.97
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	78.27	23.94	2.76	7.37	0.92	2.76	1.84	1.84	0.92	4.60
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	51.86	28.02	5.37	10.13	0.89	12.52	1.19	3.58	0.60	3.87
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	159.28	46.95	1.68	11.74	1.68	16.77	3.35	3.35	0.00	1.68
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	271.59	0.00	0.00	0.00	0.00	33.95	0.00	0.00	0.00	33.95
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	57.71	28.85	2.51	9.79	0.75	13.80	0.50	2.01	2.51	3.76
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	58.47	23.05	5.23	6.89	0.95	11.88	1.90	3.09	1.19	3.57
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	113.89	58.61	14.93	30.41	4.42	15.48	3.87	3.32	1.11	8.29
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	59.63	35.00	8.75	10.82	0.69	16.12	1.38	0.46	1.15	4.14
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	72.57	28.61	3.37	9.47	1.89	11.99	3.37	4.63	1.26	4.42
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	55.85	36.49	8.15	14.27	0.82	9.38	0.61	0.82	0.82	3.47
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	60.71	33.90	5.58	8.58	0.64	11.80	0.21	1.50	0.64	1.93
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	73.13	38.46	4.00	12.45	2.00	12.67	2.89	3.78	1.78	2.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	144.46	61.91	0.00	20.64	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	63.95	29.13	12.92	15.11	1.31	13.14	0.66	2.41	1.31	1.75
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	123.70	38.02	8.11	16.73	3.55	17.24	4.06	3.55	1.52	4.56
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	117.65	48.05	28.17	49.71	6.63	8.28	1.66	3.31	0.00	6.63
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	95.94	54.63	16.31	26.64	1.09	19.03	2.17	2.45	1.63	3.81
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	92.93	32.35	4.12	12.65	3.82	14.41	1.47	5.29	0.59	4.12
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	90.50	58.88	20.72	35.98	3.27	7.63	1.09	4.36	1.09	1.09
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	49.50	30.76	7.21	16.82	0.96	11.53	0.48	0.96	1.92	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	66.44	29.22	4.40	14.41	2.40	15.61	1.60	2.40	1.20	2.80
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	90.50	71.30	27.42	23.31	5.48	10.97	0.00	2.74	2.74	5.48
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	54.56	31.54	11.51	20.02	0.00	16.02	1.00	3.50	2.00	2.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	53.89	53.89	0.00	26.95	0.00	26.95	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	97.85	61.16	18.35	30.58	0.00	14.27	2.04	4.08	0.00	4.08
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	54.30	31.53	7.88	18.39	1.75	9.63	2.63	0.88	1.75	0.88
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	125.82	65.12	12.14	22.07	3.31	16.55	1.10	4.41	2.21	4.41
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	85.81	105.66	23.69	38.42	3.20	13.45	0.64	4.48	1.92	5.12
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	53.80	38.18	14.63	21.07	2.48	11.40	0.99	2.73	2.73	2.48
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	95.34	61.93	14.61	25.75	4.18	16.70	4.18	6.26	0.70	5.57
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	86.18	90.60	28.73	22.10	11.05	8.84	6.63	6.63	4.42	6.63
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	40.00	43.42	4.44	16.75	1.71	5.81	1.03	1.71	1.71	3.42
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	112.03	79.21	10.07	26.26	7.44	20.13	3.06	2.63	2.63	3.06
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	67.11	87.00	16.33	31.25	3.55	11.72	2.49	3.20	1.78	4.26
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	39.84	40.96	5.89	14.03	2.81	7.01	1.12	2.24	1.40	2.52
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	93.93	52.37	10.81	20.78	5.82	17.46	6.23	5.82	2.49	4.57
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	67.60	94.99	14.57	33.80	5.24	6.41	2.91	2.33	0.00	2.91
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	34.99	48.57	9.35	23.83	0.90	6.94	1.21	3.02	0.90	1.81
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	80.56	55.93	8.77	12.94	3.34	11.69	3.34	3.34	0.83	2.92
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	50.53	151.60	14.44	14.44	0.00	7.22	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	55.41	45.25	15.70	12.93	0.92	2.77	1.85	1.85	3.69	5.54
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	100.16	59.19	5.12	18.78	5.69	21.63	5.69	1.71	3.98	1.14
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	40.76	84.43	9.26	21.97	1.52	8.43	2.63	2.49	1.80	5.11
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	37.84	42.76	5.70	9.59	1.30	7.00	2.59	1.04	1.81	1.04
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	103.81	58.77	3.86	18.02	6.01	18.45	4.29	3.86	2.57	4.72
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	51.45	87.02	8.89	25.41	2.54	4.45	1.27	5.08	0.64	1.27
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	49.64	58.45	9.87	17.35	2.14	5.34	1.60	3.20	3.74	2.40
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	70.04	46.70	5.99	11.37	2.99	13.47	3.59	3.89	0.60	4.49
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	25.43	60.74	6.36	10.59	1.13	3.81	0.85	2.54	0.71	3.39
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	27.39	28.03	4.46	7.33	0.96	5.10	1.59	0.96	0.64	1.91
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	64.13	61.70	6.19	13.71	2.43	14.59	5.75	3.10	0.88	4.20
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	39.44	78.49	9.10	20.10	1.90	3.41	2.28	1.52	1.52	1.90
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	39.21	52.56	9.66	8.24	1.42	8.81	1.99	1.70	1.42	1.99
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	47.19	39.08	4.92	11.31	1.72	8.60	3.20	2.95	1.23	4.18
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	56.04	56.70	6.52	13.69	0.65	6.52	0.65	3.91	0.65	5.21
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	36.17	43.22	2.94	10.88	0.29	4.12	0.29	2.35	3.82	1.76
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	52.19	39.50	3.17	7.50	2.88	7.21	2.88	2.59	1.44	3.17
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	56.05	48.63	3.71	11.13	1.24	8.66	0.82	5.77	2.06	5.36
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	41.69	47.05	2.68	10.12	0.30	3.87	1.19	1.49	1.19	3.57
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	11.30	15.07	0.00	3.77	0.00	0.00	0.00	3.77	3.77	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	23.17	17.82	5.35	7.13	0.00	0.00	0.00	7.13	1.78	1.78
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	23.33	35.81	1.97	5.59	0.33	1.64	0.66	2.63	2.30	4.93
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	23.14	16.83	3.16	7.36	1.05	1.05	0.00	4.21	3.16	5.26
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	15.42	24.71	2.57	7.51	0.20	2.57	0.40	2.57	1.19	3.56
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	40.98	26.08	3.73	15.83	0.00	7.45	0.93	7.45	0.00	6.52
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	24.78	31.17	1.50	7.51	0.00	3.38	0.38	5.63	1.88	5.26
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	38.62	21.57	0.53	3.46	0.53	2.93	0.80	2.93	2.40	4.53
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	10.52	23.53	2.26	3.17	0.11	1.81	1.02	2.04	0.90	2.60
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	27.26	16.94	2.95	10.31	0.00	2.21	0.74	3.68	0.74	2.95
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	18.69	34.08	2.56	3.30	0.00	2.20	0.37	1.83	2.20	3.66
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	18.67	26.45	1.56	10.89	0.00	1.56	0.00	1.56	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	21.38	29.39	2.14	5.88	1.07	2.67	0.00	0.53	0.53	3.74
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	23.18	7.73	3.86	11.59	0.00	7.73	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	31.31	28.28	4.04	9.09	0.00	4.04	3.03	7.07	2.02	1.01
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	29.94	19.40	3.37	4.64	0.00	5.48	0.42	3.37	1.26	5.48
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	35.41	29.96	0.00	9.53	1.36	12.26	0.00	2.72	1.36	2.72
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	31.15	13.99	3.81	6.36	0.64	8.27	0.00	1.27	1.27	1.91
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	23.49	21.06	4.86	5.67	0.81	3.24	1.62	0.81	1.62	4.05
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	28.70	19.64	0.00	4.53	3.02	19.64	0.00	6.04	0.00	1.51
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	177.02	34.26	22.84	17.13	11.42	91.36	0.00	0.00	5.71	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	202.27	13.05	3.26	9.79	22.84	65.25	0.00	0.00	0.00	3.26
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	57.03	57.03	14.26	0.00	0.00	23.76	0.00	4.75	4.75	4.75
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	225.88	12.55	25.10	0.00	25.10	50.20	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	25.64	10.56	10.56	4.31	9.05	6.03	3.66	4.74	6.68	1.29
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	25.61	10.97	10.97	4.18	0.52	3.14	0.00	5.23	5.75	2.09
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	44.05	15.35	8.01	8.68	6.67	4.00	8.01	2.00	2.67	1.33
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	37.15	18.78	7.10	7.51	12.52	3.76	5.43	3.76	2.09	4.17
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	38.79	35.37	63.13	15.97	23.96	6.46	8.56	3.80	3.61	5.70
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	116.50	90.96	97.35	41.49	62.24	17.55	28.73	7.98	23.94	7.98
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	23.80	5.44	21.08	8.16	8.84	2.04	5.44	0.68	1.36	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	67.99	69.83	47.78	23.89	51.45	3.68	9.19	5.51	18.38	5.51
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	19.67	10.04	7.95	7.12	6.70	0.84	4.19	0.84	2.51	1.26
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	30.91	22.55	14.64	7.21	12.32	4.42	4.42	2.09	1.39	2.56
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	17.83	12.16	32.43	13.24	10.54	4.05	4.32	3.51	1.89	1.35
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	22.29	21.65	25.02	12.82	8.41	4.41	5.68	6.94	4.63	3.15
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	55.67	267.23	322.91	111.35	89.08	11.13	11.13	33.40	22.27	33.40
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	14.39	16.88	12.91	6.45	7.45	1.99	3.47	3.47	0.99	2.48
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	21.92	10.29	11.91	3.79	6.77	0.81	3.79	1.62	1.89	2.71
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	17.23	13.83	13.37	7.71	7.25	3.40	3.63	2.72	1.13	1.36
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	16.98	11.76	29.88	10.29	8.82	0.82	4.90	3.10	2.29	2.45
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	16.04	17.68	25.15	13.30	7.47	5.10	5.65	6.20	3.10	3.65
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	21.75	9.55	21.75	5.83	6.90	3.18	6.37	3.71	2.12	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	25.81	9.00	12.61	7.80	4.80	2.40	1.80	1.80	1.20	1.20
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	34.13	28.22	21.66	9.19	11.16	5.58	5.91	6.24	2.30	3.94
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	17.08	13.99	13.82	5.53	8.46	2.60	2.93	2.28	0.98	2.11
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	34.04	35.81	45.68	23.81	15.17	7.41	7.06	8.11	4.41	4.94
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	16.88	5.63	11.25	6.33	7.03	2.81	2.81	3.52	1.41	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	18.39	8.73	18.39	11.95	5.52	1.84	0.92	1.84	0.92	1.38
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	17.67	9.00	12.53	4.50	4.82	1.61	4.82	1.61	0.64	1.93
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	26.56	28.63	30.35	11.38	22.07	6.55	4.48	5.86	2.41	5.52
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	40.46	161.82	283.19	53.10	83.44	12.64	17.70	17.70	15.17	12.64
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	30.97	20.50	30.30	15.37	9.80	3.56	6.02	6.68	1.78	3.79
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	19.05	10.58	13.13	5.50	6.77	2.12	2.96	2.54	2.12	1.27
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	19.70	16.38	17.33	8.78	8.78	2.61	3.32	3.56	2.14	3.80
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	21.46	8.58	7.73	3.00	5.15	0.86	3.00	3.00	1.29	2.58
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	54.17	153.47	162.50	54.17	126.39	18.06	27.08	9.03	0.00	27.08
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	25.66	13.00	24.99	6.00	9.33	3.67	3.67	3.00	3.00	2.67
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	45.99	13.08	18.03	7.66	4.06	2.71	3.61	4.51	3.16	3.61
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	16.67	4.36	13.09	5.56	5.16	2.38	2.78	1.59	0.40	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	13.93	5.57	13.93	7.43	1.86	2.79	0.93	3.71	0.93	2.79
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	26.86	11.73	7.57	3.41	5.68	4.54	3.78	3.41	2.27	2.65
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	22.49	10.75	7.17	3.26	6.19	3.58	2.93	1.63	0.98	4.89
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	22.66	13.07	26.58	6.54	9.15	2.61	3.49	2.18	2.18	3.49
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	50.66	18.09	21.26	8.59	8.59	5.88	6.33	7.24	2.71	3.62
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	20.28	7.06	13.23	3.53	1.76	3.53	0.88	1.76	0.88	1.76
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	17.29	9.31	7.98	5.32	6.65	1.33	0.66	1.99	1.33	1.33
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	21.83	11.91	8.43	3.47	7.44	3.97	5.46	4.46	0.00	3.97
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	23.74	14.16	7.27	3.45	4.98	3.06	4.21	1.91	0.38	2.30
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	21.78	8.47	26.31	3.63	9.07	4.54	2.12	2.12	1.21	3.02
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	30.28	13.04	10.39	7.51	2.43	3.98	3.76	3.09	1.77	3.54
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	21.01	5.42	9.49	2.71	4.74	2.71	3.39	2.03	0.68	1.36
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	51.10	122.63	127.74	30.66	25.55	0.00	10.22	35.77	5.11	5.11
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	29.87	7.93	6.71	1.83	1.83	1.83	5.49	1.83	0.61	1.83
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	21.40	9.44	9.76	1.57	5.98	1.26	2.20	1.89	1.26	2.83
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	35.11	12.71	27.24	6.96	6.66	3.93	6.36	2.42	0.91	2.42
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	18.99	3.96	8.70	3.16	3.16	3.96	1.58	1.58	1.58	1.58
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	41.94	20.41	46.48	13.60	11.34	7.94	3.40	4.53	5.67	7.94
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	45.52	60.69	85.98	30.35	20.23	10.12	10.12	10.12	0.00	5.06
Myoblast, donor1	11241-116D8	18.51	14.16	21.24	9.44	9.07	3.85	2.48	1.37	0.62	2.36
Myoblast, donor2	11322-117D8	18.80	29.54	27.81	13.81	8.25	4.60	1.73	1.73	1.73	4.03
Myoblast, donor3	11398-118D3	21.19	30.77	16.98	8.74	5.55	6.56	4.37	1.18	2.02	4.37
NK T cell leukemia cell line:KHYG-1	10777-110G3	0.00	33.27	1.61	4.38	2.77	0.00	6.13	2.04	4.23	1.90
Natural Killer Cells, donor1	11230-116C6	33.83	83.03	16.91	44.28	9.84	7.69	4.92	2.46	12.61	4.92
Natural Killer Cells, donor2	11311-117C6	25.63	87.45	15.38	34.38	7.84	3.62	5.13	1.51	14.17	1.81
Natural Killer Cells, donor3	11387-118C1	20.98	84.66	11.78	32.03	6.44	3.68	3.68	2.39	9.94	1.66
Neural stem cells, donor1	11275-116H6	41.74	19.60	6.17	5.08	6.17	7.62	3.63	5.08	9.80	3.99
Neural stem cells, donor2	11352-117H2	38.51	17.33	3.85	1.93	0.00	17.33	1.93	1.93	5.78	0.00
Neurons, donor1	11494-119E9	14.79	2.28	9.10	2.28	1.14	4.55	0.00	0.00	1.14	1.14
Neurons, donor2	11574-120E8	8.37	4.40	2.20	0.88	1.10	1.76	1.32	0.22	1.98	0.44
Neurons, donor3	11655-122E8	16.44	2.47	6.58	0.82	0.82	3.29	0.00	0.00	0.82	0.00
Neutrophils, donor1	11233-116C9	61.25	47.33	21.34	25.98	0.93	11.14	0.93	7.42	6.50	1.86
Neutrophils, donor2	11314-117C9	31.89	28.99	5.80	5.80	0.00	2.90	0.00	5.80	2.90	0.00
Neutrophils, donor3	11390-118C4	91.63	63.53	20.16	46.42	0.61	23.21	0.61	7.94	11.00	7.33
Nucleus Pulposus Cell, donor1	11252-116F1	23.63	33.60	21.97	16.15	2.73	3.44	2.97	3.32	0.95	2.85
Nucleus Pulposus Cell, donor2	11409-118E5	9.77	16.28	9.12	10.74	0.98	0.65	1.63	2.28	1.95	1.30
Nucleus Pulposus Cell, donor3	11462-119B4	15.24	15.84	13.64	8.62	1.40	2.21	2.01	3.41	3.21	2.81
Olfactory epithelial cells, donor1	11933-125I7	16.79	20.37	15.14	11.15	6.74	2.06	2.48	4.40	1.10	4.40
Olfactory epithelial cells, donor2	11934-125I8	29.38	25.19	12.88	7.96	9.84	6.37	5.21	3.62	2.03	5.07
Olfactory epithelial cells, donor3	11935-125I9	23.84	19.98	12.71	7.38	10.67	4.99	3.97	3.97	2.27	3.52
Olfactory epithelial cells, donor4	11936-126A1	31.17	22.99	65.84	19.09	16.17	5.65	5.26	4.97	2.53	4.19
Oligodendrocyte - precursors, donor1	11496-119F2	66.20	41.53	5.42	4.81	3.01	22.27	3.61	3.61	1.81	3.61
Osteoblast - differentiated, donor1	11276-116H7	18.08	14.68	32.54	13.61	5.32	4.25	2.77	5.74	2.55	4.47
Osteoblast - differentiated, donor2	11353-117H3	8.00	9.14	6.86	3.43	2.29	2.29	1.14	4.57	5.72	1.14
Osteoblast - differentiated, donor3	11425-118G3	5.59	10.55	26.69	9.31	1.86	2.48	0.62	1.24	1.24	0.62
Osteoblast, donor1	11277-116H8	11.92	2.15	13.49	6.06	0.98	3.91	1.56	0.39	1.76	0.00
Osteoblast, donor2	11354-117H4	29.50	11.94	6.32	5.62	7.02	9.83	4.21	4.21	5.62	3.51
Osteoblast, donor3	11426-118G4	21.15	14.93	14.22	9.42	2.67	4.62	2.13	2.49	3.38	2.31
Pancreatic stromal cells, donor1	11249-116E7	22.83	34.87	28.13	18.62	10.61	7.08	8.42	6.49	2.27	4.63
Pericytes, donor1	11491-119E6	2.89	4.12	0.78	1.56	0.67	0.56	0.45	0.78	1.00	0.45
Pericytes, donor2	11571-120E5	3.17	5.43	4.98	3.62	0.45	0.23	1.36	1.36	0.45	0.45
Pericytes, donor3	11652-122E5	2.44	7.73	13.83	7.53	4.07	1.42	1.42	0.81	1.42	1.42
Perineurial Cells, donor1	11499-119F5	20.68	18.20	17.29	8.48	11.30	7.80	9.27	5.09	3.62	1.81
Perineurial Cells, donor2	11579-120F4	14.45	20.79	4.78	4.78	1.29	4.69	1.75	1.20	0.74	2.76
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	28.37	65.34	55.14	96.58	2.55	2.55	2.87	4.46	9.88	2.23
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	25.71	54.11	25.22	60.97	1.71	4.41	2.20	6.37	4.65	2.20
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	17.08	70.79	39.08	56.55	1.81	2.07	3.24	4.27	9.19	1.81
Placental Epithelial Cells, donor1	11278-116H9	19.37	1.91	4.30	2.63	9.09	5.98	4.30	1.43	1.43	0.00
Placental Epithelial Cells, donor2	11355-117H5	15.52	2.22	1.11	1.11	12.20	2.22	6.65	2.22	2.22	0.00
Placental Epithelial Cells, donor3	11427-118G5	18.85	3.14	4.91	3.53	6.28	3.73	5.69	1.18	3.34	0.79
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	8.86	6.65	10.44	3.16	1.58	1.90	4.11	1.27	0.95	0.63
Preadipocyte - breast, donor1	11467-119B9	27.20	6.00	11.82	3.38	9.00	6.19	3.19	6.19	3.00	2.81
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	25.45	24.54	35.11	8.75	11.75	12.79	3.00	3.92	2.48	4.70
Preadipocyte - breast, donor2	11328-117E5	18.46	16.66	18.46	3.60	4.28	4.95	2.93	4.95	1.58	1.35
Preadipocyte - omental, donor1	11468-119C1	35.59	6.07	29.73	5.22	10.55	11.19	4.05	8.95	5.11	1.92
Preadipocyte - omental, donor2	11329-117E6	29.68	15.71	8.29	3.93	13.09	5.67	3.93	3.93	2.18	6.11
Preadipocyte - omental, donor3	11403-118D8	26.79	10.03	8.74	3.15	8.59	7.59	3.87	4.44	3.44	3.87
Preadipocyte - perirenal, donor1	11469-119C2	2.95	2.95	9.84	1.97	12.80	2.95	1.97	5.91	1.97	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	11.36	8.29	4.61	4.30	4.30	2.15	2.76	1.23	0.61	1.54
Preadipocyte - subcutaneous, donor2	11356-117H6	24.08	32.23	13.28	13.81	2.66	5.49	5.67	1.59	2.12	3.36
Preadipocyte - subcutaneous, donor3	11428-118G6	12.60	22.14	8.85	5.28	4.94	2.72	5.45	3.58	4.77	3.92
Preadipocyte - visceral, donor1	11280-116I2	34.56	42.10	12.11	16.02	13.41	7.36	9.04	4.28	3.26	4.47
Preadipocyte - visceral, donor2	11357-117H7	21.17	26.69	15.65	14.27	14.27	3.22	11.50	4.60	4.60	1.84
Preadipocyte - visceral, donor3	11429-118G7	18.29	30.09	11.60	13.17	17.87	4.91	9.93	3.97	2.09	3.76
Prostate Epithelial Cells (polarized), donor1	11253-116F2	2.26	30.32	16.59	7.24	66.38	0.45	8.90	8.45	5.58	2.72
Prostate Epithelial Cells, donor2	11331-117E8	10.29	26.95	14.49	13.27	95.74	3.66	23.02	3.66	4.47	2.84
Prostate Epithelial Cells, donor3	11404-118D9	116.90	21.74	6.00	6.98	19.53	34.84	7.04	7.47	7.35	3.37
Prostate Stromal Cells, donor1	11254-116F3	14.92	17.88	11.16	5.70	8.20	3.64	5.92	3.76	2.28	3.99
Prostate Stromal Cells, donor2	11332-117E9	17.03	21.52	11.48	10.04	5.56	5.02	4.48	2.69	3.41	1.61
Prostate Stromal Cells, donor3	11405-118E1	14.60	19.81	14.18	6.26	6.78	3.02	5.53	4.17	1.98	2.61
Renal Cortical Epithelial Cells, donor1	11516-119H4	3.28	27.01	6.57	11.68	4.01	1.09	3.28	1.09	1.09	0.73
Renal Cortical Epithelial Cells, donor2	11596-120H3	31.33	23.57	17.81	19.06	13.10	11.09	7.21	1.25	1.66	2.50
Renal Epithelial Cells, donor1	11517-119H5	2.03	12.17	0.00	3.04	2.03	0.00	1.01	0.00	0.51	0.00
Renal Epithelial Cells, donor2	11597-120H4	6.40	12.80	1.42	2.85	2.13	0.00	1.42	0.00	2.85	0.00
Renal Epithelial Cells, donor3	11678-122H4	22.44	29.11	6.14	11.43	5.61	5.50	6.46	1.91	2.65	3.49
Renal Glomerular Endothelial Cells, donor1	11514-119H2	2.72	14.98	2.72	4.09	0.00	0.00	0.68	2.04	0.68	1.36
Renal Glomerular Endothelial Cells, donor2	11594-120H1	8.49	14.55	6.20	12.26	2.02	1.35	2.16	0.94	0.81	0.27
Renal Glomerular Endothelial Cells, donor3	11675-122H1	29.75	24.87	4.22	7.10	5.55	10.43	5.33	2.22	2.44	3.11
Renal Glomerular Endothelial Cells, donor4	11783-124B1	1.33	6.65	0.67	2.00	0.00	1.33	0.00	0.67	2.00	0.67
Renal Mesangial Cells, donor1	11518-119H6	4.40	12.55	2.42	4.18	2.20	0.88	1.54	1.32	2.20	1.54
Renal Mesangial Cells, donor2	11598-120H5	1.88	15.05	1.25	2.51	1.25	1.88	0.63	3.13	3.13	0.63
Renal Mesangial Cells, donor3	11679-122H5	1.39	8.04	1.94	3.61	0.55	0.00	1.66	0.28	0.55	0.55
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	15.03	40.53	4.56	7.78	3.22	4.83	4.56	0.81	1.34	1.61
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	16.87	19.82	1.69	5.06	0.42	2.95	1.69	0.42	0.00	1.69
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	4.82	21.21	2.12	6.75	1.93	0.77	2.31	1.54	0.77	1.93
Retinal Pigment Epithelial Cells, donor0	11215-116A9	22.30	8.04	5.96	5.96	0.78	7.78	1.56	0.52	1.04	1.04
Retinal Pigment Epithelial Cells, donor1	11528-119I7	6.82	3.70	0.28	1.42	1.71	1.14	1.14	0.57	1.14	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	5.15	4.12	1.03	6.17	0.00	1.03	1.03	1.03	0.00	1.03
Retinal Pigment Epithelial Cells, donor3	11689-122I6	20.32	1.51	5.02	4.01	1.51	6.02	1.00	1.51	1.51	0.50
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	149.67	33.68	24.05	10.56	8.55	34.08	4.54	6.95	2.81	6.82
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	41.99	12.51	12.51	7.15	22.34	8.04	8.93	6.25	4.47	1.79
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	32.47	8.26	12.66	10.46	15.96	17.61	6.05	10.46	8.26	2.20
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	68.45	27.26	23.78	15.66	48.14	16.82	22.62	11.02	11.02	4.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	24.18	18.98	7.02	4.03	17.42	6.89	11.44	5.85	2.34	4.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	17.68	17.18	5.06	4.27	7.25	4.17	7.55	2.88	2.68	2.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	18.29	13.50	4.24	3.35	11.82	5.69	7.70	1.34	1.67	2.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	21.96	21.83	7.32	6.08	12.78	8.06	9.80	2.23	2.60	5.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	20.63	16.08	4.89	5.36	10.61	3.61	8.39	1.75	1.86	3.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	18.95	13.87	5.78	2.54	10.86	4.85	6.24	3.47	2.31	3.93
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	19.99	17.94	6.02	4.24	9.31	5.48	6.98	2.60	3.83	2.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	21.78	18.76	4.54	4.69	12.40	5.14	7.11	2.87	3.03	3.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	18.99	15.95	3.58	3.40	10.21	3.76	7.71	1.79	2.15	2.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	15.64	17.36	6.03	4.45	8.89	4.59	7.17	2.73	1.86	2.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	17.92	13.63	4.08	3.43	7.73	4.61	6.01	1.29	2.15	3.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	17.26	19.03	3.10	5.75	10.40	5.75	5.75	3.32	1.99	3.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	22.94	20.84	6.12	3.25	11.28	5.35	10.32	3.44	3.25	3.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	23.01	22.36	6.34	3.91	9.60	5.59	6.06	2.61	2.14	3.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	23.11	16.35	5.83	4.70	13.15	6.76	9.40	3.57	3.76	2.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	26.67	23.36	7.70	6.37	11.55	6.24	10.35	3.58	2.65	2.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	20.05	22.58	6.04	5.65	9.25	4.58	7.79	2.63	3.31	4.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	17.19	18.14	5.16	3.63	9.36	5.92	8.59	2.48	2.29	3.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	17.83	16.77	6.19	6.83	11.11	5.55	8.54	2.46	2.67	3.95
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	21.30	16.26	6.45	5.05	13.73	4.20	4.77	3.08	2.24	3.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	21.87	18.29	4.27	5.64	7.18	6.32	8.72	2.39	3.08	2.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	19.14	17.14	7.11	5.29	10.76	5.47	7.84	2.37	2.92	2.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	18.52	15.82	5.40	4.29	9.93	5.15	5.15	1.96	2.08	4.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	19.75	15.85	4.03	3.49	9.94	4.57	7.66	3.36	2.42	2.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	20.05	10.61	4.48	3.54	5.66	4.72	5.66	1.65	2.83	1.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	19.05	19.25	5.95	3.77	8.53	4.17	4.37	3.57	3.17	3.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	17.07	14.50	6.31	3.04	11.46	4.91	7.02	2.81	2.34	1.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	18.04	13.06	6.22	2.49	7.05	5.60	5.18	2.07	4.35	2.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	23.67	13.27	5.09	4.42	8.41	7.30	6.86	1.33	3.10	3.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	22.14	18.80	3.97	3.97	10.86	6.27	5.64	3.34	2.30	2.92
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	21.00	14.80	5.25	4.58	9.56	5.92	7.40	3.10	2.02	2.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	28.78	24.18	8.34	5.62	11.41	6.64	9.88	1.53	2.90	2.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	21.79	18.32	7.90	4.43	14.27	4.43	5.78	2.70	1.74	5.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	16.68	11.69	5.33	4.81	7.22	4.30	4.99	2.41	3.61	2.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	23.18	20.85	6.31	4.12	9.33	4.39	7.54	3.43	2.47	3.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	21.51	17.07	7.22	4.93	11.66	5.25	6.90	3.12	2.13	2.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	19.26	17.72	6.48	3.58	12.10	4.77	9.37	3.75	4.09	2.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	18.64	19.53	5.77	3.99	10.95	6.21	6.07	1.92	2.66	4.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	23.99	17.59	6.66	4.80	11.46	5.06	9.60	2.13	1.87	1.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	20.05	14.93	8.99	5.53	12.44	6.36	8.16	4.56	2.63	4.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	12.86	21.19	5.71	3.81	10.71	3.57	7.62	1.90	3.81	4.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	29.43	34.87	12.50	9.07	22.57	5.04	14.31	4.43	4.03	4.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	16.86	18.65	6.59	5.65	13.56	4.52	8.19	4.99	3.30	3.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	27.25	16.07	5.59	5.59	13.97	7.69	8.38	9.08	4.19	2.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	27.20	14.20	7.86	4.53	18.74	7.86	6.95	5.74	6.35	5.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	15.67	17.13	5.39	6.85	13.58	4.90	8.44	4.65	3.06	4.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	31.88	20.52	11.35	9.32	20.09	12.95	11.94	7.71	4.80	5.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	29.81	14.60	8.52	5.48	13.39	7.30	7.30	5.48	3.04	2.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	15.97	18.08	8.44	4.22	10.85	4.82	8.74	3.01	4.52	3.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	22.17	13.57	8.60	3.85	11.76	5.88	6.79	6.56	3.17	2.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	30.55	16.47	10.18	8.69	15.88	8.39	11.08	4.79	4.49	3.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	18.77	10.98	7.67	5.31	15.82	6.85	7.08	4.49	2.83	4.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	20.92	9.82	8.54	7.04	11.10	6.19	6.83	4.06	2.35	3.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	32.45	24.04	16.83	4.21	19.83	9.62	6.01	3.61	4.81	1.80
Schwann Cells, donor1	11498-119F4	3.95	10.34	6.96	4.89	1.32	0.75	0.38	1.13	0.94	0.19
Schwann Cells, donor2	11578-120F3	3.40	13.61	3.40	10.21	0.00	3.40	3.40	10.21	6.80	0.00
Schwann Cells, donor3	11659-122F3	9.42	13.14	23.22	5.04	5.26	2.63	4.38	1.75	5.48	1.31
Sebocyte, donor1	11220-116B5	25.75	18.62	2.74	4.38	16.43	5.48	16.43	3.83	2.74	3.29
Sebocyte, donor2	11301-117B5	14.25	11.49	1.84	6.43	14.25	2.76	10.11	1.84	1.38	1.38
Sebocyte, donor3	11378-118B1	8.66	14.43	8.45	4.33	7.63	2.06	3.50	2.27	2.06	2.27
Sertoli Cells, donor1	11255-116F4	23.19	16.57	33.13	9.94	14.91	13.25	1.66	8.28	9.94	4.97
Sertoli Cells, donor2	11333-117F1	16.95	2.82	59.31	8.47	16.95	5.65	0.00	16.95	16.95	0.00
Skeletal Muscle Cells, donor1	11281-116I3	16.89	16.80	17.86	13.02	5.45	2.02	3.78	6.07	5.37	3.70
Skeletal Muscle Cells, donor2	11358-117H8	10.12	3.61	7.95	2.89	0.00	0.00	0.72	0.72	0.72	0.72
Skeletal Muscle Cells, donor3	11430-118G8	5.85	15.05	12.54	8.36	8.36	2.51	1.67	0.84	1.67	2.51
Skeletal Muscle Cells, donor4	11451-119A2	21.21	24.35	7.85	9.74	3.77	5.03	4.24	1.89	0.63	2.36
Skeletal Muscle Cells, donor5	11455-119A6	22.74	21.70	7.28	5.20	3.42	5.50	2.97	2.23	1.04	2.23
Skeletal Muscle Cells, donor6	11459-119B1	20.16	27.24	5.54	8.77	2.31	8.46	4.77	1.85	0.92	2.92
Skeletal Muscle Satellite Cells, donor1	11240-116D7	18.52	27.22	46.87	33.64	7.94	5.04	10.08	3.02	2.02	3.40
Skeletal Muscle Satellite Cells, donor2	11321-117D7	16.55	36.39	17.55	14.70	5.56	3.00	4.71	4.00	2.00	4.71
Skeletal Muscle Satellite Cells, donor3	11397-118D2	21.53	25.00	44.05	17.36	4.37	5.36	3.37	2.18	0.89	2.68
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	17.52	13.40	10.36	5.56	4.80	2.95	3.96	3.37	4.21	3.71
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	15.92	13.75	3.62	4.34	1.45	0.72	1.45	2.17	4.34	1.45
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	10.87	6.60	8.94	5.37	5.37	2.20	2.75	2.48	1.79	0.96
Skin - palm, donor1	10286-104F7	225.63	48.35	169.22	56.41	102.07	34.92	13.43	18.80	32.23	10.74
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	15.86	8.94	2.31	2.88	15.57	2.59	7.64	1.59	2.88	1.44
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	59.71	34.35	17.18	4.09	71.16	8.18	38.44	9.81	17.99	4.09
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	17.14	9.35	2.99	2.21	8.44	4.41	8.05	1.43	1.30	1.43
Small Airway Epithelial Cells, donor1	11256-116F5	57.97	17.24	8.90	15.01	47.96	16.96	19.88	3.89	5.98	2.92
Small Airway Epithelial Cells, donor2	11334-117F2	53.31	30.80	8.58	13.08	25.88	16.60	19.83	5.20	5.77	3.09
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	44.40	38.69	5.50	8.88	56.24	25.58	41.87	6.34	8.03	2.96
Small Airway Epithelial Cells, donor3	11406-118E2	80.27	35.75	7.05	10.27	19.94	21.29	12.82	8.92	9.52	3.60
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	25.00	12.03	9.26	3.70	8.95	2.16	7.71	4.01	4.01	3.09
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	13.12	16.23	11.12	10.00	21.34	3.78	4.45	8.23	6.00	2.22
Smooth Muscle Cells - Aortic, donor0	11210-116A4	11.17	22.34	9.41	5.88	5.88	1.76	2.35	1.76	0.00	1.76
Smooth Muscle Cells - Aortic, donor1	11283-116I5	5.97	12.60	25.41	8.84	7.07	4.20	1.77	1.10	0.88	1.33
Smooth Muscle Cells - Aortic, donor2	11360-117I1	7.88	16.14	7.88	6.30	16.93	5.12	2.76	1.97	1.18	3.15
Smooth Muscle Cells - Aortic, donor3	11432-118H1	9.27	17.00	10.04	5.41	6.95	3.09	4.64	2.32	0.77	1.55
Smooth Muscle Cells - Bladder, donor1	11519-119H7	6.00	18.01	24.02	11.01	0.00	2.00	2.00	5.00	1.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	10.51	21.03	8.65	8.12	7.59	1.73	2.00	3.73	2.66	3.46
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	17.29	23.50	15.96	9.31	11.75	4.43	5.32	6.21	3.10	3.77
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	21.13	13.32	28.42	10.50	34.44	5.25	6.53	5.25	2.43	3.33
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	14.98	15.30	11.07	3.58	4.23	5.86	5.86	3.26	4.56	1.63
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	21.56	16.24	17.72	6.79	7.68	9.75	3.84	6.20	5.02	2.95
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	14.09	15.23	36.87	5.55	13.24	4.41	3.42	5.13	2.70	1.28
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	1.46	5.21	5.37	5.69	0.33	0.00	0.33	0.65	0.16	0.49
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	18.57	19.48	74.89	19.18	3.65	3.04	2.74	3.96	3.04	2.13
Smooth Muscle Cells - Carotid, donor1	11285-116I7	14.40	19.70	32.83	14.40	6.06	3.79	1.26	4.29	2.78	1.52
Smooth Muscle Cells - Carotid, donor2	11362-117I3	0.00	6.12	0.00	6.12	6.12	6.12	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	6.68	12.40	7.15	9.54	5.25	0.95	0.48	4.77	0.48	0.48
Smooth Muscle Cells - Colonic, donor1	11239-116D6	14.30	15.19	5.46	4.87	5.60	2.95	3.39	2.95	2.51	3.39
Smooth Muscle Cells - Colonic, donor2	11320-117D6	11.62	9.47	35.30	11.84	6.03	3.87	3.23	1.08	3.01	1.29
Smooth Muscle Cells - Colonic, donor3	11396-118D1	12.80	13.33	31.59	10.71	4.30	3.67	3.57	2.20	1.78	2.31
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	12.06	22.89	9.90	8.82	14.23	2.47	2.63	3.40	1.55	2.17
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	9.70	16.17	18.32	7.55	32.34	3.23	5.39	1.08	1.08	2.16
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	6.28	14.35	14.94	6.57	12.55	1.20	2.69	1.20	1.49	0.60
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	2.05	9.90	2.39	2.05	0.68	0.34	0.00	1.02	1.02	0.68
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	20.34	26.46	7.77	11.70	2.28	4.63	2.43	6.67	3.61	5.42
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	37.04	18.12	65.82	18.82	57.06	9.76	11.37	7.85	8.45	3.42
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	8.19	28.90	20.25	13.20	5.01	3.41	2.50	1.82	1.37	2.50
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	6.64	12.08	7.25	4.23	3.02	1.81	1.21	1.21	0.00	1.21
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	22.78	23.58	4.77	4.50	2.38	9.27	3.44	1.32	0.26	2.65
Smooth Muscle Cells - Prostate, donor1	11257-116F6	24.50	20.37	12.12	10.25	8.79	6.92	7.99	5.33	4.13	3.06
Smooth Muscle Cells - Prostate, donor2	11335-117F3	16.90	22.79	8.26	6.89	6.64	2.25	6.39	4.26	2.38	5.01
Smooth Muscle Cells - Prostate, donor3	11465-119B7	15.73	13.95	44.64	17.50	6.09	3.04	1.78	1.52	2.03	1.52
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	21.56	30.00	31.96	17.49	26.39	7.24	11.16	4.98	2.56	3.92
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	16.50	14.25	18.00	6.00	6.00	5.25	3.75	3.00	4.50	0.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	7.75	11.63	5.17	10.34	0.00	2.58	3.88	1.29	1.29	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	11.16	10.23	7.91	6.98	8.37	1.40	1.86	6.51	3.72	2.33
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	7.57	19.19	10.60	8.58	10.60	2.52	3.53	0.50	0.50	3.03
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	12.22	19.12	15.36	8.78	23.50	4.07	3.45	3.13	2.19	3.45
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	2.36	12.39	5.01	2.36	2.65	0.00	1.18	0.29	0.59	0.29
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	31.91	70.23	31.32	22.24	19.83	13.66	10.58	4.92	5.08	6.08
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	14.48	26.63	38.31	18.22	7.94	2.80	7.94	3.74	1.87	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	9.07	19.29	7.05	7.05	13.24	2.01	3.45	3.74	2.88	3.45
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	11.22	23.71	14.53	8.41	6.88	1.78	1.78	2.80	2.04	2.29
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	8.84	18.43	11.28	10.91	11.09	3.20	2.44	2.07	1.69	1.50
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	24.32	35.91	8.11	9.78	9.08	8.24	8.52	3.07	3.91	3.35
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	14.66	27.48	11.98	8.13	8.71	5.70	3.69	6.37	3.18	4.19
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	7.62	2.38	0.00	0.95	1.43	0.48	0.00	0.48	0.48	0.95
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	11.01	23.98	9.05	8.32	13.95	2.94	3.43	3.91	2.20	4.40
Smooth Muscle Cells - Uterine, donor1	11258-116F7	37.12	11.93	12.81	6.63	10.83	10.38	6.19	7.51	3.31	1.99
Smooth Muscle Cells - Uterine, donor3	11466-119B8	36.57	19.02	9.66	4.68	12.00	11.12	7.61	4.97	3.80	2.05
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	22.35	12.05	14.38	4.66	2.53	2.53	1.94	12.44	5.44	4.28
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	25.12	7.40	34.64	6.35	26.18	5.55	6.88	7.67	3.17	2.12
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	26.41	12.65	11.90	6.32	7.07	3.35	5.21	6.70	4.09	3.72
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	26.59	13.30	38.09	9.34	19.04	4.67	8.98	4.31	4.67	2.87
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	23.56	8.80	28.11	6.81	18.74	5.68	7.38	2.27	1.42	2.27
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	20.09	11.42	23.24	9.45	8.67	3.54	2.76	5.12	1.97	3.54
Smooth muscle cells - airway, control, donor1	11966-126D4	23.11	13.21	9.65	5.59	8.38	2.29	4.06	8.89	1.78	2.79
Smooth muscle cells - airway, control, donor2	11967-126D5	25.96	13.18	19.17	6.79	6.79	2.80	5.59	3.19	2.40	3.19
Smooth muscle cells - airway, control, donor3	11968-126D6	23.83	12.96	8.78	1.25	6.27	4.18	2.51	5.85	3.76	2.93
Smooth muscle cells - airway, control, donor4	11969-126D7	21.08	11.46	12.38	5.04	0.46	1.83	2.29	4.58	3.21	0.92
Synoviocyte, donor1	11291-117A4	22.72	16.66	11.61	7.57	3.03	4.88	1.85	3.37	2.52	3.70
Synoviocyte, donor2	11368-117I9	8.55	16.76	54.31	13.75	4.86	3.02	1.01	2.01	0.50	1.84
Synoviocyte, donor3	11440-118H9	18.77	21.00	27.70	21.22	4.24	1.56	4.47	1.79	0.67	2.90
Trabecular Meshwork Cells, donor1	11532-120A2	4.65	18.58	12.86	6.43	1.07	1.07	1.43	0.71	0.71	1.79
Trabecular Meshwork Cells, donor2	11612-122A1	1.98	19.82	5.95	3.96	1.98	1.98	0.00	1.98	0.00	5.95
Trabecular Meshwork Cells, donor3	11693-123A1	3.24	20.14	12.04	6.71	0.46	0.46	0.69	1.16	0.23	2.08
Tracheal Epithelial Cells, donor1	11292-117A5	35.84	4.73	5.23	5.45	11.61	10.90	11.33	1.29	1.65	0.86
Tracheal Epithelial Cells, donor2	11369-118A1	11.98	5.80	2.71	4.64	15.85	3.87	8.50	1.16	0.39	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	15.46	7.44	1.72	1.72	5.15	1.72	3.44	0.00	1.72	1.15
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	147.88	33.59	21.41	11.32	7.50	33.34	3.57	4.18	3.69	7.50
Urethra, donor2	10319-105A4	109.70	23.38	46.76	12.59	39.57	8.99	7.19	8.99	14.39	7.19
Urothelial Cells, donor1	11520-119H8	3.45	6.64	1.86	3.45	6.91	1.06	3.98	0.00	1.06	0.27
Urothelial Cells, donor2	11600-120H7	5.61	4.81	3.20	5.21	9.21	0.00	5.21	2.00	1.20	0.40
Urothelial Cells, donor3	11681-122H7	5.27	5.50	2.06	4.35	8.94	2.06	4.35	0.92	0.69	0.46
Urothelial cells, donor0	11216-116B1	47.03	19.39	2.23	10.92	43.02	18.28	27.42	1.11	2.01	2.90
Whole blood (ribopure), donor090309, donation1	12179-129A1	8.90	37.37	13.35	38.26	0.89	1.78	4.45	2.67	8.90	0.89
Whole blood (ribopure), donor090309, donation2	12180-129A2	20.01	34.31	11.44	45.75	1.43	1.43	2.86	2.86	8.58	1.43
Whole blood (ribopure), donor090309, donation3	12181-129A3	6.16	34.91	5.48	26.70	1.37	2.05	2.74	3.42	3.42	0.68
Whole blood (ribopure), donor090325, donation1	12176-128I7	9.64	38.91	9.99	30.65	1.38	0.34	3.10	2.41	8.95	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	10.46	36.60	18.01	36.60	2.32	1.16	1.16	1.74	8.13	2.32
Whole blood (ribopure), donor090612, donation1	12182-129A4	15.62	46.86	12.49	31.24	5.21	2.08	2.08	6.25	6.25	1.04
Whole blood (ribopure), donor090612, donation2	12183-129A5	11.93	53.23	11.93	36.71	5.51	2.75	5.51	6.42	5.51	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	11.87	39.25	10.95	30.13	1.83	1.83	4.56	1.83	13.69	0.00
Wilms' tumor cell line:G-401	10809-111A8	25.04	9.87	0.49	0.86	1.60	3.21	4.93	0.12	0.12	0.86
Wilms' tumor cell line:HFWT	10597-108E3	32.56	21.12	16.72	16.72	36.96	7.04	42.24	2.64	7.92	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	40.50	38.27	35.19	20.67	78.21	11.45	36.31	4.47	5.03	1.40
achilles tendon, donor2	10292-104G4	33.06	59.93	41.33	41.33	16.53	2.07	0.00	6.20	12.40	2.07
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	0.00	26.01	0.51	5.61	0.51	0.00	2.29	0.00	0.25	0.51
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	0.00	19.04	1.16	2.79	0.46	0.00	2.32	1.16	1.63	1.63
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	0.12	9.02	0.83	2.85	1.31	0.00	1.19	0.00	2.49	0.59
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	0.00	3.54	0.54	1.09	2.45	0.00	5.71	0.00	2.18	0.27
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	0.00	0.00	0.28	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	1.06	4.44	1.48	2.33	0.42	0.00	0.63	0.21	0.42	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	6.61	27.32	0.88	2.20	0.88	1.32	6.61	1.76	0.88	0.44
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	6.53	6.94	4.08	9.39	0.41	1.23	4.90	0.41	3.68	0.41
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	1.55	11.65	1.55	3.49	4.27	0.39	7.38	1.94	2.72	1.16
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	6.44	0.00	0.00	0.00	0.00	1.10	0.37	0.00	0.18	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	19.50	7.80	3.90	7.80	0.00	3.90	3.90	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	0.52	0.00	0.00	0.00	0.00	0.00	0.78	0.26	0.52	0.26
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	5.26	1.17	0.00	0.00	0.58	0.29	2.92	0.00	1.46	0.29
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	0.00	24.17	0.93	5.11	0.46	0.00	5.58	6.51	5.11	4.18
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	0.00	2.88	1.23	1.23	0.00	0.00	0.00	0.41	2.06	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	0.00	20.87	0.61	2.15	2.15	0.00	5.83	5.83	2.76	6.45
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	0.00	30.30	0.85	1.28	4.27	0.00	11.09	5.12	3.84	5.97
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	0.00	35.49	2.12	3.03	4.85	0.00	16.07	6.67	6.07	7.89
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	0.00	29.61	0.72	1.68	2.89	0.00	14.44	6.74	4.57	6.98
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	0.00	3.34	0.45	1.11	0.00	0.00	0.67	1.11	2.00	0.45
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	18.35	0.00	0.00	0.00	0.00	4.34	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	172.81	0.00	0.00	0.00	0.00	13.01	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	13.94	0.38	0.00	0.00	0.00	3.01	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	4.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	155.58	0.00	0.00	0.00	0.00	29.99	0.00	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	84.54	14.84	10.60	5.89	9.18	13.42	12.25	2.35	4.47	2.83
adipose tissue, adult, pool1	10010-101C1	43.59	44.98	44.05	20.63	3.26	10.24	1.40	4.96	3.88	7.60
adipose, donor1	10184-103D4	22.28	15.25	9.97	3.52	1.17	8.21	1.17	0.59	0.00	2.35
adipose, donor2	10185-103D5	16.22	7.30	3.65	0.41	0.41	3.24	4.87	0.00	1.22	0.41
adipose, donor3	10186-103D6	13.61	5.17	1.91	1.09	0.54	1.91	3.27	0.27	1.36	1.09
adipose, donor4	10187-103D7	7.80	4.33	1.73	0.87	0.87	1.73	0.87	0.00	0.00	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	87.75	5.05	0.32	0.47	0.16	4.89	3.00	0.00	0.79	0.00
adrenal gland, adult, pool1	10081-102A9	69.12	18.19	3.64	3.64	0.00	10.91	3.64	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	0.00	41.36	40.02	46.56	4.14	0.00	4.00	0.93	0.67	1.60
alveolar cell carcinoma cell line:SW 1573	10708-109H6	71.82	37.87	20.72	13.93	17.86	10.72	9.29	3.57	3.93	5.72
amniotic membrane cells, donor1	12235-129G3	229.99	56.34	93.90	29.44	79.29	52.40	32.46	8.81	6.49	10.90
amniotic membrane cells, donor2	12236-129G4	41.92	31.78	37.53	7.78	79.79	9.13	12.85	6.76	4.73	7.78
amniotic membrane cells, donor3	12237-129G5	326.42	86.02	145.53	48.61	126.97	50.97	43.90	18.85	10.61	12.96
amygdala - adult, donor10196	10167-103B5	35.57	5.93	2.37	0.00	1.19	0.00	1.19	1.19	0.00	0.00
amygdala, adult, donor10252	10151-102I7	51.30	14.80	3.24	2.23	2.03	5.27	0.41	2.23	1.62	1.22
amygdala, newborn, donor10223	10360-105E9	24.21	0.97	2.26	0.65	0.97	4.84	0.00	0.65	0.97	0.32
anaplastic carcinoma cell line:8305C	10428-106D5	41.25	11.59	17.32	18.08	8.28	9.80	4.84	7.51	4.33	2.55
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	65.30	17.87	1.76	2.21	0.66	12.80	0.44	4.41	3.97	4.19
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	31.73	5.34	0.33	0.33	1.34	1.67	5.34	0.67	0.00	1.34
aorta, adult, pool1	10052-101G7	33.93	38.05	20.01	8.43	5.10	4.90	1.37	2.35	3.92	8.83
appendix, adult	10189-103D9	37.65	54.34	24.84	13.58	34.54	4.66	7.37	6.21	8.93	6.60
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	20.64	27.51	5.50	7.57	40.93	3.78	30.95	1.72	2.75	6.53
artery, adult	10190-103E1	157.61	16.30	17.66	12.23	1.36	16.30	1.36	5.43	2.72	8.15
astrocytoma cell line:TM-31	10425-106D2	53.89	43.61	29.41	17.24	9.13	10.72	4.49	1.74	4.64	2.32
b cell line:RPMI1788	10427-106D4	12.49	26.02	0.74	6.69	0.89	0.74	6.99	0.74	0.45	0.59
basal cell carcinoma cell line:TE 354.T	10702-109G9	25.80	30.24	15.81	12.21	10.82	6.38	3.33	3.61	4.44	5.55
bile duct carcinoma cell line:HuCCT1	10432-106D9	63.41	38.60	30.27	21.93	8.93	30.66	6.95	3.37	2.68	3.87
bile duct carcinoma cell line:TFK-1	10496-107C1	96.58	8.70	7.36	2.51	4.35	18.75	2.34	7.03	2.51	3.01
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	6.71	6.15	0.56	0.00	0.00	1.68	2.80	1.68	0.00	0.00
bladder, adult, pool1	10011-101C2	67.57	52.15	34.87	15.32	14.78	9.99	5.76	10.32	7.50	17.71
blood, adult, pool1	10053-101G8	19.93	37.65	15.50	28.79	4.43	4.43	2.21	6.64	2.21	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	52.24	120.74	33.40	20.55	11.99	22.27	10.28	13.70	6.85	21.41
bone marrow, adult	10192-103E3	37.79	37.79	18.22	17.55	4.72	7.42	3.37	4.72	4.72	3.37
brain, adult, donor1	10084-102B3	15.38	3.08	0.00	0.00	0.00	3.08	1.03	0.00	3.08	0.00
brain, adult, pool1	10012-101C3	41.43	9.91	8.35	3.23	2.67	4.01	2.23	0.78	3.45	1.67
brain, fetal, pool1	10085-102B4	13.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00	2.67	0.00
breast carcinoma cell line:MCF7	10482-107A5	68.72	26.76	7.27	10.24	29.40	3.30	11.56	8.59	8.92	4.96
breast carcinoma cell line:MDA-MB-453	10419-106C5	52.92	19.85	3.00	0.62	24.59	6.74	10.73	1.25	2.12	6.37
breast, adult, donor1	10080-102A8	33.46	34.09	47.98	13.89	2.53	5.05	1.89	3.79	1.89	4.42
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	35.70	17.02	6.22	7.75	15.12	10.93	12.83	1.27	2.16	1.91
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	54.11	43.91	29.99	11.13	47.31	14.84	19.48	3.09	4.02	6.49
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	14.04	14.04	0.92	4.37	2.07	2.53	7.14	2.99	4.14	2.76
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	24.45	33.41	33.65	10.17	35.34	2.91	6.05	4.12	2.66	2.42
carcinoid cell line:NCI-H1770	10703-109H1	53.60	4.23	1.88	0.47	3.76	6.58	4.23	0.94	4.70	0.94
carcinoid cell line:NCI-H727	10735-110B6	71.43	23.95	10.50	12.03	11.38	17.61	7.98	3.39	7.22	3.28
carcinoid cell line:SK-PN-DW	10719-109I8	50.39	1.90	0.32	0.00	1.58	6.97	1.90	0.32	1.27	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	26.62	9.58	1.60	2.40	0.80	5.59	0.80	0.80	4.53	1.86
caudate nucleus - adult, donor10196	10177-103C6	92.11	6.91	9.21	3.45	0.00	6.91	3.45	6.91	2.30	0.00
caudate nucleus, adult, donor10252	10164-103B2	74.13	14.56	2.34	1.34	1.17	5.52	1.67	1.84	2.01	1.51
caudate nucleus, adult, donor10258	10379-105H1	42.03	0.76	1.53	0.00	0.76	3.06	0.00	2.29	0.76	0.00
caudate nucleus, newborn, donor10223	10354-105E3	35.16	2.56	2.93	1.10	0.37	9.89	0.00	3.66	1.46	1.46
cerebellum - adult, donor10196	10173-103C2	75.75	8.74	2.91	0.00	0.00	8.74	0.00	2.91	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	68.96	7.69	4.06	1.07	0.43	5.76	0.64	1.92	2.56	1.07
cerebellum, adult, pool1	10083-102B2	22.77	1.38	2.76	0.34	0.34	3.79	0.34	0.69	1.03	0.34
cerebellum, newborn, donor10223	10357-105E6	26.57	0.00	3.32	0.83	0.00	1.66	0.00	3.32	4.15	0.00
cerebral meninges, adult	10188-103D8	54.97	12.61	13.36	3.53	3.78	5.55	1.26	1.51	3.28	1.01
cerebrospinal fluid, donor2	10294-104G6	152.75	13.89	13.89	2.92	5.85	14.62	2.19	3.65	1.46	2.19
cervical cancer cell line:D98-AH2	10552-107I3	90.44	6.18	21.71	11.65	15.38	13.37	2.44	1.73	0.72	1.87
cervical cancer cell line:ME-180	10553-107I4	166.21	4.81	14.25	4.14	55.52	49.88	16.07	0.50	0.66	0.50
cervix, adult, pool1	10013-101C4	53.96	49.14	37.48	23.20	47.35	10.39	9.03	15.01	15.75	10.92
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	23.27	31.91	8.22	6.27	6.41	7.80	2.51	10.17	3.20	10.45
chondrosarcoma cell line:SW 1353	10700-109G7	82.29	11.76	20.90	13.06	15.68	18.29	7.84	1.31	1.31	3.92
choriocarcinoma cell line:BeWo	10423-106C9	0.37	57.66	2.49	7.71	9.69	0.00	19.39	9.20	5.72	11.93
choriocarcinoma cell line:SCH	10785-110H2	31.17	45.84	20.95	9.86	6.53	7.52	10.35	4.81	2.46	2.71
choriocarcinoma cell line:T3M-3	10618-108G6	85.15	48.38	3.32	3.08	10.91	13.52	26.80	22.77	15.42	9.96
chorionic membrane cells, donor1	12238-129G6	105.14	25.93	26.78	8.83	8.55	16.24	13.11	2.56	2.28	3.13
chorionic membrane cells, donor2	12239-129G7	33.01	24.56	7.16	6.16	10.64	6.36	9.55	2.88	3.58	4.77
chorionic membrane cells, donor3	12240-129G8	115.39	33.52	13.19	14.29	4.95	18.68	10.99	1.65	5.49	7.69
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	0.00	0.00	0.00	0.00	4.04	0.00	2.02	0.00	2.02	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	12.10	2.31	1.73	0.96	0.38	2.50	1.73	0.19	0.38	0.19
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	47.52	0.63	0.00	0.21	0.42	6.76	0.21	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	61.63	0.00	0.26	0.00	0.00	7.19	0.00	0.00	0.26	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	78.61	0.00	0.00	0.00	0.00	8.47	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	69.23	0.00	0.00	0.00	0.00	10.18	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	87.45	0.00	0.59	0.00	0.00	8.83	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	35.97	0.26	0.00	0.00	0.00	7.04	0.52	0.00	0.00	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	28.57	29.49	1.60	4.80	1.83	1.37	5.49	1.14	0.69	2.29
clear cell carcinoma cell line:TEN	10636-108I6	28.11	16.31	14.57	6.07	11.10	7.63	7.63	2.26	0.69	2.60
colon carcinoma cell line:CACO-2	10513-107D9	0.00	46.86	13.00	9.52	113.49	0.00	36.97	10.07	6.22	3.84
colon carcinoma cell line:COLO-320	10420-106C6	122.77	20.52	4.56	3.80	8.36	23.57	12.92	4.18	4.18	4.56
colon, adult, donor1	10082-102B1	22.61	24.99	32.13	11.90	33.32	4.76	10.71	10.71	4.76	7.14
colon, adult, pool1	10014-101C5	99.41	37.84	24.79	14.22	49.35	32.90	8.23	8.46	11.63	9.40
colon, fetal, donor1	10070-101I7	90.84	29.66	16.07	16.69	43.26	15.45	15.45	7.42	8.03	2.47
common myeloid progenitor CMP, donor1	12130-128D6	13.75	27.50	4.58	22.92	0.00	0.00	9.17	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	0.00	19.12	2.55	3.82	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	0.00	24.00	0.91	4.23	0.00	0.00	0.15	0.15	0.15	0.75
cord blood derived cell line:COBL-a untreated	10449-106F8	0.00	29.75	0.85	6.20	0.28	0.00	0.00	0.00	0.28	0.71
corpus callosum, adult, pool1	10042-101F6	34.83	22.89	10.95	3.43	2.10	3.32	1.44	2.76	4.31	3.65
cruciate ligament, donor2	10295-104G7	42.95	34.85	56.73	45.39	5.67	5.67	1.62	10.54	2.43	5.67
diaphragm, fetal, donor1	10069-101I6	105.14	33.71	48.96	10.43	2.41	4.82	0.80	4.01	4.01	3.21
diencephalon, adult	10193-103E4	40.80	6.96	3.36	0.72	0.72	4.32	0.48	0.48	2.16	0.72
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	0.00	22.04	1.15	4.13	0.69	0.00	2.30	0.92	0.92	0.46
ductal cell carcinoma cell line:KLM-1	10438-106E6	67.70	43.34	39.24	23.08	52.57	10.00	21.80	8.72	9.74	8.21
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	54.16	34.66	6.74	9.39	10.59	12.04	1.93	2.17	1.20	5.06
ductus deferens, adult	10196-103E7	47.34	24.42	15.45	11.46	6.48	4.98	1.50	1.99	4.49	6.98
duodenum, fetal, donor1, tech_rep1	10071-101I8	53.29	15.84	28.80	7.20	14.40	11.52	5.76	1.44	4.32	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	68.42	16.18	35.31	11.77	16.92	15.45	7.36	0.74	10.30	0.74
dura mater, adult, donor1	10041-101F5	26.68	74.99	18.17	23.04	4.38	6.36	3.06	10.57	5.29	14.37
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	38.86	6.22	4.66	4.44	2.66	11.77	0.89	1.11	2.22	1.11
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	35.82	5.59	2.72	1.43	6.88	16.05	4.87	1.58	5.59	2.29
embryonic pancreas cell line:1B2C6	10604-108F1	73.38	37.00	14.80	20.35	6.17	17.27	4.32	2.47	1.85	2.47
embryonic pancreas cell line:1C3D3	10605-108F2	27.55	27.24	4.84	13.02	4.24	2.42	2.12	2.42	1.51	0.30
embryonic pancreas cell line:1C3IKEI	10606-108F3	58.35	50.02	13.89	14.20	6.79	12.66	3.40	2.78	1.85	4.63
embryonic pancreas cell line:2C6	10603-108E9	72.24	72.24	30.21	23.64	10.51	17.08	6.57	1.31	2.63	9.19
endometrial carcinoma cell line:OMC-2	10497-107C2	20.11	10.39	1.68	1.68	10.39	3.69	4.69	1.68	1.34	2.35
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	0.00	32.98	21.20	9.97	53.46	0.00	13.96	11.78	7.25	7.79
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	0.00	19.62	10.45	4.18	28.14	0.00	20.10	2.89	4.02	3.38
epidermoid carcinoma cell line:A431	10426-106D3	60.91	35.57	47.80	24.57	58.91	25.12	21.34	3.89	2.56	3.67
epidermoid carcinoma cell line:Ca Ski	10431-106D8	62.03	17.82	25.41	7.81	16.17	23.10	9.35	0.44	0.99	1.87
epididymis, adult	10197-103E8	57.98	29.72	30.98	15.91	4.19	6.91	2.51	3.14	7.33	6.49
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	55.88	29.98	15.97	15.26	9.58	9.40	5.14	4.08	6.74	2.84
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	35.78	24.77	6.29	7.86	3.54	7.08	5.11	3.54	3.15	0.79
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	48.49	45.21	36.56	12.32	18.48	14.28	5.90	1.97	1.31	3.28
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	45.17	47.83	52.26	15.85	23.33	14.07	6.30	2.85	0.79	3.84
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	46.83	45.15	37.64	11.65	18.93	15.35	8.63	1.57	0.90	3.14
esophagus, adult, pool1	10015-101C6	88.76	51.81	48.84	23.36	89.83	29.84	13.59	14.76	12.64	13.80
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	110.71	0.88	0.00	0.13	0.13	12.65	0.38	0.13	1.38	0.00
eye - muscle inferior rectus, donor1	10272-104E2	169.02	41.05	26.56	19.32	4.83	19.32	2.41	14.49	0.00	7.24
eye - muscle lateral, donor2	10298-104H1	218.84	14.73	14.73	25.25	2.10	12.63	2.10	2.10	2.10	2.10
eye - muscle medial, donor2	10299-104H2	175.61	34.23	26.79	7.44	5.95	5.95	2.98	5.95	2.98	0.00
eye - muscle superior, donor2	10297-104G9	104.33	28.66	21.78	11.46	6.88	5.73	3.44	5.73	8.03	2.29
eye - vitreous humor, donor1	10268-104D7	71.41	5.83	7.29	11.66	7.29	2.91	0.00	1.46	0.00	1.46
eye, fetal, donor1	10054-101G9	46.27	12.71	8.64	4.07	5.85	7.88	4.32	4.83	4.83	2.29
fibrosarcoma cell line:HT-1080	10758-110E2	14.23	34.88	13.59	8.46	6.67	3.97	4.23	2.18	2.31	2.31
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	33.48	23.27	2.85	4.04	1.90	13.53	1.19	0.24	0.47	3.56
frontal lobe, adult, pool1	10040-101F4	49.26	8.44	4.41	1.97	1.60	3.94	2.81	1.31	5.91	1.03
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	24.02	48.04	51.64	21.62	265.12	9.91	21.02	9.31	7.51	6.31
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	38.49	37.49	23.59	19.11	21.12	10.06	15.82	4.30	1.55	4.39
gall bladder, adult	10198-103E9	28.97	23.66	39.84	14.97	14.97	6.04	4.35	6.04	9.66	4.10
gamma delta positive T cells, donor1	11937-126A2	8.05	89.12	2.68	38.65	5.37	2.15	8.05	1.07	22.55	1.61
gamma delta positive T cells, donor2	11938-126A3	1.87	68.72	10.46	28.76	7.10	0.00	8.96	1.12	20.54	4.11
gastric adenocarcinoma cell line:MKN1	10614-108G2	44.99	20.07	33.79	12.88	8.66	8.45	4.01	1.27	0.84	1.69
gastric adenocarcinoma cell line:MKN45	10612-108F9	68.47	27.85	8.32	6.00	8.70	8.51	8.32	1.74	2.13	2.32
gastric cancer cell line:AZ521	10549-107H9	0.00	7.05	1.15	0.82	1.48	0.00	7.05	0.49	0.66	0.66
gastric cancer cell line:GSS	10560-108A2	55.83	14.64	0.00	0.92	2.75	2.75	7.32	0.00	2.75	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	20.79	26.96	5.25	2.28	9.60	5.71	4.11	1.60	1.14	1.60
giant cell carcinoma cell line:LU65	10487-107B1	72.17	8.61	3.79	4.02	6.77	28.46	2.75	1.38	1.03	1.15
giant cell carcinoma cell line:Lu99B	10433-106E1	51.51	49.41	27.29	33.87	10.50	11.48	7.42	4.34	3.08	7.28
glassy cell carcinoma cell line:HOKUG	10688-109F4	152.64	70.09	45.14	23.69	147.90	24.94	33.67	17.46	7.98	13.47
glioblastoma cell line:A172, tech_rep1	10444-106F3	33.57	25.23	27.65	14.78	9.39	5.28	3.59	2.11	2.43	4.43
glioblastoma cell line:A172, tech_rep2	10444-106F3	39.60	33.85	29.21	14.32	7.30	6.04	4.35	2.95	1.54	5.48
glioblastoma cell line:T98G	10485-107A8	35.43	24.50	5.30	5.41	7.73	7.73	5.63	2.32	1.10	4.08
glioma cell line:GI-1	10413-106B8	32.22	12.30	3.81	1.46	0.88	7.91	1.76	3.81	3.51	2.64
globus pallidus - adult, donor10196	10175-103C4	100.59	8.75	6.56	0.00	4.37	10.93	1.46	0.73	4.37	0.73
globus pallidus, adult, donor10252	10161-103A8	92.51	37.10	10.01	2.44	1.95	6.83	0.73	4.15	3.66	2.93
globus pallidus, adult, donor10258	10367-105F7	71.20	6.85	2.74	0.00	0.00	4.11	2.74	1.37	4.11	2.74
globus pallidus, newborn, donor10223	10364-105F4	25.58	1.60	1.07	1.60	0.53	4.80	0.00	2.13	3.20	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	17.13	26.92	2.45	7.34	0.00	0.00	2.45	7.34	9.79	2.45
granulocyte macrophage progenitor, donor2	12135-128E2	10.93	0.00	0.00	10.93	0.00	0.00	0.00	21.86	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	0.00	5.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	33.60	24.96	8.64	7.36	2.56	5.76	1.92	2.88	4.16	4.80
hIPS +CCl2, biol_rep1	14383-156B9	5.97	4.13	1.84	1.38	2.30	1.38	0.92	0.00	0.00	0.00
hIPS +CCl2, biol_rep2	14384-156C1	5.94	4.12	3.20	1.83	0.91	1.83	2.29	0.00	0.46	0.46
hIPS +CCl2, biol_rep3	14385-156C2	7.09	5.80	1.93	0.00	0.00	3.22	1.93	0.00	0.00	0.64
hIPS, biol_rep1	14380-156B6	4.31	0.00	0.00	1.44	1.44	0.00	1.44	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	4.80	3.43	0.00	2.06	0.00	0.69	0.00	0.00	0.69	0.00
hIPS, biol_rep3	14382-156B8	65.10	1.10	1.10	0.00	2.21	4.41	2.21	1.10	1.10	0.00
hairy cell leukemia cell line:Mo	10712-109I1	2.87	14.94	1.15	2.30	1.72	0.00	11.21	0.57	0.57	0.00
heart - mitral valve, adult	10205-103F7	174.00	36.77	32.59	17.04	5.98	43.95	2.39	7.18	2.99	9.27
heart - pulmonic valve, adult	10206-103F8	159.24	61.97	52.03	15.95	5.49	34.25	0.52	4.45	6.28	12.03
heart - tricuspid valve, adult	10207-103F9	227.31	32.47	75.77	16.65	4.16	65.78	3.33	3.33	2.50	3.33
heart, adult, diseased post-infarction, donor1	10050-101G5	65.91	36.53	11.43	8.16	25.30	10.00	12.24	8.77	4.69	8.37
heart, adult, diseased, donor1	10051-101G6	136.69	25.98	11.50	4.68	2.98	29.38	0.85	4.26	1.70	7.66
heart, adult, pool1	10016-101C7	276.20	63.01	24.84	9.20	10.58	71.29	0.69	5.98	2.76	18.63
heart, fetal, pool1	10046-101G1	164.39	33.88	15.50	5.34	2.16	36.45	1.03	3.70	3.29	5.34
hepatic mesenchymal tumor cell line:LI90	10778-110G4	43.81	17.59	16.35	4.32	4.32	9.87	4.01	5.24	2.47	4.01
hepatoblastoma cell line:HuH-6	10633-108I3	0.00	16.65	5.95	2.38	5.95	0.00	1.19	2.38	3.57	5.95
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	42.65	17.79	1.99	3.09	3.20	10.06	7.51	0.22	0.11	1.66
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	39.45	25.61	1.46	3.76	4.25	9.10	7.04	0.12	0.97	1.46
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	45.27	26.78	1.92	3.64	3.94	8.49	8.59	0.61	1.01	2.63
hepatoma cell line:Li-7	10484-107A7	48.49	21.58	23.02	4.78	12.12	12.57	2.34	3.00	1.56	2.34
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	0.00	21.61	2.41	3.62	0.80	0.00	1.31	0.90	0.60	1.51
hippocampus - adult, donor10196	10169-103B7	52.05	6.62	8.52	0.95	0.00	5.68	0.95	1.89	3.79	0.95
hippocampus, adult, donor10252	10153-102I9	63.27	20.82	4.69	1.63	1.63	5.92	1.02	2.45	3.27	3.06
hippocampus, adult, donor10258	10374-105G5	55.27	3.49	1.00	0.50	1.49	3.49	2.99	1.99	7.97	0.00
hippocampus, newborn, donor10223	10363-105F3	23.26	2.11	2.11	0.70	0.70	1.76	0.00	1.41	1.41	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	19.53	1.22	0.61	0.00	0.00	6.10	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	7.66	4.32	0.20	0.59	0.39	2.75	0.79	0.00	0.20	0.39
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	9.90	4.82	0.76	0.51	0.51	2.29	0.51	0.25	0.00	0.76
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	7.33	7.33	3.95	3.38	0.56	0.00	1.69	0.00	0.00	1.13
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	10.07	10.07	2.84	3.10	0.52	2.07	1.03	0.52	0.00	0.52
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	11.77	8.35	2.28	3.42	0.38	0.76	1.14	0.00	0.00	1.52
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	23.06	5.84	2.34	2.34	1.75	3.80	2.92	0.00	0.29	0.29
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	22.40	4.09	3.02	3.45	1.94	1.94	1.72	0.43	1.08	0.22
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	21.69	4.17	2.50	3.34	2.09	3.75	4.17	0.00	0.00	1.67
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	17.05	7.34	4.97	2.60	6.16	4.03	3.55	0.47	0.47	2.60
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	19.93	5.46	4.02	1.93	3.05	4.50	2.57	0.80	2.09	0.96
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	22.22	1.35	4.04	0.67	2.02	4.71	6.06	1.35	2.02	1.35
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	7.20	5.32	0.78	1.10	0.63	2.97	2.35	0.16	0.16	0.47
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	10.81	5.90	0.00	0.98	0.49	3.44	2.46	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	8.73	5.24	0.00	0.00	1.75	1.75	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	15.85	10.31	5.73	3.44	0.00	3.05	1.72	0.00	0.19	2.67
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	8.29	9.16	5.23	5.23	0.87	2.18	0.87	0.00	0.44	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	11.49	10.49	5.50	1.00	1.50	0.00	0.00	0.50	0.00	1.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	19.59	3.58	3.58	1.70	1.51	1.51	2.83	0.00	0.57	0.75
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	11.82	7.28	5.46	2.27	1.36	4.55	4.55	0.00	1.82	0.45
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	18.79	1.88	1.88	2.82	1.25	1.57	5.01	0.31	0.63	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	11.92	5.72	2.94	0.82	1.31	3.10	2.78	0.16	1.14	0.82
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	14.81	4.94	3.19	1.16	1.45	2.61	6.39	0.87	1.16	0.29
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	15.84	3.89	2.39	0.90	0.60	2.99	1.49	0.60	1.49	0.60
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	7.57	5.54	0.55	0.92	0.92	3.88	1.11	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	8.84	6.28	0.57	0.57	0.57	2.00	0.57	0.57	0.57	0.29
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	8.57	5.31	2.04	2.04	0.41	2.86	2.04	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	11.27	16.20	9.86	4.93	2.46	3.52	1.76	0.35	1.06	1.06
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	8.87	11.40	5.07	1.90	0.95	1.27	2.22	0.32	0.00	1.58
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	8.17	13.92	5.14	3.03	0.91	1.82	2.12	0.30	0.30	0.91
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	28.96	5.69	1.03	3.10	3.10	3.62	4.14	1.03	0.52	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	29.89	6.64	3.32	2.66	5.98	6.64	4.65	0.00	0.66	1.33
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	25.14	5.13	3.59	2.31	3.08	2.31	5.90	0.77	1.80	1.80
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	17.13	7.41	6.14	2.05	4.86	5.37	7.67	1.79	1.79	1.53
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	26.50	3.03	4.54	3.79	6.82	3.79	3.79	0.76	1.51	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	32.26	4.37	7.06	3.02	5.38	1.68	5.38	0.00	2.69	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	9.18	6.04	1.45	0.48	1.21	2.66	0.97	0.72	0.00	0.24
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	6.24	3.57	0.89	0.89	0.89	2.67	0.89	0.45	1.34	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	10.73	3.90	2.44	0.98	1.46	4.88	0.49	0.00	0.00	0.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	11.00	9.47	6.11	3.06	0.92	1.22	1.53	0.31	0.00	1.22
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	52.05	39.04	9.76	13.01	3.25	16.27	6.51	0.00	0.00	6.51
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	12.24	10.59	4.63	5.63	1.32	2.32	2.65	0.66	0.00	0.66
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	20.80	3.28	6.02	1.64	1.64	2.19	5.47	0.00	2.74	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	19.54	3.26	2.53	2.90	2.17	1.81	4.34	0.36	1.45	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	19.22	3.56	2.49	3.20	1.42	1.78	4.63	0.36	0.36	0.71
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	17.90	4.77	2.39	1.19	1.19	7.16	5.97	1.19	1.19	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	23.43	6.36	6.64	2.98	5.15	4.74	4.74	0.41	2.17	0.81
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	10.78	3.77	7.81	1.89	3.50	1.62	3.23	0.54	2.16	0.54
immature langerhans cells, donor1	11904-125F5	83.54	40.68	19.86	26.15	4.36	24.94	2.18	1.45	4.12	0.73
immature langerhans cells, donor2	11905-125F6	160.80	14.26	22.97	12.67	12.67	51.49	3.17	0.79	5.54	0.00
insula, adult, pool1	10039-101F3	35.20	7.38	3.97	2.84	1.61	2.56	1.14	0.47	3.22	0.76
keratoacanthoma cell line:HKA-1	10791-110H8	49.42	2.93	4.88	2.28	16.91	9.43	8.13	0.98	1.95	0.33
kidney, adult, pool1	10017-101C8	65.68	38.95	8.81	8.71	7.91	13.42	4.71	5.11	6.51	8.81
kidney, fetal, pool1	10045-101F9	38.69	17.33	5.38	4.03	7.64	6.79	3.32	2.55	5.94	1.70
large cell lung carcinoma cell line:IA-LM	10509-107D5	85.35	109.78	47.72	49.00	9.23	23.58	8.24	3.55	3.83	6.25
large cell lung carcinoma cell line:NCI-H460	10839-111E2	5.81	29.17	68.15	26.82	41.20	0.55	3.59	9.54	3.46	2.76
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	96.89	29.18	16.15	12.11	23.67	24.96	14.31	9.17	9.73	6.61
left atrium, adult, donor1	10079-102A7	186.88	40.32	25.06	10.35	13.62	46.86	1.63	3.27	2.18	8.72
left ventricle, adult, donor1	10078-102A6	218.44	34.38	17.19	9.10	4.55	39.44	2.02	5.56	0.00	4.55
leiomyoblastoma cell line:G-402	10721-110A1	51.44	19.70	6.02	4.10	4.65	3.28	6.02	0.82	0.55	1.64
leiomyoma cell line:10964C	10569-108B2	20.12	13.65	11.14	5.39	11.50	8.26	3.59	3.95	3.95	1.80
leiomyoma cell line:15242A	10570-108B3	28.26	10.87	8.15	3.26	10.87	5.43	7.61	2.72	1.63	1.09
leiomyoma cell line:15425	10571-108B4	38.61	19.91	15.05	6.07	17.73	10.44	7.28	5.83	6.07	2.43
leiomyosarcoma cell line:Hs 5.T	10722-110A2	25.40	12.70	12.70	0.00	6.35	6.35	12.70	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	19.87	19.87	16.73	9.41	3.14	9.41	1.05	0.00	0.00	1.05
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	46.40	0.35	0.24	0.00	0.12	9.09	0.12	0.00	0.12	0.12
liposarcoma cell line:KMLS-1	10782-110G8	21.09	17.34	12.81	3.91	5.00	1.87	4.84	0.62	1.56	3.28
liposarcoma cell line:SW 872	10726-110A6	42.28	77.25	19.25	12.43	10.84	8.65	7.68	4.02	3.41	6.34
liver, adult, pool1	10018-101C9	88.16	22.69	8.43	4.70	22.20	13.45	2.27	2.11	2.27	5.83
liver, fetal, pool1	10086-102B5	51.74	6.58	1.88	2.82	0.00	10.35	0.00	0.00	0.94	0.94
locus coeruleus - adult, donor10196	10182-103D2	145.39	8.60	9.62	2.48	2.48	16.19	3.06	1.90	2.19	2.19
locus coeruleus, adult, donor10252	10165-103B3	81.57	12.92	6.27	0.92	2.40	12.36	2.58	2.40	1.48	0.74
locus coeruleus, adult, donor10258	10375-105G6	47.12	4.23	1.69	0.85	0.85	4.23	1.13	1.13	2.26	1.13
locus coeruleus, newborn, donor10223	10362-105F2	42.48	6.31	6.73	3.36	0.84	11.78	0.00	4.21	6.31	1.26
lung adenocarcinoma cell line:A549	10499-107C4	23.39	55.08	6.50	8.17	9.00	2.35	6.09	5.26	2.35	5.67
lung adenocarcinoma cell line:PC-14	10408-106B3	26.20	122.02	65.49	50.33	199.24	7.58	52.39	8.27	2.07	8.27
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	147.90	105.45	107.03	53.12	44.69	40.34	32.16	4.75	7.91	8.30
lung, adult, pool1	10019-101D1	63.32	61.66	18.19	21.85	6.73	15.95	6.14	8.39	5.91	9.45
lung, fetal, donor1	10068-101I5	75.92	50.23	27.97	15.98	10.56	19.69	8.28	15.41	23.40	12.84
lung, right lower lobe, adult, donor1	10075-102A3	35.28	49.03	21.54	12.37	5.50	8.71	3.21	8.71	3.21	11.46
lymph node, adult, donor1	10077-102A5	27.93	37.40	11.83	10.89	0.00	3.31	3.79	1.89	3.31	3.31
lymphangiectasia cell line:DS-1	10727-110A7	0.00	44.71	5.04	9.21	1.53	0.00	1.53	1.53	0.88	1.32
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	33.81	30.03	1.21	2.87	5.28	0.60	7.70	0.45	1.36	0.60
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	135.92	27.18	11.89	16.14	40.78	70.51	12.74	9.34	7.65	0.85
mature adipocyte, donor1	12231-129F8	81.69	92.35	39.07	18.20	7.55	10.66	0.89	10.21	0.89	30.64
mature adipocyte, donor2	12232-129F9	77.62	62.67	21.79	12.45	3.74	10.79	0.00	8.92	3.32	19.09
mature adipocyte, donor3	12233-129G1	90.32	78.70	44.09	17.78	21.10	15.41	1.90	11.62	1.90	17.78
mature adipocyte, donor4	12234-129G2	81.07	71.07	102.13	29.48	24.48	16.85	3.42	9.21	2.37	13.16
maxillary sinus tumor cell line:HSQ-89	10414-106B9	64.33	35.50	50.27	18.58	13.82	6.67	8.10	5.96	6.43	5.96
medial frontal gyrus - adult, donor10196	10170-103B8	62.04	2.26	3.38	1.13	2.26	1.13	3.38	0.00	3.38	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	101.88	19.86	6.80	2.57	5.52	14.16	2.39	1.84	7.54	2.21
medial frontal gyrus, adult, donor10258	10368-105F8	51.15	4.13	1.91	0.64	1.59	4.77	2.54	0.00	4.45	0.64
medial frontal gyrus, newborn, donor10223	10352-105E1	46.91	1.71	2.99	0.00	0.85	15.35	0.43	2.13	2.56	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	71.04	3.21	5.91	2.70	3.04	9.11	2.03	0.17	3.54	0.34
medial temporal gyrus, adult, donor10252	10156-103A3	109.93	15.92	5.31	2.55	2.97	10.19	2.97	4.46	5.94	2.76
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	36.60	1.93	1.93	0.00	1.93	0.00	1.93	0.00	11.56	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	129.18	28.71	14.35	14.35	0.00	28.71	0.00	14.35	14.35	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	21.54	1.79	2.15	0.36	2.15	5.38	1.08	1.08	2.15	1.08
medulla oblongata - adult, donor10196	10174-103C3	85.02	8.44	12.98	3.24	0.65	10.38	1.95	0.65	5.19	2.60
medulla oblongata, adult, donor10252	10155-103A2	82.05	27.56	7.28	2.17	4.18	8.82	2.79	4.18	4.49	5.73
medulla oblongata, adult, pool1	10038-101F2	45.30	16.57	5.71	3.43	2.20	4.16	1.63	2.12	3.35	3.18
medulla oblongata, newborn, donor10223	10361-105F1	38.88	2.43	5.21	3.12	4.86	5.21	1.39	5.55	5.90	1.04
medulloblastoma cell line:D283 Med	10838-111E1	54.69	3.32	1.55	0.44	1.99	9.52	0.44	0.22	4.21	1.11
medulloblastoma cell line:ONS-76	10759-110E3	25.56	60.40	24.09	7.58	49.77	6.24	12.47	4.28	3.55	4.40
melanoma cell line:COLO 679	10514-107E1	45.71	6.76	0.72	0.57	0.86	9.49	3.02	1.72	2.87	1.15
melanoma cell line:G-361	10465-106H6	42.62	7.87	0.54	1.09	2.99	7.60	6.24	2.44	1.36	3.53
meningioma cell line:HKBMM	10691-109F7	10.13	20.26	5.25	5.61	0.54	2.89	1.45	0.36	0.54	2.89
merkel cell carcinoma cell line:MKL-1	10843-111E6	5.29	0.00	0.00	0.00	0.88	0.00	0.88	0.00	0.00	0.88
merkel cell carcinoma cell line:MS-1	10844-111E7	4.93	0.00	0.00	0.00	0.52	1.81	0.26	0.00	0.00	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	17.03	26.70	29.31	15.34	7.67	4.45	7.36	2.15	1.99	4.45
mesenchymal precursor cell - adipose, donor2	11748-123G2	15.81	24.72	39.08	13.63	1.82	6.00	2.00	2.36	3.45	3.45
mesenchymal precursor cell - adipose, donor3	11749-123G3	20.71	28.57	10.35	10.77	3.73	9.52	9.11	2.90	1.24	3.73
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	21.35	27.95	24.86	17.42	9.41	4.64	2.39	5.06	0.84	5.34
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	26.00	26.38	8.28	7.70	4.24	5.78	0.96	5.20	1.35	5.58
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	20.13	15.27	28.46	13.19	4.86	4.16	3.47	2.78	0.69	4.16
mesenchymal precursor cell - cardiac, donor1	11752-123G6	27.98	20.25	30.89	10.47	3.60	8.75	1.72	3.43	0.34	2.92
mesenchymal precursor cell - cardiac, donor2	11753-123G7	25.30	19.44	10.93	8.63	4.60	9.09	3.22	4.14	1.73	3.22
mesenchymal precursor cell - cardiac, donor3	11754-123G8	15.78	19.10	25.07	10.21	11.14	5.44	6.90	2.39	2.65	1.46
mesenchymal precursor cell - cardiac, donor4	11755-123G9	18.91	24.58	12.29	8.24	7.83	6.62	3.65	2.30	1.08	2.43
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	22.05	34.00	9.10	11.24	15.51	8.82	6.97	5.26	2.99	2.70
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	23.71	9.22	20.75	11.53	1.98	3.95	2.31	5.60	0.99	1.98
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	20.76	25.74	6.92	8.86	10.10	9.55	7.89	3.74	3.18	2.49
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	29.67	24.44	31.42	15.01	21.64	9.43	10.82	9.08	11.52	2.79
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	23.48	22.25	7.96	9.39	11.02	10.00	7.96	6.33	3.88	2.04
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	14.02	13.30	19.41	12.22	9.71	3.59	3.59	1.80	2.16	1.08
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	21.93	28.03	7.55	10.45	5.38	4.76	2.28	3.83	1.34	3.93
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	19.38	9.80	39.44	9.80	27.59	7.98	5.93	4.79	2.74	0.46
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	41.54	40.28	20.56	9.65	36.92	15.94	16.78	3.36	10.49	3.36
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	21.37	10.91	5.38	4.03	6.58	6.58	4.48	4.33	1.94	1.34
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	21.18	29.50	11.03	11.55	13.13	7.70	6.13	3.85	1.49	3.06
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	35.34	14.73	9.57	10.31	6.63	7.36	2.21	12.52	8.84	1.84
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	15.74	10.87	34.91	13.16	17.17	5.15	8.58	7.15	3.72	0.86
mesenchymal stem cell line:Hu5/E18	10568-108B1	15.16	20.63	4.21	5.47	5.05	5.05	4.63	3.37	5.05	2.95
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	11.87	11.42	7.76	5.48	6.85	3.65	1.37	1.83	1.37	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	17.39	18.93	9.98	7.16	8.44	2.30	5.12	4.09	3.33	2.81
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	16.49	20.94	10.73	6.28	6.28	2.36	4.19	4.71	2.36	2.36
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	12.63	18.79	11.09	6.16	4.62	0.92	3.08	3.70	3.70	3.70
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	16.24	19.06	13.89	6.35	8.71	3.77	5.88	3.06	4.00	4.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	14.55	15.57	9.14	7.11	6.09	4.06	4.06	1.69	1.69	4.40
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	19.65	18.08	14.54	10.22	6.68	2.36	5.89	3.54	3.54	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	11.58	20.39	11.58	6.02	6.02	1.85	5.56	5.56	1.85	2.78
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	48.30	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	14.42	28.55	17.59	5.48	7.79	4.33	7.79	5.48	4.33	3.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	13.83	17.85	12.72	7.36	5.80	2.23	4.24	4.02	2.68	4.91
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	14.42	25.72	9.61	5.77	6.97	2.16	4.33	3.36	1.20	2.40
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	30.80	52.07	19.80	14.67	19.07	3.67	13.93	5.13	3.67	6.60
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	14.43	16.78	7.72	8.39	5.71	1.68	4.36	4.36	2.35	3.69
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	10.64	16.78	15.97	5.73	7.37	3.28	4.50	3.68	3.28	2.46
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	22.77	19.33	9.88	7.30	9.45	4.30	8.16	3.44	3.44	3.01
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	41.02	8.20	10.94	5.47	2.73	0.00	8.20	5.47	2.73	2.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	36.15	10.33	10.33	5.16	20.66	0.00	10.33	10.33	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	17.54	20.14	12.67	6.50	11.37	2.60	7.15	2.27	4.22	3.25
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	20.37	16.00	2.91	5.82	8.73	2.91	8.73	1.45	4.36	4.36
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	21.86	12.79	11.73	8.00	11.19	3.20	8.00	5.33	3.20	2.13
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	16.36	15.54	8.18	4.91	4.09	0.82	3.27	1.64	2.45	2.45
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	22.16	14.38	11.66	7.77	12.83	3.50	7.00	5.83	3.50	1.94
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	8.39	12.59	12.59	2.10	4.20	0.00	2.10	4.20	2.10	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	13.91	11.92	6.95	4.97	9.93	2.98	6.95	3.97	1.99	1.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	23.84	9.53	4.77	4.77	14.30	0.00	9.53	14.30	9.53	4.77
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	24.31	12.45	15.42	5.93	7.71	2.37	4.74	1.19	2.96	2.96
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	8.53	17.06	14.62	7.31	18.28	4.87	6.09	4.87	6.09	2.44
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	27.05	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	18.37	10.77	14.57	9.50	13.93	3.17	6.97	5.70	3.17	5.70
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	10.69	14.83	14.14	6.55	46.56	0.69	12.07	10.00	0.34	1.38
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	4.30	10.75	17.19	12.90	40.83	4.30	10.75	8.60	2.15	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	7.98	3.99	0.00	3.99	27.94	0.00	7.98	0.00	3.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	6.89	10.33	3.44	3.44	10.33	6.89	0.00	10.33	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	5.70	14.26	10.19	7.33	13.85	0.41	6.52	5.30	2.04	2.04
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	4.77	20.66	8.74	7.94	16.68	0.00	5.56	3.18	0.79	2.38
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	6.48	11.79	5.90	5.31	11.79	0.00	1.77	3.54	1.77	2.95
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	8.42	12.78	11.22	4.36	11.22	0.31	2.18	6.23	2.18	2.49
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	9.36	9.36	16.04	0.00	6.68	0.00	5.35	2.67	0.00	4.01
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	15.37	15.37	11.83	2.37	18.92	1.18	5.91	8.28	0.00	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	28.25	10.27	15.41	2.57	20.54	0.00	7.70	7.70	2.57	2.57
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	22.03	14.46	13.08	1.38	19.96	3.44	2.75	4.13	0.69	2.07
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	43.05	9.90	2.47	1.48	7.42	3.96	1.48	1.98	0.00	5.94
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	32.52	10.09	2.24	3.36	10.09	4.49	1.12	4.49	0.00	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	36.89	13.99	8.90	1.91	5.72	2.54	2.54	1.91	0.64	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	62.06	14.10	4.84	2.01	4.43	5.64	0.40	2.82	0.00	1.61
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	56.70	8.72	4.36	2.18	8.72	8.72	0.00	2.18	0.00	8.72
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	53.22	19.01	5.07	3.80	1.27	5.07	1.27	0.00	2.53	2.53
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	34.59	10.32	1.82	1.82	2.43	3.03	0.00	4.86	0.00	3.64
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	81.34	4.52	0.00	9.04	4.52	9.04	0.00	0.00	0.00	4.52
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	56.01	8.24	4.12	0.82	1.65	2.47	0.00	4.94	0.00	2.47
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	30.16	7.94	10.12	2.98	7.54	3.97	2.38	1.59	0.20	1.98
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	28.88	10.06	7.46	4.87	6.17	3.24	2.27	1.30	1.30	2.27
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	31.58	12.22	6.11	6.11	6.11	4.07	1.02	1.02	1.02	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	41.01	61.90	82.79	32.50	5.42	3.87	9.28	9.28	5.42	6.19
mesothelioma cell line:ACC-MESO-1	10493-107B7	301.21	107.02	19.84	37.80	11.58	51.03	10.16	5.43	5.67	16.30
mesothelioma cell line:ACC-MESO-4	10494-107B8	84.56	31.51	6.26	7.18	7.65	24.56	5.10	1.39	1.39	2.78
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	34.19	34.19	12.82	8.55	8.55	4.27	4.27	12.82	4.27	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	34.73	25.79	10.38	11.92	4.32	12.33	2.98	2.36	2.26	2.77
mesothelioma cell line:Mero-25	10850-111F4	16.79	9.99	2.50	3.86	0.23	6.13	0.23	1.59	2.50	1.13
mesothelioma cell line:Mero-41	10851-111F5	16.38	22.74	10.76	11.25	3.42	3.67	2.20	1.47	0.98	1.71
mesothelioma cell line:Mero-48a	10852-111F6	20.59	18.16	2.88	4.87	4.65	5.09	3.99	1.11	1.33	2.66
mesothelioma cell line:Mero-82	10853-111F7	26.28	29.43	20.50	14.19	2.37	7.88	0.26	3.15	3.42	3.15
mesothelioma cell line:Mero-83	10854-111F8	21.28	13.11	19.23	8.51	2.89	6.30	1.70	1.53	1.36	0.51
mesothelioma cell line:Mero-84	10855-111F9	25.53	23.26	10.36	12.64	8.34	5.81	4.30	1.26	0.25	1.77
mesothelioma cell line:Mero-95	10856-111G1	20.29	8.07	3.93	2.69	0.21	4.97	0.41	1.24	1.04	1.24
mesothelioma cell line:NCI-H2052	10847-111F1	31.97	18.22	11.26	9.44	5.63	15.07	7.12	2.48	1.99	2.82
mesothelioma cell line:NCI-H226	10846-111E9	25.34	11.04	21.00	8.87	1.63	13.57	2.90	1.09	0.36	1.63
mesothelioma cell line:NCI-H2452	10848-111F2	55.69	38.95	12.30	16.57	5.47	20.33	5.81	1.54	3.07	3.42
mesothelioma cell line:NCI-H28	10845-111E8	20.61	17.05	1.53	2.80	1.78	3.82	3.31	1.78	1.02	3.05
mesothelioma cell line:No36	10857-111G2	24.79	19.90	5.87	4.57	1.63	4.89	2.61	1.63	0.65	4.89
mesothelioma cell line:ONE58	10858-111G3	27.37	11.38	9.21	5.96	1.35	8.94	0.27	2.17	0.54	1.35
migratory langerhans cells, donor1	11901-125F2	2.49	55.85	4.61	22.26	2.11	0.19	3.26	1.54	1.73	0.77
migratory langerhans cells, donor2	11902-125F3	0.85	50.56	3.66	15.51	0.37	0.00	3.30	0.37	2.56	0.12
migratory langerhans cells, donor3	11903-125F4	2.15	53.66	2.33	12.56	1.08	0.36	1.26	1.62	1.97	0.36
mixed mullerian tumor cell line:HTMMT	10689-109F5	31.34	41.79	7.84	8.16	1.31	6.53	1.31	2.29	2.29	7.84
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	16.53	11.02	6.15	3.18	5.51	2.97	1.91	1.27	0.00	1.48
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	211.70	17.05	11.06	3.46	4.61	52.52	1.38	1.61	0.69	3.46
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	1.33	34.63	7.80	11.61	1.71	0.19	3.23	0.95	1.52	0.38
myelodysplastic syndrome cell line:SKM-1	10772-110F7	7.58	2.03	0.18	0.74	0.37	2.40	1.66	0.37	1.11	0.18
myeloma cell line:PCM6	10474-106I6	0.40	30.64	3.56	13.64	0.00	0.00	0.00	0.99	0.99	2.97
myxofibrosarcoma cell line:MFH-ino	10600-108E6	55.80	32.97	17.76	11.67	10.15	7.61	12.17	4.57	2.54	3.55
myxofibrosarcoma cell line:NMFH-1	10684-109E9	21.38	41.58	20.99	12.55	6.86	6.47	2.75	6.28	1.57	7.06
nasal epithelial cells, donor1, tech_rep1	12226-129F3	84.57	12.03	1.00	2.34	7.58	25.85	6.35	2.34	4.01	1.89
nasal epithelial cells, donor1, tech_rep2	12226-129F3	84.28	7.35	1.76	2.43	7.50	24.42	5.44	2.06	2.94	0.81
nasal epithelial cells, donor2	12227-129F4	46.92	14.35	5.52	8.83	19.32	17.66	8.28	4.97	4.97	2.76
neuroblastoma cell line:CHP-134	10508-107D4	63.96	0.00	0.00	0.00	0.46	5.29	0.23	0.00	0.00	0.00
neuroblastoma cell line:NB-1	10539-107G8	35.17	14.03	2.81	4.30	2.06	5.99	1.68	2.06	4.49	2.06
neuroblastoma cell line:NBsusSR	10607-108F4	27.20	0.63	0.84	0.21	0.21	4.64	0.00	0.00	1.48	0.00
neuroblastoma cell line:NH-12	10555-107I6	34.10	0.93	0.00	0.19	0.56	3.35	0.19	0.00	0.00	0.19
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	23.72	5.93	5.93	13.05	1.42	4.27	1.42	1.19	11.15	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	45.93	1.11	0.16	0.95	1.43	8.08	0.48	0.32	4.28	0.00
neuroectodermal tumor cell line:TASK1	10774-110F9	18.72	1.01	0.20	0.60	1.21	2.62	0.81	0.00	0.60	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	78.84	1.91	0.00	0.00	0.00	6.36	2.54	0.00	1.27	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	36.20	14.11	42.32	4.79	5.32	8.78	4.79	7.19	4.26	1.33
neutrophil PMN, donor1	12133-128D9	44.62	89.25	0.00	14.87	0.00	0.00	0.00	29.75	14.87	0.00
neutrophil PMN, donor2	12137-128E4	53.12	79.68	0.00	26.56	0.00	0.00	0.00	13.28	0.00	13.28
neutrophil PMN, donor3	12141-128E8	9.47	18.94	0.00	47.35	0.00	0.00	0.00	0.00	9.47	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	0.00	51.75	2.03	10.32	10.15	0.00	24.69	1.18	5.41	1.35
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	21.61	5.60	0.00	0.00	5.60	3.20	4.00	0.80	1.60	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	23.40	16.67	13.47	5.77	3.85	3.21	3.53	2.24	2.56	4.49
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	9.46	21.02	5.78	7.09	3.68	2.10	3.94	0.79	1.58	2.89
nucleus accumbens, adult, pool1	10037-101F1	47.15	8.91	6.19	1.69	1.59	4.12	1.59	0.75	2.81	1.78
occipital cortex - adult, donor10196	10172-103C1	107.14	10.30	0.00	0.00	4.12	18.54	2.06	2.06	4.12	0.00
occipital cortex, adult, donor10252	10163-103B1	141.16	20.66	9.93	2.95	5.37	13.95	2.95	2.68	5.90	2.68
occipital cortex, newborn, donor10223	10355-105E4	21.47	1.82	1.09	1.46	1.46	2.55	0.00	1.46	5.10	1.09
occipital lobe, adult, donor1	10076-102A4	35.16	7.87	2.89	3.15	1.05	4.99	1.31	0.79	3.94	1.31
occipital lobe, fetal, donor1	10073-102A1	6.87	0.86	2.15	0.86	0.00	0.43	0.00	0.43	2.57	0.43
occipital pole, adult, pool1	10036-101E9	26.25	4.89	3.86	1.66	1.58	2.68	1.18	0.16	2.44	0.71
olfactory region, adult	10195-103E6	46.04	9.74	4.59	1.91	2.10	4.01	2.67	1.53	5.35	1.15
optic nerve, donor1	10277-104E7	126.07	32.02	6.00	6.00	2.00	8.00	4.00	0.00	4.00	4.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	61.74	10.14	2.05	2.28	7.29	13.44	4.56	0.91	0.80	3.76
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	42.32	17.59	6.05	5.50	23.36	7.14	24.18	1.51	3.16	2.34
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	87.20	8.80	21.67	7.11	39.79	22.69	23.54	2.88	6.43	1.69
oral squamous cell carcinoma cell line:SAS	10544-107H4	51.29	29.69	5.20	6.35	1.39	13.86	2.77	3.00	1.50	2.54
osteoclastoma cell line:Hs 706.T	10704-109H2	15.87	17.05	8.82	4.70	8.23	2.06	7.94	4.70	2.94	4.41
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	95.30	89.70	51.39	57.93	6.54	20.56	13.08	6.54	4.67	8.41
osteosarcoma cell line:HS-Os-1	10558-107I9	30.96	14.21	4.88	4.24	3.61	12.94	2.12	0.64	3.39	1.70
ovary, adult, pool1	10020-101D2	41.49	28.21	34.42	12.14	3.41	7.60	2.10	9.52	11.97	5.07
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	41.80	9.53	6.42	4.03	2.57	13.57	2.93	1.65	0.37	1.28
pancreas, adult, donor1	10049-101G4	36.68	29.16	3.76	0.00	2.82	6.58	0.00	0.94	0.94	2.82
pancreatic carcinoma cell line:NOR-P1	10698-109G5	0.00	59.26	4.75	9.50	10.34	0.00	11.18	19.01	4.47	12.86
papillary adenocarcinoma cell line:8505C	10437-106E5	17.55	18.23	11.92	7.67	15.16	8.01	7.33	7.67	11.07	3.58
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	63.25	32.12	23.18	17.05	14.07	26.33	4.64	0.66	0.50	1.82
paracentral gyrus, adult, pool1	10035-101E8	41.37	10.34	5.58	1.46	2.20	4.67	2.84	1.56	3.57	1.28
parietal cortex, adult, donor10258	10373-105G4	41.84	2.20	0.73	0.00	2.20	3.67	2.94	1.47	3.67	2.20
parietal lobe - adult, donor10196	10171-103B9	67.71	2.82	4.70	0.94	3.76	3.76	0.94	0.00	2.82	0.00
parietal lobe, adult, donor10252	10157-103A4	108.60	12.26	5.99	2.28	2.85	11.40	1.71	2.00	3.14	3.14
parietal lobe, adult, pool1	10034-101E7	43.35	9.08	9.08	2.73	1.85	4.23	2.20	1.15	2.38	1.41
parietal lobe, fetal, donor1	10072-101I9	4.85	3.88	3.88	2.91	0.97	0.97	0.00	0.00	4.85	0.00
parietal lobe, newborn, donor10223	10356-105E5	27.29	2.24	2.99	0.75	1.12	7.85	0.00	1.12	4.49	0.75
parotid gland, adult	10199-103F1	40.70	14.18	23.43	5.55	6.78	9.25	0.62	1.23	6.17	1.23
penis, adult	10200-103F2	64.45	31.69	24.17	17.19	16.11	9.67	3.76	6.98	6.45	8.59
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	36.26	3.53	4.83	6.69	10.97	6.14	5.02	2.97	16.36	0.19
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	63.81	29.72	23.31	8.74	49.68	22.29	17.05	4.23	4.95	2.33
pineal gland - adult, donor10196	10179-103C8	190.28	2.58	5.16	3.23	2.58	12.26	1.29	1.94	1.94	1.94
pineal gland, adult, donor10252	10160-103A7	137.99	8.88	3.55	0.59	0.00	11.25	1.18	2.37	1.18	1.78
pineal gland, adult, donor10258	10377-105G8	109.11	3.76	1.25	1.88	0.63	1.88	0.00	0.63	0.63	0.63
pituitary gland - adult, donor10196	10180-103C9	165.94	7.08	8.09	3.04	10.12	11.13	15.18	0.00	6.07	0.00
pituitary gland, adult, donor10252	10162-103A9	229.32	18.24	5.73	4.69	9.38	28.14	3.65	5.73	5.73	2.08
pituitary gland, adult, donor10258	10378-105G9	122.58	8.51	0.85	0.85	8.51	9.36	6.81	1.70	0.85	0.00
placenta, adult, pool1	10021-101D3	175.55	37.84	15.48	9.46	6.67	31.50	8.06	4.62	3.01	8.17
plasma cell leukemia cell line:ARH-77	10840-111E3	9.40	19.47	0.53	2.91	0.53	0.66	1.72	0.00	0.13	0.79
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	16.96	69.26	22.41	9.81	25.21	3.89	3.11	6.85	2.80	14.01
pons, adult, pool1	10033-101E6	78.67	13.43	7.92	2.15	3.10	10.16	3.36	2.15	3.70	3.61
postcentral gyrus, adult, pool1	10032-101E5	30.25	6.02	4.53	1.39	2.27	1.48	1.39	0.87	3.40	0.61
promyelocytes/myelocytes PMC, donor1	12132-128D8	14.64	18.82	2.09	2.09	0.00	0.00	0.00	10.46	2.09	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	5.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	11.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	37.73	27.68	9.76	8.74	2.91	6.85	4.37	0.44	0.29	3.79
prostate cancer cell line:PC-3	10439-106E7	0.00	23.78	80.22	21.05	26.32	0.00	9.62	1.82	1.45	0.73
prostate, adult, pool1	10022-101D4	40.63	39.18	23.13	10.25	22.31	6.89	5.99	12.52	8.43	10.43
putamen, adult, donor10196	10176-103C5	67.04	9.91	1.89	0.71	1.42	4.25	1.18	2.36	2.12	1.65
putamen, adult, donor10252	10152-102I8	82.35	1.96	3.92	0.00	1.96	9.80	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	27.32	2.19	1.09	1.09	0.00	1.09	2.19	0.00	2.19	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	52.43	5.07	0.72	0.97	0.00	2.66	0.48	0.00	1.45	0.48
putamen, newborn, donor10223	10365-105F5	63.72	1.50	2.25	1.50	0.75	20.24	0.75	5.25	6.75	0.00
rectal cancer cell line:TT1TKB	10469-106I1	133.25	58.77	29.68	29.38	149.54	34.62	72.15	16.58	13.09	11.06
rectum, fetal, donor1	10067-101I4	76.50	25.04	83.46	27.82	36.17	11.13	4.17	2.78	9.74	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	9.12	23.53	26.71	18.66	5.72	2.54	5.09	0.64	0.64	1.91
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	44.32	19.47	7.87	16.98	2.07	3.73	3.31	1.66	0.41	0.00
retina, adult, pool1	10030-101E3	39.16	21.97	8.35	4.77	3.58	5.17	1.39	3.98	3.58	5.47
retinoblastoma cell line:Y79	10475-106I7	18.97	0.26	0.00	0.00	0.00	0.78	0.26	0.00	0.00	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	14.88	18.69	0.74	1.48	0.86	1.72	3.07	0.25	0.49	1.48
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	64.96	5.06	3.94	0.84	0.00	9.00	0.28	0.28	1.69	0.28
sacrococcigeal teratoma cell line:HTST	10695-109G2	38.65	45.47	108.37	47.74	8.34	6.82	5.30	15.16	11.37	4.55
salivary acinar cells, donor1	11771-123I7	21.37	29.30	37.55	23.47	82.06	3.88	16.99	10.52	2.10	4.21
salivary acinar cells, donor2	11772-123I8	25.61	17.76	22.17	6.88	31.12	4.96	11.29	7.02	6.33	4.96
salivary acinar cells, donor3	11773-123I9	135.72	48.33	82.76	24.50	124.47	32.44	24.50	18.54	10.59	19.86
salivary gland, adult, pool1	10093-102C3	41.18	14.87	3.43	3.43	17.73	4.58	1.14	3.43	0.57	4.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	38.78	36.84	11.04	17.54	7.59	12.31	9.27	4.55	4.30	6.74
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	40.32	46.20	9.40	11.87	6.94	15.05	7.52	2.94	2.23	7.99
seminal vesicle, adult	10201-103F3	59.26	22.75	22.22	14.28	5.82	7.94	3.17	3.17	4.23	7.94
serous adenocarcinoma cell line:JHOS-2	10639-108I9	26.72	13.85	7.77	5.34	18.22	7.29	4.86	2.92	4.62	1.21
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	23.65	21.89	7.80	7.55	9.06	4.53	2.77	3.02	2.77	2.52
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	27.10	22.08	2.01	2.01	16.06	8.03	8.03	3.01	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	63.80	6.04	1.34	0.67	7.25	7.92	4.03	2.69	0.81	1.75
signet ring carcinoma cell line:Kato III	10436-106E4	97.15	4.86	14.70	7.63	6.52	31.28	2.76	1.66	2.76	0.55
signet ring carcinoma cell line:NUGC-4	10483-107A6	48.51	1.42	1.81	0.39	1.55	6.71	1.94	0.13	0.00	0.13
skeletal muscle - soleus muscle, donor1	10282-104F3	964.70	32.63	32.63	3.55	15.61	120.59	0.00	9.93	4.26	14.19
skeletal muscle, adult, pool1	10023-101D5	342.78	41.62	56.13	15.71	2.88	74.60	0.48	9.95	3.60	14.63
skeletal muscle, fetal, donor1	10066-101I3	26.13	14.07	23.12	7.04	3.02	7.04	1.01	0.00	0.00	5.03
skin, adult, donor1	10074-102A2	33.93	20.36	74.64	33.93	61.07	6.79	6.79	0.00	27.14	0.00
skin, fetal, donor1	10065-101I2	54.92	31.56	27.14	11.36	54.92	14.52	11.36	3.16	13.89	4.42
small cell cervical cancer cell line:HCSC-1	10800-110I8	22.68	23.01	2.33	2.00	2.00	3.67	2.33	1.33	2.67	3.34
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	58.00	3.15	0.63	0.63	2.52	8.20	1.58	0.95	2.52	0.32
small cell lung carcinoma cell line:DMS 144	10841-111E4	0.00	0.96	0.00	0.39	0.39	0.00	1.16	0.39	2.89	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	43.18	21.10	8.24	10.55	13.68	8.57	7.58	2.64	7.58	3.13
small cell lung carcinoma cell line:NCI-H82	10842-111E5	39.41	0.97	0.00	0.00	0.16	6.59	1.13	0.16	0.97	0.16
small cell lung carcinoma cell line:WA-hT	10562-108A4	46.42	17.43	1.74	1.09	0.87	12.64	1.31	0.00	0.87	2.83
small intestine, adult, pool1	10024-101D6	221.21	24.37	20.90	11.23	58.53	62.11	10.51	5.14	8.60	4.90
small intestine, fetal, donor1	10064-101I1	127.02	13.51	5.16	3.44	16.71	21.13	12.04	1.97	6.39	0.98
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	29.24	2.56	6.15	1.54	0.51	10.26	3.59	0.00	1.03	0.00
smooth muscle, adult, pool1	10048-101G3	56.86	43.94	33.60	4.91	8.27	5.43	1.29	10.86	8.53	14.73
somatostatinoma cell line:QGP-1	10781-110G7	261.05	9.38	1.07	1.34	2.68	40.74	3.75	3.75	4.56	0.27
spinal cord - adult, donor10196	10181-103D1	104.61	14.91	9.64	5.05	3.44	12.39	3.67	1.84	2.98	2.75
spinal cord, adult, donor10252	10159-103A6	59.93	29.18	7.10	3.94	1.58	9.07	2.37	5.52	2.37	3.94
spinal cord, adult, donor10258	10369-105F9	60.19	13.14	2.08	2.08	4.15	3.46	0.69	3.46	8.99	2.08
spinal cord, fetal, donor1	10056-101H2	32.93	13.42	11.59	3.05	1.83	3.05	0.61	1.22	4.27	3.05
spinal cord, newborn, donor10223	10359-105E8	56.94	9.64	5.97	1.38	3.67	10.10	2.30	7.81	7.81	4.13
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	38.38	34.50	55.56	15.08	10.75	11.35	5.68	4.33	3.58	4.78
spleen, adult, pool1	10025-101D7	33.04	42.18	12.22	14.32	0.88	9.03	2.53	3.41	5.62	3.52
spleen, fetal, pool1	10044-101F8	22.01	24.23	5.88	8.18	0.64	5.01	0.72	2.15	3.42	1.99
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	0.21	23.81	0.41	3.52	1.76	0.00	8.49	0.72	0.31	1.14
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	87.34	41.96	11.20	17.47	9.49	14.24	7.03	3.04	1.33	2.66
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	24.46	52.77	14.33	11.18	45.78	6.29	24.81	13.28	8.04	11.53
squamous cell carcinoma cell line:T3M-5	10616-108G4	310.01	27.76	15.64	13.68	40.27	107.90	14.46	5.86	5.47	3.52
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	126.97	15.98	20.15	8.22	17.33	57.74	4.50	6.98	3.15	4.95
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	11.44	2.54	0.42	0.85	2.97	0.85	2.12	2.12	1.27	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	20.73	21.58	44.00	16.08	3.38	3.81	4.65	1.27	3.81	3.38
stomach, fetal, donor1	10062-101H8	123.88	34.18	34.18	13.88	39.52	25.63	14.95	5.34	6.41	6.41
submaxillary gland, adult	10202-103F4	47.28	18.80	6.27	3.99	8.55	3.99	0.00	5.13	6.27	2.28
substantia nigra - adult, donor10196	10178-103C7	271.37	0.00	54.27	0.00	54.27	54.27	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	59.40	21.60	6.02	2.91	2.49	6.23	1.04	3.74	2.91	2.91
substantia nigra, adult, donor10258	10371-105G2	65.17	1.03	1.03	1.03	0.52	4.14	0.52	0.52	1.55	0.00
substantia nigra, newborn, donor10223	10358-105E7	38.16	4.24	7.07	1.41	2.12	6.36	0.71	2.12	4.24	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	42.64	3.21	0.92	0.23	5.50	7.80	7.80	0.23	2.06	0.00
temporal lobe, adult, pool1	10031-101E4	21.45	5.09	2.12	1.19	0.85	2.03	0.85	0.68	2.20	1.36
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	6.41	4.27	7.83	2.85	0.00	1.42	0.71	0.00	3.56	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	3.52	4.40	4.40	3.08	0.44	1.32	0.44	0.00	5.71	0.44
tenocyte, donor1	11763-123H8	9.08	33.16	52.02	9.43	7.33	2.44	7.33	2.44	1.40	1.40
tenocyte, donor2	11765-123I1	11.45	24.03	40.82	13.73	2.29	1.53	0.76	2.29	0.76	2.29
tenocyte, donor3	11768-123I4	11.86	25.58	20.02	7.78	5.19	3.71	2.97	1.48	2.22	2.97
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	26.17	9.01	1.87	0.17	2.89	8.50	3.57	0.85	1.02	1.19
teratocarcinoma cell line:NCR-G1	10798-110I6	4.47	7.09	0.92	0.92	0.62	0.31	0.31	0.00	0.15	0.77
teratocarcinoma cell line:PA-1	10807-111A6	17.67	15.81	4.80	0.93	2.63	4.96	4.49	0.46	0.15	1.24
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	7.74	4.19	0.89	0.76	2.54	2.67	1.40	0.13	1.02	0.38
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	16.26	1.13	0.38	0.00	0.00	3.03	0.00	0.00	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	26.72	2.94	1.53	1.20	2.51	7.96	0.44	0.11	0.33	0.11
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	2.61	0.00	0.00	0.33	0.00	3.26	0.00	0.00	0.00	0.00
testis, adult, pool1	10026-101D8	46.92	30.71	12.78	10.63	6.12	9.13	1.93	4.51	5.91	7.30
testis, adult, pool2	10096-102C6	39.24	25.71	1.80	3.16	1.80	4.96	2.26	0.90	6.32	4.96
thalamus - adult, donor10196	10168-103B6	79.49	8.83	6.62	2.21	1.10	6.62	0.00	5.52	4.42	1.10
thalamus, adult, donor10252	10154-103A1	72.67	20.94	7.35	2.81	2.97	11.25	1.72	3.28	3.59	2.66
thalamus, adult, donor10258, tech_rep1	10370-105G1	63.12	3.08	1.54	0.00	3.08	1.54	1.54	0.00	6.16	1.54
thalamus, adult, donor10258, tech_rep2	10370-105G1	49.41	4.28	1.81	0.82	0.66	3.46	0.49	0.33	1.32	0.82
thalamus, newborn, donor10223	10366-105F6	42.00	5.75	4.03	0.00	2.88	6.33	0.58	0.58	6.90	0.00
throat, adult	10209-103G2	90.38	31.21	82.64	25.97	41.69	20.72	6.99	4.99	9.49	6.74
throat, fetal, donor1	10061-101H7	59.11	29.86	25.60	8.23	5.48	7.92	2.44	0.91	5.48	4.88
thymic carcinoma cell line:Ty-82	10803-111A2	22.06	0.60	5.76	0.40	25.04	3.38	3.97	0.00	1.39	0.00
thymus, adult, pool1	10027-101D9	9.25	27.24	4.18	8.05	3.58	1.99	3.18	1.09	7.85	0.40
thymus, fetal, pool1	10043-101F7	21.72	22.34	5.20	7.07	3.95	5.30	4.26	1.25	8.31	1.45
thyroid carcinoma cell line:KHM-5M	10776-110G2	21.54	40.29	6.38	15.96	3.86	11.17	4.52	4.12	2.93	4.79
thyroid carcinoma cell line:TCO-1	10783-110G9	34.22	32.27	13.97	8.66	6.29	16.90	6.57	4.33	3.91	6.01
thyroid, adult, pool1	10028-101E1	90.89	29.30	10.54	5.23	8.30	17.82	4.85	2.24	1.40	5.51
thyroid, fetal, donor1	10060-101H6	70.93	24.78	28.48	6.59	3.95	8.70	1.85	0.26	1.85	2.11
tongue epidermis (fungiform papillae), donor1	10288-104F9	267.93	76.99	83.15	33.88	46.19	36.96	3.08	9.24	9.24	24.64
tongue, adult	10203-103F5	110.01	34.65	18.37	14.65	43.26	18.14	8.37	6.05	8.37	6.98
tongue, fetal, donor1	10059-101H5	149.36	25.62	22.46	9.85	24.04	20.10	5.91	3.55	6.31	4.34
tonsil, adult, pool1	10047-101G2	60.01	55.50	22.64	20.74	42.37	18.53	8.41	6.51	6.81	5.31
trachea, adult, pool1	10029-101E2	62.17	39.02	38.94	19.39	20.61	17.75	7.20	8.75	7.53	8.10
trachea, fetal, donor1	10058-101H4	62.32	19.62	19.62	5.77	18.08	15.39	3.08	4.23	5.77	2.69
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	27.28	20.19	40.03	13.11	8.86	3.19	6.73	3.54	1.42	3.90
transitional-cell carcinoma cell line:5637	10418-106C4	39.31	17.93	8.21	6.18	11.75	18.24	5.67	2.03	1.72	2.84
transitional-cell carcinoma cell line:JMSU1	10492-107B6	40.27	47.32	3.76	12.85	3.13	13.01	4.07	1.41	1.25	5.64
tridermal teratoma cell line:HGRT	10694-109G1	135.08	41.86	49.47	34.25	34.25	15.22	24.73	13.32	9.51	1.90
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	43.85	20.49	21.84	16.42	6.26	8.97	4.06	2.20	1.02	2.45
umbilical cord, fetal, donor1	10057-101H3	39.64	31.30	18.78	4.17	10.43	18.78	2.09	0.00	8.35	2.09
uterus, adult, pool1	10100-102D1	39.76	32.08	22.01	11.94	11.77	7.17	3.92	8.70	13.48	9.04
uterus, fetal, donor1	10055-101H1	55.80	24.57	13.82	7.68	36.35	13.82	6.66	5.12	5.63	2.56
vagina, adult	10204-103F6	56.87	26.49	54.28	16.15	16.80	10.34	3.23	23.26	7.11	5.17
vein, adult	10191-103E2	24.77	32.66	27.84	16.88	3.73	3.73	3.95	1.97	6.58	3.07
xeroderma pigentosum b cell line:XPL 17	10563-108A5	13.35	26.97	0.80	9.08	0.53	1.34	2.40	0.53	0.53	1.07